,Start Date,Start Price,End Date,End Price,Weekly Returns,Bin Label,News,Basics
0,2023-01-08,115.81999969482422,2023-01-15,108.47000122070312,-0.06346052921332856,D5+,[],"{""assetTurnoverTTM"": 0.566, ""bookValue"": 2131.8, ""cashRatio"": 0.3492089381830044, ""currentRatio"": 1.9947, ""ebitPerShare"": 0.2944, ""eps"": 0.2155, ""ev"": 45127.5, ""fcfMargin"": 0.0846, ""fcfPerShareTTM"": 0.7888, ""grossMargin"": 0.6811, ""inventoryTurnoverTTM"": 3.0506, ""longtermDebtTotalAsset"": 0.2221, ""longtermDebtTotalCapital"": 0.2878, ""longtermDebtTotalEquity"": 0.5618, ""netDebtToTotalCapital"": 0.3334, ""netDebtToTotalEquity"": 0.6509, ""netMargin"": 0.1126, ""operatingMargin"": 0.1538, ""pb"": 20.5178, ""peTTM"": 128.1943, ""pfcfTTM"": 130.45, ""pretaxMargin"": 0.1634, ""psTTM"": 15.0319, ""ptbv"": 22.3334, ""quickRatio"": 1.7232, ""receivablesTurnoverTTM"": 4.7406, ""roaTTM"": 0.0664, ""roeTTM"": 0.1624, ""roicTTM"": 0.0826, ""rotcTTM"": 0.0947, ""salesPerShare"": 1.9136, ""sgaToSale"": 0.3189, ""tangibleBookValue"": 1958.5, ""totalDebtToEquity"": 0.9522, ""totalDebtToTotalAsset"": 0.3765, ""totalDebtToTotalCapital"": 0.4878, ""totalRatio"": 1.6539, ""period"": ""2022-12-31""}"
1,2023-01-15,108.47000122070312,2023-01-22,107.86000061035156,-0.005623680312406343,D1,[],"{""assetTurnoverTTM"": 0.566, ""bookValue"": 2131.8, ""cashRatio"": 0.3492089381830044, ""currentRatio"": 1.9947, ""ebitPerShare"": 0.2944, ""eps"": 0.2155, ""ev"": 45127.5, ""fcfMargin"": 0.0846, ""fcfPerShareTTM"": 0.7888, ""grossMargin"": 0.6811, ""inventoryTurnoverTTM"": 3.0506, ""longtermDebtTotalAsset"": 0.2221, ""longtermDebtTotalCapital"": 0.2878, ""longtermDebtTotalEquity"": 0.5618, ""netDebtToTotalCapital"": 0.3334, ""netDebtToTotalEquity"": 0.6509, ""netMargin"": 0.1126, ""operatingMargin"": 0.1538, ""pb"": 20.5178, ""peTTM"": 128.1943, ""pfcfTTM"": 130.45, ""pretaxMargin"": 0.1634, ""psTTM"": 15.0319, ""ptbv"": 22.3334, ""quickRatio"": 1.7232, ""receivablesTurnoverTTM"": 4.7406, ""roaTTM"": 0.0664, ""roeTTM"": 0.1624, ""roicTTM"": 0.0826, ""rotcTTM"": 0.0947, ""salesPerShare"": 1.9136, ""sgaToSale"": 0.3189, ""tangibleBookValue"": 1958.5, ""totalDebtToEquity"": 0.9522, ""totalDebtToTotalAsset"": 0.3765, ""totalDebtToTotalCapital"": 0.4878, ""totalRatio"": 1.6539, ""period"": ""2022-12-31""}"
2,2023-01-22,107.86000061035156,2023-01-29,106.72000122070312,-0.010569250724990487,D2,[],{}
3,2023-01-29,106.72000122070312,2023-02-05,108.43000030517578,0.016023229618750356,U2,"[{""date"": ""2023-01-29"", ""headline"": ""Tracking Baillie Gifford's 13F Portfolio - Q4 2022 Update"", ""summary"": ""Baillie Gifford\u00e2\u0080\u0099s 13F portfolio value decreased from ~$96.99B to ~$95.96B this quarter. Click here for a detailed analysis.""}, {""date"": ""2023-01-30"", ""headline"": ""Op-ed: Keep an eye on medical technology and alternative energy sectors"", ""summary"": ""Investors should keep a close eye on stocks in the medical technology and alternative energy sectors. By contrast, consumer staples may be in for a struggle.""}, {""date"": ""2023-02-02"", ""headline"": ""DexCom (DXCM) Gains But Lags Market: What You Should Know"", ""summary"": ""DexCom (DXCM) closed the most recent trading day at $108.03, moving +0.3% from the previous trading session.""}, {""date"": ""2023-02-03"", ""headline"": ""2 Unstoppable Growth Stocks to Buy in 2023 and Beyond"", ""summary"": ""Last year's bear market made many victims among even the most prominent corporations although growth stocks fared even worse than other categories of equities.  Among this small group of outperformers are two healthcare leaders: biotech giant Vertex Pharmaceuticals (NASDAQ: VRTX) and medical device expert DexCom (NASDAQ: DXCM).  Let's consider why Vertex Pharmaceuticals and DexCom are excellent stocks to buy.""}]",{}
4,2023-02-05,108.43000030517578,2023-02-12,117.88999938964844,0.08724521864656953,U5+,"[{""date"": ""2023-02-06"", ""headline"": ""DexCom (DXCM) to Report Q4 Earnings: What's in the Cards?"", ""summary"": ""DexCom's (DXCM) fourth-quarter results are likely to reflect rising global awareness of its real-time CGM.""}, {""date"": ""2023-02-07"", ""headline"": ""Notable earnings after Thursday`s close"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-07"", ""headline"": ""DexCom Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-07"", ""headline"": ""2 Stock-Split Stocks to Buy Without Hesitation in 2023"", ""summary"": ""While stock splits aren't value-creating vehicles per se, these events can allow more investors access to stocks that otherwise have risen to such steep prices that buying even one or two shares may be out of reach.  There were several well-known stock splits that took place in 2022, and the current market environment has discounted some of these companies even further.  If you're bargain-hunting for wonderful businesses that fit this bill in the 2023 market environment, here are two recent stock-split stocks that are primed to deliver sustainable growth for investors in the next decade and beyond.""}, {""date"": ""2023-02-08"", ""headline"": ""DexCom up 4% in after-hours trading on quarterly bottom line beat"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-08"", ""headline"": ""DexCom Inc. stock falls Thursday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-08"", ""headline"": ""DexCom Non-GAAP EPS of $0.34 beats by $0.06, revenue of $815.2M in-line"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-08"", ""headline"": ""DexCom sees FY23 revenue of $3.35B-$3.49B, consensus $3.47B"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-08"", ""headline"": ""DexCom reports Q4 EPS 22c, consensus 27c"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-08"", ""headline"": ""DexCom options imply 6.0% move in share price post-earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-08"", ""headline"": ""GLOBAL BRIEFING: US \""not looking for conflict\"" with China, says Biden"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-08"", ""headline"": ""Will Ferrell, Alicia Silverstone star in Super Bowl ads"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-08"", ""headline"": ""DarioHealth announces agreement with DexCom"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-08"", ""headline"": ""Top 5 4th Quarter Trades of JAG CAPITAL MANAGEMENT, LLC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-09"", ""headline"": ""DexCom Inc. stock rises Friday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-09"", ""headline"": ""What You Missed On Wall Street On Friday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-09"", ""headline"": ""DexCom (DXCM) Q4 2022 Earnings Call Transcript"", ""summary"": ""Image source: The Motley Fool.  DexCom\u00a0(NASDAQ: DXCM)Q4\u00a02022 Earnings CallFeb 09, 2023, 4:30 p.m. ETContents:  Prepared Remarks Questions and Answers Call Participants  Prepared Remarks:  OperatorLadies and gentlemen, welcome to the Dexcom fourth quarter 2022 earnings release conference call.""}, {""date"": ""2023-02-09"", ""headline"": ""Hot Stocks: SPOT climbs on activist interest; DXCM, AYX rise on earnings; MGA drops"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-09"", ""headline"": ""DexCom (DXCM) Tops Q4 Earnings and Revenue Estimates"", ""summary"": ""DexCom (DXCM) delivered earnings and revenue surprises of 30.77% and 0.02%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?""}, {""date"": ""2023-02-09"", ""headline"": ""DexCom, Inc. (DXCM) Q4 2022 Earnings Call Transcript"", ""summary"": ""DexCom, Inc. (NASDAQ:NASDAQ:DXCM) Q4 2022 Earnings Conference Call February 9, 2023 4:30 PM ETCompany ParticipantsSean Christensen - Vice President of Finance & Investor RelationsJereme...""}, {""date"": ""2023-02-09"", ""headline"": ""Dexcom Reports Fourth Quarter and Fiscal Year 2022 Financial Results"", ""summary"": ""SAN DIEGO, February 09, 2023--Dexcom Reports Fourth Quarter and Fiscal Year 2022 Financial Results""}, {""date"": ""2023-02-09"", ""headline"": ""DexCom looks forward to G7 system launch after 2022 profit jump"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-09"", ""headline"": ""DexCom: Q4 Earnings Snapshot"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-09"", ""headline"": ""Notable companies reporting after market close"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-09"", ""headline"": ""Dexcom (DXCM) Receives a Buy from BTIG"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-09"", ""headline"": ""Fly Intel: After-Hours Movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-10"", ""headline"": ""Cramer's lightning round: Triton International is not a buy"", ""summary"": ""\""Mad Money\"" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.""}, {""date"": ""2023-02-10"", ""headline"": ""IBD Stock Of The Day Dexcom Bounds Off A New Entry After Topping Bullish Calls"", ""summary"": ""Dexcom stock is Friday's IBD Stock Of The Day. Shares are bounding off their 50-day line after the diabetes devices giant beat views.""}, {""date"": ""2023-02-10"", ""headline"": ""NEW YORK MARKET CLOSE: Tech shares struggle but Dow and S&P rise"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-10"", ""headline"": ""PayPal, DexCom rise; Expedia, Lyft fall"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-10"", ""headline"": ""Dexcom, A Top 10% Profit Machine, Just Reported Skyrocketing Earnings"", ""summary"": ""Dexcom stock rose Friday after beating fourth-quarter sales and earnings expectations and reiterating its 2023 sales outlook.""}, {""date"": ""2023-02-10"", ""headline"": ""DexCom (DXCM) Q4 Earnings Beat Estimates, Volumes Remain Strong"", ""summary"": ""DexCom's (DXCM) fourth-quarter results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system.""}, {""date"": ""2023-02-10"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-10"", ""headline"": ""DexCom continues earnings boost as it prepares to launch new glucose device; up 10%"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-10"", ""headline"": ""John Travolta, Adam Driver star in Super Bowl ads"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-10"", ""headline"": ""Hillstream, Lixte top healthcare gainers; Phathom, Sensus lead losers` pack"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-10"", ""headline"": ""Early notable gainers among liquid option names on February 10th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-10"", ""headline"": ""Stocks making the biggest premarket moves: Lyft, Expedia, Yelp and more"", ""summary"": ""These are the stocks posting the largest moves in the premarket.""}, {""date"": ""2023-02-10"", ""headline"": ""DexCom price target raised to $125 from $114 at Cowen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-10"", ""headline"": ""Lyft, DexCom, Expedia, Spotify, and More of Today\u2019s Stock Market Movers"", ""summary"": ""Lyft issues a first-quarter revenue forecast below analysts' expectations; Spotify rises after ValueAct Capital Management secures a stake in the...""}, {""date"": ""2023-02-11"", ""headline"": ""DexCom Full Year 2022 Earnings: EPS Misses Expectations"", ""summary"": ""DexCom ( NASDAQ:DXCM ) Full Year 2022 Results Key Financial Results Revenue: US$2.91b (up 19% from FY 2021). Net...""}, {""date"": ""2023-02-11"", ""headline"": ""Wall Street Breakfast: What Moved Markets"", ""summary"": ""Listen on the go! A daily podcast of Wall Street Breakfast will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify.""}, {""date"": ""2023-02-11"", ""headline"": ""Super Bowl spotlight will include Apple, DraftKings, GM and Diageo"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-12"", ""headline"": ""Doja Cat, John Travolta, Ben Affleck star in Super Bowl ads"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-12"", ""headline"": ""Barclays Remains a Hold on Dexcom (DXCM)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
5,2023-02-12,117.88999938964844,2023-02-19,114.76000213623047,-0.026550150730536015,D3,"[{""date"": ""2023-02-12"", ""headline"": ""Doja Cat, John Travolta, Ben Affleck star in Super Bowl ads"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-12"", ""headline"": ""Barclays Remains a Hold on Dexcom (DXCM)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-13"", ""headline"": ""Dow Jones Leader Salesforce Headlines 4 Stocks In Or Near Buy Zone"", ""summary"": ""Dow Jones software titan Salesforce is one of the top stocks to buy and watch in today's stock market rally. CRM stock neared a new entry.""}, {""date"": ""2023-02-13"", ""headline"": ""DexCom Inc. stock rises Monday, still underperforms market"", ""summary"": ""Shares of DexCom Inc. inched 0.33% higher to $118.28 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""2023-02-13"", ""headline"": ""2 Growth Stocks That Could Help Make You a Fortune"", ""summary"": ""Looking beyond share price, you don't have to search hard to find compelling businesses with abundant growth opportunities that boast strong financials to boot.  DexCom (NASDAQ: DXCM) is one of the world's leading developers and manufacturers of continuous glucose monitoring (CGM) devices, which help people monitor and manage their blood sugar levels.  While primarily used by the type 1 diabetes population, and increasingly, those with type 2 diabetes, there could be use cases for these products in individuals with prediabetes as well.""}, {""date"": ""2023-02-13"", ""headline"": ""2 Top Healthcare Stocks to Buy for the Long Haul"", ""summary"": ""The healthcare industry is booming, and this presents no shortage of opportunities to invest in promising businesses.""}, {""date"": ""2023-02-13"", ""headline"": ""Dexcom G7 Continuous Glucose Monitoring System Will Be Available to Medicare Beneficiaries at Launch"", ""summary"": ""SAN DIEGO, February 13, 2023--Dexcom G7 Continuous Glucose Monitoring System Will be Available to Medicare Beneficiaries at Launch""}, {""date"": ""2023-02-13"", ""headline"": ""Robert W. Baird Keeps Their Buy Rating on Dexcom (DXCM)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-13"", ""headline"": ""DexCom`s G7 receives CMS approval, says Piper Sandler"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-13"", ""headline"": ""DexCom: G7 CGM System to be covered for Medicare beneficiaries"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-13"", ""headline"": ""DexCom price target raised to $110 from $103 at Barclays"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-14"", ""headline"": ""DexCom Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of DexCom Inc. inched 0.23% higher to $118.55 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-02-14"", ""headline"": ""June 2024 Options Now Available For DexCom (DXCM)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-14"", ""headline"": ""Top 5 4th Quarter Trades of Atika Capital Management LLC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-15"", ""headline"": ""DexCom Inc. stock rises Wednesday, outperforms market"", ""summary"": ""Shares of DexCom Inc. advanced 1.37% to $120.17 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""2023-02-16"", ""headline"": ""DexCom Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of DexCom Inc. slid 2.42% to $117.26 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-02-16"", ""headline"": ""DexCom: Multiple Catalyst In FY 2023"", ""summary"": ""DexCom has implemented a bridge program for early adopters and is making steady progress toward its goal of G7 coverage. Click here to read why DXCM stock is a Buy.""}, {""date"": ""2023-02-17"", ""headline"": ""The Week On Wall Street - Economic Purgatory"", ""summary"": ""Except for Jobs, economic data dictates the economy is in a state of contraction, while Inflation remains sticky. Read more here.""}, {""date"": ""2023-02-17"", ""headline"": ""DexCom Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of DexCom Inc. slid 2.13% to $114.76 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2023-02-17"", ""headline"": ""Does DexCom (DXCM) Have a Long Runway for Growth?"", ""summary"": ""Baron Funds, an investment management company, released its \u201cBaron Small Cap Fund\u201d fourth-quarter 2022 investor letter. A copy of the same can be downloaded here. The fund was 4.24% up in the fourth quarter compared to a 4.13% return for the Russell 2000 Growth Index and a 7.56% return for the S&P 500 Index. For 2022, [\u2026]""}, {""date"": ""2023-02-18"", ""headline"": ""Deere Leads 5 Stocks With Hot Products Near Buy Points"", ""summary"": ""Deere, fresh off Friday's strong earnings move, leads this weekend's watch list of 5 stocks near buy points.""}, {""date"": ""2023-02-19"", ""headline"": ""2 No-Brainer Growth Stocks to Buy Right Now"", ""summary"": ""Vertex Pharmaceuticals (NASDAQ: VRTX) has amassed a profitable and high-revenue growth business around a relatively small portfolio of drugs.  While the addressable market for Vertex's existing portfolio of cystic fibrosis drugs is massive -- management estimates that as many as 20,000 people globally could benefit from the company's products but are not yet taking them -- and additional indications for these drugs are expanding its patient population, the company is looking to new sources of growth.  It currently has an impressive pipeline of products spanning disease areas ranging from rare blood disorders to type 1 diabetes to acute pain.""}, {""date"": ""2023-02-19"", ""headline"": ""2 Healthcare Stocks You Can Buy and Hold for the Next Decade"", ""summary"": ""From medical devices to life-saving medicines and treatments, there's a simple reason why healthcare companies perform well against a wide range of economic backdrops and market environments.  Not only are the best healthcare stocks known for their steady growth in a variety of markets, but these businesses can present a tempting buying proposition for long-term investors.  If you're looking to add more healthcare stocks to your buy basket this month, here are two no-brainer choices to consider when you do.""}]",{}
6,2023-02-19,114.76000213623047,2023-02-26,110.08999633789062,-0.040693671239184215,D5,"[{""date"": ""2023-02-19"", ""headline"": ""2 No-Brainer Growth Stocks to Buy Right Now"", ""summary"": ""Vertex Pharmaceuticals (NASDAQ: VRTX) has amassed a profitable and high-revenue growth business around a relatively small portfolio of drugs.  While the addressable market for Vertex's existing portfolio of cystic fibrosis drugs is massive -- management estimates that as many as 20,000 people globally could benefit from the company's products but are not yet taking them -- and additional indications for these drugs are expanding its patient population, the company is looking to new sources of growth.  It currently has an impressive pipeline of products spanning disease areas ranging from rare blood disorders to type 1 diabetes to acute pain.""}, {""date"": ""2023-02-19"", ""headline"": ""2 Healthcare Stocks You Can Buy and Hold for the Next Decade"", ""summary"": ""From medical devices to life-saving medicines and treatments, there's a simple reason why healthcare companies perform well against a wide range of economic backdrops and market environments.  Not only are the best healthcare stocks known for their steady growth in a variety of markets, but these businesses can present a tempting buying proposition for long-term investors.  If you're looking to add more healthcare stocks to your buy basket this month, here are two no-brainer choices to consider when you do.""}, {""date"": ""2023-02-20"", ""headline"": ""Why Investors Need to Take Advantage of These 2 Medical Stocks Now"", ""summary"": ""Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.""}, {""date"": ""2023-02-20"", ""headline"": ""2 Exceptional Growth Stocks Billionaires Keep Buying With Both Hands"", ""summary"": ""A poor performance from the broad market didn't stop these billionaire hedge fund managers from placing big bets on three supercharged growth stocks.""}, {""date"": ""2023-02-21"", ""headline"": ""Dexcom G6 Continuous Glucose Monitoring System Launches in Singapore"", ""summary"": ""SINGAPORE, February 22, 2023--Dexcom, Inc. (NASDAQ:DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today the launch of its Dexcom G6 CGM System in Singapore for people with diabetes ages two years and older, including pregnant women, and the appointment of DKSH Singapore Pte Ltd as sales, marketing, and distribution service provider.""}, {""date"": ""2023-02-21"", ""headline"": ""DexCom selloff on Apple article should be bought, says Oppenheimer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-21"", ""headline"": ""Baird points to elements of Apple report making it `less worried` about DexCom"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-21"", ""headline"": ""DexCom Inc. stock falls Tuesday, still outperforms market"", ""summary"": ""Shares of DexCom Inc. sank 0.65% to $114.01 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-02-21"", ""headline"": ""3 Healthcare Stocks to Buy and Hold for the Next 10 Years"", ""summary"": ""The healthcare industry has long proven itself to be a resilient place for investors to park their cash.  Vertex Pharmaceuticals (NASDAQ: VRTX) has continued to report explosive financial growth from its core portfolio of products, all while expanding its pipeline into new disease areas ripe for disruption.  It's delivered a total return of 24% over the past year, compared to the S&P 500's negative return of 7% in that same period.""}, {""date"": ""2023-02-22"", ""headline"": ""Dexcom Slumps As A New Rival Reportedly Arrives On Scene: Apple"", ""summary"": ""Dexcom stock slumped Wednesday on a report Apple is working to add a blood glucose monitor to its popular Apple Watch.""}, {""date"": ""2023-02-22"", ""headline"": ""Dexcom drops on report that Apple has made glucose tracking breakthrough"", ""summary"": ""A new breakthrough by Apple could be bad news for medical device company Dexcom. With CNBC's Melissa Lee and the Fast Money traders, Karen Finerman, Dan Nathan, Courtney Garcia and Guy Adami.""}, {""date"": ""2023-02-22"", ""headline"": ""Health Care Down Slightly as Apple, Amazon Step Up Health Efforts -- Health Care Roundup"", ""summary"": ""Health-care companies fell slightly as competition from Silicon Valley mounted. Shares of medical-device maker Dexcom fell after reports that Apple may add a...""}, {""date"": ""2023-02-22"", ""headline"": ""DexCom Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of DexCom Inc. slipped 2.07% to $111.65 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-02-22"", ""headline"": ""Apple nears bid to shake up glucose monitoring market \ufffd\ufffd\ufffd Bloomberg"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-22"", ""headline"": ""Diabetes management stocks slide on report of tech giant`s breakthroughs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-22"", ""headline"": ""Apple hits breakthroughs in glucose monitoring project, Bloomberg reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-22"", ""headline"": ""Dexcom Showcases Accuracy, Simplicity and Connectivity of Its CGM Portfolio at ATTD Conference as Access to CGM Expands Globally"", ""summary"": ""SAN DIEGO, February 22, 2023--Dexcom Showcases Accuracy, Simplicity and Connectivity of its CGM Portfolio at ATTD Conference as Access to CGM Expands Globally""}, {""date"": ""2023-02-23"", ""headline"": ""DexCom Inc. stock rises Thursday, still underperforms market"", ""summary"": ""Shares of DexCom Inc. inched 0.20% higher to $111.87 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the...""}, {""date"": ""2023-02-23"", ""headline"": ""Becton Dickinson & Co. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Becton Dickinson & Co. shed 0.28% to $239.72 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the...""}, {""date"": ""2023-02-23"", ""headline"": ""Dexcom Announces Upcoming Conference Presentations"", ""summary"": ""SAN DIEGO, February 23, 2023--DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming investor conferences:""}, {""date"": ""2023-02-23"", ""headline"": ""Frank Sands` Top 4th-Quarter Trades"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-24"", ""headline"": ""Baron Small Cap Fund Q4 2022 Quarterly Letter"", ""summary"": ""Baron Small Cap Fund (the \u00e2\u0080\u009cFund\u00e2\u0080\u009d) was up 4.24% (Institutional Shares) in the fourth quarter of 2022. Click here to read the full fund letter.""}, {""date"": ""2023-02-24"", ""headline"": ""DexCom Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of DexCom Inc. slid 1.59% to $110.09 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-02-24"", ""headline"": ""Becton Dickinson & Co. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Becton Dickinson & Co. dropped 0.75% to $237.92 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P...""}, {""date"": ""2023-02-24"", ""headline"": ""Better Buy: Abbott Laboratories or DexCom Stock?"", ""summary"": ""According to MarketStudyReport, a market research firm,  the global diabetes care devices market was $23.3 billion in 2022 and is projected to reach $32.7 billion by 2028, representing a compound annual growth rate of 4.95% over this period.  Abbott Laboratories (NYSE: ABT) and DexCom (NASDAQ: DXCM) are both poised to benefit from increased spending on diabetes care devices as they manufacture continuous glucose monitoring devices used by diabetes patients.  Abbott Laboratories stock is down over 4% in 2023 and more than 10% over the past 12 months.""}, {""date"": ""2023-02-24"", ""headline"": ""2 Stock-Split Stocks with Explosive Potential to Buy in 2023"", ""summary"": ""Stock splits don't actually do anything to augment the values of the companies that perform them, but they can make a stock that has reached a particularly bloated price more accessible to the average investor again.  2022 saw its fair share of stock splits from large companies across a range of sectors.  Amazon (NASDAQ: AMZN) underwent a 20-for-1 stock split on June 3, 2022.""}, {""date"": ""2023-02-24"", ""headline"": ""Apple: Still Early For The Holy Grail"", ""summary"": ""Apple continues working on turning the Apple Watch into a medical device. Meanwhile, AAPL stock is already priced for a Holy Grail new product. Read more here.""}]",{}
7,2023-02-26,110.08999633789062,2023-03-05,122.91999816894531,0.11654103240839953,U5+,"[{""date"": ""2023-02-27"", ""headline"": ""2 \ufffd\ufffd\ufffdStrong Buy\ufffd\ufffd\ufffd Stocks That Billionaire Israel Englander Is Making Huge Bets On"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-27"", ""headline"": ""Start Putting Together Your Shopping List For Beaten-Down Tech Stocks"", ""summary"": ""Put together a stock shopping list. You have time to understand the stocks you are investing in.""}, {""date"": ""2023-02-27"", ""headline"": ""Becton Dickinson & Co. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Becton Dickinson & Co. slumped 0.43% to $236.89 Monday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""2023-02-28"", ""headline"": ""2 \u201cStrong Buy\u201d Stocks That Billionaire Israel Englander Is Making Huge Bets On"", ""summary"": ""After the year\u2019s early rally appeared to hit a brick wall in recent times, the markets seem uncertain which direction to take next, making the seesawing conditions not easy for investors to navigate. Against such a backdrop, maybe the best solution for investors is to follow in the footsteps of legendary Wall Street names - ones like Israel Englander. The Millennium Management Chairman and CEO founded the hedge fund in 1989 with $35 million and now the firm is an almost $53 billion going concern""}, {""date"": ""2023-02-28"", ""headline"": ""Becton Dickinson & Co. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. dropped 0.99% to $234.55 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P...""}, {""date"": ""2023-02-28"", ""headline"": ""Should Abbott and DexCom Investors Be Worried About Apple's Latest News?"", ""summary"": ""Abbott Laboratories\u00a0(NYSE: ABT) and DexCom (NASDAQ: DXCM) enjoy symbiotic relationships with Apple (NASDAQ: AAPL).  The two companies' popular continuous glucose monitoring (CGM) devices used by many patients with diabetes connect to iPhones and Apple Watches.  Bloomberg reported last week about one of Apple's major development efforts.""}, {""date"": ""2023-02-28"", ""headline"": ""What Do Sanofi And Dexcom See In DarioHealth That The Market Is Missing?"", ""summary"": ""DarioHealth (NASDAQ: DRIO) Partners With Dexcom (NASDAQ: DXCM) The Global Leader in Continuous Glucose Monitoring (CGM) To Integrate Dario's Multi-Chronic Condition Platform.""}, {""date"": ""2023-02-28"", ""headline"": ""Billionaire Israel Englander Is Making Huge Bets on These 2 \ufffd\ufffd\ufffdStrong Buy` Stocks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-01"", ""headline"": ""DexCom rises as Medicare updates coverage for continuous glucose monitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-01"", ""headline"": ""DexCom Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of DexCom Inc. slid 0.23% to $110.76 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2023-03-02"", ""headline"": ""Dexcom Nears Breakout On A Surprise Medicare Decision For Its Devices"", ""summary"": ""Dexcom stock popped Thursday after CMS said it would cover continuous glucose monitors for a broader group of type 2 diabetics.""}, {""date"": ""2023-03-02"", ""headline"": ""DexCom Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of DexCom Inc. advanced 9.46% to $121.24 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-03-02"", ""headline"": ""Where to Invest $1,000 in a 2023 Nasdaq Bear Market"", ""summary"": ""The bear market of the past year has kept investors on their toes.  While stocks across a variety of sectors feel the pain, few have been hit as hard as those on the growth-centric Nasdaq Composite index.  Many of these growth stocks have seen some improvement in 2023.""}, {""date"": ""2023-03-02"", ""headline"": ""Tandem Diabetes: Top-Line Growth Remarkable, Not At 0.04% FCF Yield"", ""summary"": ""Tandem Diabetes achieved remarkable top-line growth coupled with pump shipments. Check out why I rate TNDM stock a Hold at this time.""}, {""date"": ""2023-03-02"", ""headline"": ""Early notable gainers among liquid option names on March 2nd"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-02"", ""headline"": ""DexCom CEO sells $4.23M in common stock"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-03"", ""headline"": ""DexCom (DXCM) Gains But Lags Market: What You Should Know"", ""summary"": ""DexCom (DXCM) closed the most recent trading day at $122.92, moving +1.39% from the previous trading session.""}, {""date"": ""2023-03-03"", ""headline"": ""Here's Why DexCom (NASDAQ:DXCM) Has Caught The Eye Of Investors"", ""summary"": ""It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...""}, {""date"": ""2023-03-03"", ""headline"": ""DexCom Inc. stock rises Friday, still underperforms market"", ""summary"": ""Shares of DexCom Inc. rallied 1.39% to $122.92 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-03-03"", ""headline"": ""1 High-Flying Growth Stock With 19% Upside, According to Wall Street"", ""summary"": ""Medical device specialist DexCom (NASDAQ: DXCM) has been on fire over the past year, significantly outperforming the broader market.  The healthcare company can thank several tailwinds for its performance, including the continued adoption of the technology it has helped pioneer -- continuous glucose monitoring (CGM) -- and the launch of new products.  Should investors follow the Street's advice and buy DexCom's shares?""}, {""date"": ""2023-03-03"", ""headline"": ""Analysts` Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN) and Dexcom (DXCM)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-03"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), Veru (VERU) and Gilead Sciences (GILD)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-03"", ""headline"": ""CMS earlier Basal coverage approval adds confidence for DexCom, says BofA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-03"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Selecta Biosciences (SELB), Dexcom (DXCM) and Zai Lab (ZLAB)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
8,2023-03-05,122.91999816894531,2023-03-12,107.7699966430664,-0.12325090914056347,D5+,"[{""date"": ""2023-03-05"", ""headline"": ""DexCom down more than 7% after FDA gives nod to Abbott CGM sensors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-06"", ""headline"": ""Dexcom Pummeled On A New FDA Clearance For Key Rival Abbott Laboratories"", ""summary"": ""Dexcom stock toppled Monday after the FDA cleared Abbott Laboratories to pair its body-worn glucose monitors with automated insulin pumps.""}, {""date"": ""2023-03-06"", ""headline"": ""DexCom Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of DexCom Inc. shed 7.87% to $113.25 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-03-06"", ""headline"": ""5 Stocks That Powered Nasdaq ETF Last Week"", ""summary"": ""The tech-heavy Nasdaq Composite Index outperformed last week, gaining 2.6%, while the S&P 500 and the Dow Jones were up 1.9% and 1.7%, respectively.""}, {""date"": ""2023-03-06"", ""headline"": ""DexCom slips as Abbott wins FDA nod for CGM integration"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-06"", ""headline"": ""DexCom put volume heavy and directionally bearish"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-06"", ""headline"": ""Video: Nasdaq 100 Movers: DXCM, ENPH"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-06"", ""headline"": ""Video: S&P 500 Movers: DXCM, LUMN"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-07"", ""headline"": ""DexCom Inc. stock rises Tuesday, outperforms market"", ""summary"": ""Shares of DexCom Inc. inched 0.49% higher to $113.81 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P...""}, {""date"": ""2023-03-07"", ""headline"": ""What Makes DexCom (DXCM) an Attractive Investment Bet?"", ""summary"": ""ClearBridge Investments, an investment management company, released its \u201cClearBridge Large Cap Growth Strategy\u201d fourth quarter 2022 investor letter. A copy of the same can be downloaded here. In the fourth quarter, the strategy outperformed its benchmark, the Russell 1000 Growth Index. The strategy gained in seven out of nine sectors it invested in the quarter on [\u2026]""}, {""date"": ""2023-03-07"", ""headline"": ""BofA says buy DexCom on weakness after Abbott`s Libre gets pump integration"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-08"", ""headline"": ""DexCom Inc. stock outperforms market despite losses on the day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-08"", ""headline"": ""DexCom Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of DexCom Inc. dropped 0.94% to $112.74 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-03-08"", ""headline"": ""DexCom pullback on Abbott news a buying opportunity, says Jefferies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-09"", ""headline"": ""DexCom (DXCM) Stock Moves -0.59%: What You Should Know"", ""summary"": ""In the latest trading session, DexCom (DXCM) closed at $112.08, marking a -0.59% move from the previous day.""}, {""date"": ""2023-03-09"", ""headline"": ""2 Top Stocks to Buy in March and Hold Forever"", ""summary"": ""If you're looking for more great stocks to add to your portfolio this month, you don't have to look far to find quality businesses with compelling growth stories.  Provided you have the capital on hand to invest right now that you can put into your portfolio and leave alone for the next few years, even the current choppy waters of the market are still presenting investors with wonderful opportunities to buy great companies.  Here are two names to consider adding to your portfolio in the near future and holding for years.""}, {""date"": ""2023-03-09"", ""headline"": ""Want to Get Richer? 2 Top Stocks to Buy Now and Hold Forever"", ""summary"": ""You don't need to have a lot of cash on hand to start investing in the stock market.  Marketed as 60% smaller than its predecessor, with the fastest warm-up time of any such device on the market, and as part of the most-covered and reimbursed CGM brand commercialized to date, the G7 should be the latest in a long line of strong growth catalysts for DexCom.""}, {""date"": ""2023-03-10"", ""headline"": ""DexCom Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of DexCom Inc. slid 3.85% to $107.77 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-03-12"", ""headline"": ""Silicon Valley Bank signed exclusive banking deals with some clients, leaving them unable to diversify"", ""summary"": ""Silicon Valley Bank required some clients to agree to exclusivity clauses, disabling them from diversifying where they held their money, SEC records show.""}]",{}
9,2023-03-12,107.7699966430664,2023-03-19,113.93000030517578,0.05715879979574723,U5+,"[{""date"": ""2023-03-12"", ""headline"": ""Silicon Valley Bank signed exclusive banking deals with some clients, leaving them unable to diversify"", ""summary"": ""Silicon Valley Bank required some clients to agree to exclusivity clauses, disabling them from diversifying where they held their money, SEC records show.""}, {""date"": ""2023-03-13"", ""headline"": ""DexCom Comments on SVB Relationship"", ""summary"": ""SAN DIEGO, March 13, 2023--DexCom, Inc. (NASDAQ: DXCM), today issued the following statement in response to speculation following the developments at Silicon Valley Bank, including a recent CNBC article:""}, {""date"": ""2023-03-13"", ""headline"": ""DexCom has no material exposure to developments at Silicon Valley Bank"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-15"", ""headline"": ""DexCom (DXCM) Gains As Market Dips: What You Should Know"", ""summary"": ""DexCom (DXCM) closed the most recent trading day at $113.72, moving +0.49% from the previous trading session.""}, {""date"": ""2023-03-15"", ""headline"": ""DexCom: Riding The Growth Wave"", ""summary"": ""DexCom has built itself an impressive market position against large competitors in the diabetes space. Click here to read my most recent analysis of DXCM stock.""}, {""date"": ""2023-03-15"", ""headline"": ""DexCom Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of DexCom Inc. inched 0.49% higher to $113.72 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P...""}, {""date"": ""2023-03-16"", ""headline"": ""DexCom Inc. stock rises Thursday, still underperforms market"", ""summary"": ""Shares of DexCom Inc. inched 0.74% higher to $114.56 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the...""}, {""date"": ""2023-03-16"", ""headline"": ""DexCom Stock Gets A Composite Rating Upgrade After 4 Up Days"", ""summary"": ""The IBD SmartSelect Composite Rating for DexCom rose from 94 to 97 Thursday.  The new score means the company is now outperforming 97% of all stocks in terms of the most important fundamental and technical stock-picking criteria.  DexCom is currently forming a consolidation, with a 125.65 buy point.""}, {""date"": ""2023-03-17"", ""headline"": ""DexCom Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of DexCom Inc. slipped 0.55% to $113.93 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-03-18"", ""headline"": ""Why Nick Jonas is raising awareness for diabetes at SXSW"", ""summary"": ""Superstar recording artist Nick Jonas shares his experience with diabetes and why he's using his platform to improve access to diabetes care. Nick joins Yahoo Finance Senior Reporter Allie Garfinkle from SXSW in Austin, TX to discuss how health technology like continuous glucose monitoring (CGM) is easing the burden of managing diabetes.\u00a0 Watch as Nick opens up about his partnership with DexCom (DXCM), fatherhood, and his struggle with diabetes.""}]",{}
10,2023-03-19,113.93000030517578,2023-03-26,114.08999633789062,0.0014043362791738012,U1,"[{""date"": ""2023-03-20"", ""headline"": ""DexCom Inc. stock rises Monday, outperforms market"", ""summary"": ""Shares of DexCom Inc. rallied 2.88% to $117.21 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-03-20"", ""headline"": ""How to Find Strong Medical Stocks Slated for Positive Earnings Surprises"", ""summary"": ""Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.""}, {""date"": ""2023-03-20"", ""headline"": ""Abbott Labs: Steadily Getting Back To Normal"", ""summary"": ""Abbott has had a crazy couple of years, with a formula recall and a COVID testing boom. Find out why I rate ABT stock a hold.""}, {""date"": ""2023-03-20"", ""headline"": ""Elliott Wave Technical Analysis: DexCom Inc."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-20"", ""headline"": ""Is DexCom (DXCM) Stock Undervalued?"", ""summary"": ""Brown Capital Management, an investment management company, released its \u201cThe Brown Capital Management Mid Company Fund\u201d fourth quarter 2022 investor letter. A copy of the same can be downloaded here. The Mid Company Fund returned 5.43% in the quarter compared to a 6.90% return for the Russell Midcap Growth Index. For the full year, the fund [\u2026]""}, {""date"": ""2023-03-21"", ""headline"": ""DexCom (DXCM) Outpaces Stock Market Gains: What You Should Know"", ""summary"": ""DexCom (DXCM) closed the most recent trading day at $118.98, moving +1.51% from the previous trading session.""}, {""date"": ""2023-03-21"", ""headline"": ""DexCom Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of DexCom Inc. rose 1.51% to $118.98 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-03-21"", ""headline"": ""Manitoba Becomes a Provincial Trailblazer in Providing Simplified Access to Advanced Glucose Monitors"", ""summary"": ""BURNABY, British Columbia, March 21, 2023--Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, announced that its Dexcom G6 CGM System will be available to people of all ages with type 1 and type 2 diabetes in Manitoba who meet eligibility criteria.""}, {""date"": ""2023-03-21"", ""headline"": ""DexCom announces expanded coverage for G6 CGM System in Manitoba"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-22"", ""headline"": ""DexCom Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-22"", ""headline"": ""DexCom Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of DexCom Inc. shed 3.35% to $115.00 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-03-23"", ""headline"": ""Have $1,000? 2 Stock-Split Companies to Add to Your Buy Basket Right Now."", ""summary"": ""Modern investing has made buying into great companies more accessible than ever, particularly with so many brokerages offering fractional shares.  Another way that high-flying stocks can become more accessible to the average investor is through stock splits.  If you have $1,000 to put into the market right now, here are two companies that recently underwent stock splits to consider holding for years.""}, {""date"": ""2023-03-24"", ""headline"": ""DexCom Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of DexCom Inc. shed 0.36% to $114.09 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-03-24"", ""headline"": ""Dexcom Stock Option Trade Could Return $465 While Risking Just $35"", ""summary"": ""From a prime commercial ad spot during the Super Bowl to this year's star diabetes solutions and glucose monitoring systems, Dexcom returns to my list of stocks that have been excellent to trade using options.  Dexcom sits with a Composite Rating in IBD of 96, ranking second in its industry group according to IBD Stock Checkup.""}, {""date"": ""2023-03-24"", ""headline"": ""Dexcom (DXCM) Launches G6 Glucose Monitoring System in Canada"", ""summary"": ""Dexcom (DXCM) announces the availability of standard of care in diabetes management - G6 CGM system - for type 1 and 2 patients with basal and bolus insulin or using an insulin pump in Canada.""}, {""date"": ""2023-03-24"", ""headline"": ""DexCom, Inc.'s (NASDAQ:DXCM) Stock Has Fared Decently: Is the Market Following Strong Financials?"", ""summary"": ""DexCom's (NASDAQ:DXCM) stock up by 2.7% over the past three months. Since the market usually pay for a company\u2019s...""}, {""date"": ""2023-03-25"", ""headline"": ""Nasdaq Bear Market: 2 Growth Stocks to Buy That Keep Bucking the Trend"", ""summary"": ""The past 15 months haven't been easy for growth stock investors.  The Nasdaq Composite index has fallen a disappointing 25% since the beginning of 2022, making this an unusually long bear market.  You don't need an economics degree to see that every bear market in history has been wiped away by subsequent recoveries.""}, {""date"": ""2023-03-26"", ""headline"": ""Global continuous glucose monitoring market to hit $32B by 2031 \ufffd\ufffd\ufffd report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
11,2023-03-26,114.08999633789062,2023-04-02,116.18000030517578,0.018318906428004267,U2,"[{""date"": ""2023-03-26"", ""headline"": ""Global continuous glucose monitoring market to hit $32B by 2031 \ufffd\ufffd\ufffd report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-27"", ""headline"": ""DexCom Q1 report can be a catalyst for shares, says Jefferies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-28"", ""headline"": ""Why did Tandem Diabetes Care stock go down today?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-28"", ""headline"": ""DexCom Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of DexCom Inc. slipped 1.94% to $113.82 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-03-29"", ""headline"": ""UBS Initiates Coverage of DexCom (DXCM) with Buy Recommendation"", ""summary"": """"}, {""date"": ""2023-03-29"", ""headline"": ""DexCom Inc. stock rises Wednesday, still underperforms market"", ""summary"": ""Shares of DexCom Inc. inched 0.13% higher to $113.96 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P...""}, {""date"": ""2023-03-29"", ""headline"": ""Street Wrap: Today`s Top 15 Upgrades, Downgrades, Initiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-29"", ""headline"": ""Where Will DexCom Be in 1 Year?"", ""summary"": ""Diabetes-focused medical device specialist DexCom (NASDAQ: DXCM) has been successful thanks to its continuous glucose monitoring (CGM) devices that allow diabetes patients to check their blood glucose levels in real time.  While the growing adoption of this technology has generally bolstered its revenue, the company's top-line growth rates have dropped of late.  How will the next 12 months go for DexCom?""}, {""date"": ""2023-03-29"", ""headline"": ""DexCom initiated with a Buy at UBS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-30"", ""headline"": ""DexCom Inc. stock rises Thursday, still underperforms market"", ""summary"": ""Shares of DexCom Inc. inched 0.39% higher to $114.40 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P...""}, {""date"": ""2023-03-31"", ""headline"": ""DexCom (DXCM) Outpaces Stock Market Gains: What You Should Know"", ""summary"": ""DexCom (DXCM) closed the most recent trading day at $116.18, moving +1.56% from the previous trading session.""}, {""date"": ""2023-03-31"", ""headline"": ""DexCom Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of DexCom Inc. rallied 1.56% to $116.18 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-03-31"", ""headline"": ""2 All-Weather Stocks to Buy Without Hesitation Right Now"", ""summary"": ""Despite near-term economic clouds, long-term investors can still find compelling buying opportunities.""}, {""date"": ""2023-03-31"", ""headline"": ""Mednow Achieves Record Q2 2023 Financial Results with Quarterly Revenue of $11.3 Million; 17% Q/Q Revenue Growth and 466% Y/Y Revenue Growth; Adjusted EBITDA Improved 32% Y/Y; and Cash Flow from Operations Improved by 7% Q/Q"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-02"", ""headline"": ""Nick Jonas and Dexcom talk partnership, the future of diabetes management tech"", ""summary"": ""When Nick Jonas attended SXSW this year, it wasn't to perform \u2013 instead, it was to raise awareness about continuous glucose monitoring, or CGM, a technology that can provide real-time blood glucose readings to help manage diabetes.""}]","{""assetTurnoverTTM"": 0.5751, ""bookValue"": 2233, ""cashRatio"": 0.3341554959785523, ""currentRatio"": 2.0201, ""ebitPerShare"": 0.1128, ""eps"": 0.1161, ""ev"": 46439.067, ""fcfMargin"": 0.1088, ""fcfPerShareTTM"": 1.0733, ""grossMargin"": 0.6239, ""inventoryTurnoverTTM"": 2.9963, ""longtermDebtTotalAsset"": 0.2173, ""longtermDebtTotalCapital"": 0.2811, ""longtermDebtTotalEquity"": 0.5367, ""netDebtToTotalCapital"": 0.3301, ""netDebtToTotalEquity"": 0.6304, ""netMargin"": 0.0655, ""operatingMargin"": 0.0637, ""pb"": 20.1663, ""peTTM"": 153.9534, ""pfcfTTM"": 108.2485, ""pretaxMargin"": 0.087, ""psTTM"": 14.8987, ""ptbv"": 21.7606, ""quickRatio"": 1.7263, ""receivablesTurnoverTTM"": 5.1172, ""roaTTM"": 0.0557, ""roeTTM"": 0.1385, ""roicTTM"": 0.0706, ""rotcTTM"": 0.0959, ""salesPerShare"": 1.7718, ""sgaToSale"": 0.3761, ""tangibleBookValue"": 2069.4, ""totalDebtToEquity"": 0.9095, ""totalDebtToTotalAsset"": 0.3682, ""totalDebtToTotalCapital"": 0.4763, ""totalRatio"": 1.6802, ""period"": ""2023-03-31""}"
12,2023-04-02,116.18000030517578,2023-04-09,112.47000122070312,-0.03193319912831316,D4,"[{""date"": ""2023-04-02"", ""headline"": ""Fly Insider: Kohl`s, 89Bio among week`s notable insider trades"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-02"", ""headline"": ""Nick Jonas and Dexcom talk partnership, the future of diabetes management tech"", ""summary"": ""When Nick Jonas attended SXSW this year, it wasn't to perform \u2013 instead, it was to raise awareness about continuous glucose monitoring, or CGM, a technology that can provide real-time blood glucose readings to help manage diabetes.""}, {""date"": ""2023-04-03"", ""headline"": ""DexCom Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of DexCom Inc. slumped 0.81% to $115.24 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-04-03"", ""headline"": ""What Investors Need to Know About the Growing Digital Health Space"", ""summary"": ""In this piece, we will look at how big the digital health space is, as well as who the major players are.""}, {""date"": ""2023-04-03"", ""headline"": ""Goldman leans to growth picks in either recession scenario"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-04"", ""headline"": ""DexCom Inc. stock rises Tuesday, outperforms market"", ""summary"": ""Shares of DexCom Inc. inched 0.35% higher to $115.64 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-04-05"", ""headline"": ""DexCom Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of DexCom Inc. shed 2.44% to $112.82 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2023-04-05"", ""headline"": ""2 Explosive Growth Stocks to Buy in April"", ""summary"": ""With even the most tried-and-true companies across a wide selection of industries seeing share prices buckle in this environment, it's more important than ever to consider where you put your investing capital to work and ensure that the underlying businesses align with your portfolio goals and risk tolerance.  If you're on the hunt for two compelling businesses to add to your buy basket this month, here are two names to consider right now.  DexCom (NASDAQ: DXCM) continues to derive substantial revenue growth and profits from its market-leading portfolio of continuous glucose monitoring (CGM) devices.""}, {""date"": ""2023-04-05"", ""headline"": ""Dexcom Publishes Annual Sustainability Report"", ""summary"": ""SAN DIEGO, April 05, 2023--DexCom, Inc. (NASDAQ:DXCM), the leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today released its annual Sustainability Report, which provides updates on key environmental, social, and governance (ESG) initiatives that are aligned with Dexcom\u2019s core values and business strategy.""}, {""date"": ""2023-04-06"", ""headline"": ""DexCom Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of DexCom Inc. sank 0.31% to $112.47 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-04-06"", ""headline"": ""3 No-Brainer Medical Device Stocks to Buy Right Now"", ""summary"": ""On top of that, labor shortages for hospital staff, tightened hospital spending, and supply chain issues slowed sales of medical equipment.  Edwards Lifesciences focuses on devices for critical care monitoring and to treat structural heart disease.  About 10 years ago, the company pioneered transcatheter heart valves (TAVR) that don't require open-heart surgery.""}, {""date"": ""2023-04-06"", ""headline"": ""Dexcom Schedules First Quarter 2023 Earnings Release and Conference Call for April 27, 2023 at 4:30 p.m. Eastern Time"", ""summary"": ""SAN DIEGO, April 06, 2023--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2023 financial results after market close on Thursday, April 27, 2023. Management will hold a conference call to review the company's first quarter 2023 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations website at investors.dexcom.com and will be""}, {""date"": ""2023-04-06"", ""headline"": ""Here\u2019s Why DexCom (DXCM) Surged in Q4"", ""summary"": ""Aristotle Atlantic Partners, LLC, an investment advisor, released its \u201cFocus Growth Strategy\u201d fourth quarter 2022 investor letter. A copy of the same can be downloaded here. In the fourth quarter, Aristotle Atlantic\u2019s Focus Growth strategy posted a return of 2.66% net of fees compared to a 2.20% return for the Russell 1000 Growth Index. Stock selection [\u2026]""}, {""date"": ""2023-04-06"", ""headline"": ""Abbott recalls millions of FreeStyle Libre glucose monitoring devices"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-08"", ""headline"": ""A Nasdaq Bull Market Is Coming: 2 Fantastic Stocks to Buy and Hold"", ""summary"": ""DexCom (NASDAQ: DXCM) has a leadership position in the diabetes care space thanks to its continuous glucose monitoring (CGM) devices, which track patients' glucose levels.  DexCom generated about 40% of that amount with its top line totaling just shy of $3 billion, up 20% from 2021.  A number of factors drove DexCom's continued growth, even amid increased competition in the diabetes care space.""}]","{""assetTurnoverTTM"": 0.5751, ""bookValue"": 2233, ""cashRatio"": 0.3341554959785523, ""currentRatio"": 2.0201, ""ebitPerShare"": 0.1128, ""eps"": 0.1161, ""ev"": 46439.067, ""fcfMargin"": 0.1088, ""fcfPerShareTTM"": 1.0733, ""grossMargin"": 0.6239, ""inventoryTurnoverTTM"": 2.9963, ""longtermDebtTotalAsset"": 0.2173, ""longtermDebtTotalCapital"": 0.2811, ""longtermDebtTotalEquity"": 0.5367, ""netDebtToTotalCapital"": 0.3301, ""netDebtToTotalEquity"": 0.6304, ""netMargin"": 0.0655, ""operatingMargin"": 0.0637, ""pb"": 20.1663, ""peTTM"": 153.9534, ""pfcfTTM"": 108.2485, ""pretaxMargin"": 0.087, ""psTTM"": 14.8987, ""ptbv"": 21.7606, ""quickRatio"": 1.7263, ""receivablesTurnoverTTM"": 5.1172, ""roaTTM"": 0.0557, ""roeTTM"": 0.1385, ""roicTTM"": 0.0706, ""rotcTTM"": 0.0959, ""salesPerShare"": 1.7718, ""sgaToSale"": 0.3761, ""tangibleBookValue"": 2069.4, ""totalDebtToEquity"": 0.9095, ""totalDebtToTotalAsset"": 0.3682, ""totalDebtToTotalCapital"": 0.4763, ""totalRatio"": 1.6802, ""period"": ""2023-03-31""}"
13,2023-04-09,112.47000122070312,2023-04-16,115.69999694824219,0.02871873115036916,U3,"[{""date"": ""2023-04-10"", ""headline"": ""DexCom Inc. stock rises Monday, still underperforms market"", ""summary"": ""Shares of DexCom Inc. inched 0.05% higher to $112.53 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-04-11"", ""headline"": ""DexCom Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of DexCom Inc. advanced 2.23% to $115.04 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-04-11"", ""headline"": ""Elliott Wave Technical Analysis: DexCom Inc. - Tuesday, April 11"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-12"", ""headline"": ""10-Year 10-Baggers"", ""summary"": ""In the Russell 1,000, 33 names are up more than 1,000% since April 12th, 2013. Over the same 10-year period, the S&P 500 tracking ETF (SPY) is up 211%.""}, {""date"": ""2023-04-12"", ""headline"": ""DexCom Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of DexCom Inc. shed 0.19% to $114.82 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-04-13"", ""headline"": ""DexCom Stock Sets Up; Can It Catch Up To Company's Torrid Growth?"", ""summary"": ""After taking a detour from its torrid growth pace, DexCom is back on the fast lane. Can DexCom stock reflect that rapid growth?""}, {""date"": ""2023-04-13"", ""headline"": ""DexCom Inc. stock rises Thursday, still underperforms market"", ""summary"": ""Shares of DexCom Inc. rose 1.27% to $116.28 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-04-13"", ""headline"": ""2 Stocks That Turned $40,000 Into $1 Million in 10 Years"", ""summary"": ""Two stocks that have turned $40,000 investments into more than $1 million over the past decade are DexCom\u00a0(NASDAQ: DXCM) and\u00a0Tesla\u00a0(NASDAQ: TSLA).  Diabetes is a growing concern for the healthcare industry as the disease is related to many other health problems.  An estimated 38% of the adult U.S. population has pre-diabetes, which in many cases will end up resulting in diabetes.""}, {""date"": ""2023-04-13"", ""headline"": ""3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio"", ""summary"": ""Investors continue to be optimistic about DexCom (DXCM) owing to its strong product portfolio.""}, {""date"": ""2023-04-14"", ""headline"": ""DexCom Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of DexCom Inc. slipped 0.50% to $115.70 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-04-14"", ""headline"": ""ClearBridge Large Cap Growth Strategy Q1 2023 Portfolio Manager Commentary"", ""summary"": ""The ClearBridge Large Cap Growth Strategy outperformed its benchmark in the first quarter. Click here to read the full fund letter.""}]","{""assetTurnoverTTM"": 0.5751, ""bookValue"": 2233, ""cashRatio"": 0.3341554959785523, ""currentRatio"": 2.0201, ""ebitPerShare"": 0.1128, ""eps"": 0.1161, ""ev"": 46439.067, ""fcfMargin"": 0.1088, ""fcfPerShareTTM"": 1.0733, ""grossMargin"": 0.6239, ""inventoryTurnoverTTM"": 2.9963, ""longtermDebtTotalAsset"": 0.2173, ""longtermDebtTotalCapital"": 0.2811, ""longtermDebtTotalEquity"": 0.5367, ""netDebtToTotalCapital"": 0.3301, ""netDebtToTotalEquity"": 0.6304, ""netMargin"": 0.0655, ""operatingMargin"": 0.0637, ""pb"": 20.1663, ""peTTM"": 153.9534, ""pfcfTTM"": 108.2485, ""pretaxMargin"": 0.087, ""psTTM"": 14.8987, ""ptbv"": 21.7606, ""quickRatio"": 1.7263, ""receivablesTurnoverTTM"": 5.1172, ""roaTTM"": 0.0557, ""roeTTM"": 0.1385, ""roicTTM"": 0.0706, ""rotcTTM"": 0.0959, ""salesPerShare"": 1.7718, ""sgaToSale"": 0.3761, ""tangibleBookValue"": 2069.4, ""totalDebtToEquity"": 0.9095, ""totalDebtToTotalAsset"": 0.3682, ""totalDebtToTotalCapital"": 0.4763, ""totalRatio"": 1.6802, ""period"": ""2023-03-31""}"
14,2023-04-16,115.69999694824219,2023-04-23,123.7300033569336,0.06940368729900293,U5+,"[{""date"": ""2022-08-23"", ""headline"": ""Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio"", ""summary"": ""Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.""}, {""date"": ""2023-04-16"", ""headline"": ""Notable Monday Option Activity: DXCM, TWLO, WIX"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-17"", ""headline"": ""Dexcom, A Top 3% Stock, Nears A Breakout On A 'Landmark' Medicare Win"", ""summary"": ""Dexcom stock closed in on a breakout Monday after Medicare officials announced the biggest-ever expansion for coverage of CGMs in the U.S.""}, {""date"": ""2023-04-17"", ""headline"": ""DexCom Inc. stock rises Monday, outperforms market"", ""summary"": ""Shares of DexCom Inc. advanced 2.55% to $118.65 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-04-17"", ""headline"": ""Dexcom Commends Decision to Expand CGM Medicare Coverage to Include People With Diabetes Using All Types of Insulin"", ""summary"": ""SAN DIEGO, April 17, 2023--Dexcom Commends Decision to Expand CGM Medicare Coverage to Include People with Diabetes Using All Types of Insulin""}, {""date"": ""2023-04-17"", ""headline"": ""DexCom raised, AngioDynamics cut as RayJay reviews post-COVID MedTech"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-17"", ""headline"": ""DexCom price target raised to $132 from $126 at BTIG"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-17"", ""headline"": ""DexCom commends expansion of CGM Medicare to diabetics using all insulin types"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-17"", ""headline"": ""DexCom upgraded to Strong Buy from Outperform at Raymond James"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-18"", ""headline"": ""DexCom Inc. stock rises Tuesday, outperforms market"", ""summary"": ""Shares of DexCom Inc. inched 0.24% higher to $118.93 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-04-18"", ""headline"": ""Abbott Laboratories: Why I Am Fearful Ahead Of Q1 Earnings"", ""summary"": """"}, {""date"": ""2023-04-18"", ""headline"": ""BTIG Maintains DexCom (DXCM) Buy Recommendation"", ""summary"": """"}, {""date"": ""2023-04-18"", ""headline"": ""Raymond James Upgrades DexCom (DXCM)"", ""summary"": """"}, {""date"": ""2023-04-19"", ""headline"": ""DexCom Inc. stock rises Wednesday, outperforms market"", ""summary"": ""Shares of DexCom Inc. rose 4.36% to $124.12 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-04-19"", ""headline"": ""Are Medical Stocks Lagging  DexCom (DXCM) This Year?"", ""summary"": ""Here is how DexCom (DXCM) and Lantheus Holdings (LNTH) have performed compared to their sector so far this year.""}, {""date"": ""2023-04-20"", ""headline"": ""DexCom Inc. stock rises Friday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-20"", ""headline"": ""Elliott Wave Technical Analysis: DexCom Inc"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-20"", ""headline"": ""DexCom Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of DexCom Inc. slid 1.55% to $122.19 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-04-20"", ""headline"": ""There's Been No Shortage Of Growth Recently For DexCom's (NASDAQ:DXCM) Returns On Capital"", ""summary"": ""If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...""}, {""date"": ""2023-04-21"", ""headline"": ""ClearBridge Large Cap Growth ESG Strategy Q1 2023 Portfolio Manager Commentary"", ""summary"": """"}]",{}
15,2023-04-23,123.7300033569336,2023-04-30,121.33999633789062,-0.019316309336453563,D2,"[{""date"": ""2023-04-23"", ""headline"": ""DexCom Inc. stock rises Monday, still underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-24"", ""headline"": ""DexCom (DXCM) to Report Q1 Earnings: What's in the Cards?"", ""summary"": ""DexCom's (DXCM) first-quarter results likely to reflect rising volumes across all channels.""}, {""date"": ""2023-04-25"", ""headline"": ""DexCom Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of DexCom Inc. inched 0.10% higher to $123.96 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P...""}, {""date"": ""2023-04-25"", ""headline"": ""2 Monster Stocks to Buy Without Any Hesitation"", ""summary"": ""Eli Lilly (NYSE: LLY) and DexCom (NASDAQ: DXCM) have characteristics in common that, in my view, make them monster stocks to buy without hesitation.  Both companies also have major tailwinds that should help drive revenue for years.  For DexCom, profits will be driven by the trend toward greater numbers of diabetes patients and their need for continuous glucose monitoring devices (CGMs).""}, {""date"": ""2023-04-26"", ""headline"": ""DexCom sees FY23 revenue $3.40B-$3.52B, consensus $3.47B"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-26"", ""headline"": ""DexCom Non-GAAP EPS of $0.17 beats by $0.02, revenue of $741.5M beats by $20.98M"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-26"", ""headline"": ""DexCom reports Q1 EPS 17c, consensus 15c"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-26"", ""headline"": ""Notable companies reporting after market close"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-26"", ""headline"": ""GLOBAL BRIEFING: Samsung posts weakest profit in 14 years in Q1"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-26"", ""headline"": ""DexCom Inc. stock rises Wednesday, outperforms market"", ""summary"": ""Shares of DexCom Inc. inched 0.78% higher to $124.93 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P...""}, {""date"": ""2023-04-26"", ""headline"": ""Medical Device Stocks' Q1 Earnings on Apr 27: WST, DXCM, BAX"", ""summary"": ""Medical Device companies' Q1 results are likely to reflect strength in customer demand. Let's see how WST, DXCM and BAX are placed ahead of their earnings releases.""}, {""date"": ""2023-04-26"", ""headline"": ""\ufffd\ufffd\ufffdSell In May Effect\ufffd\ufffd\ufffd: Uncovering Investment Opportunities During Seasonal Weakness"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-27"", ""headline"": ""Dexcom (DXCM) Gets a Buy from Bernstein"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-27"", ""headline"": ""Dow Jones Futures: Amazon Continues Earnings Surge For Tech Titans, But Cloudflare, Snap Plunge"", ""summary"": ""Amazon jumped late after Meta and Microsoft surged on earnings. But Cloudflare and Snap were the latest to plunge. Megacaps led Thursday's market rally but the gains were broad-based.""}, {""date"": ""2023-04-27"", ""headline"": ""Dexcom's Sales Growth Is Slowing, And The Top 2% Stock Just Skidded"", ""summary"": ""Dexcom lagged the most bullish expectations for its adjusted earnings late Thursday, but otherwise beat. Still, Dexcom stock skidded.""}, {""date"": ""2023-04-27"", ""headline"": ""DexCom (DXCM) Q1 Earnings and Revenues Beat Estimates"", ""summary"": ""DexCom (DXCM) delivered earnings and revenue surprises of 13.33% and 3.01%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?""}, {""date"": ""2023-04-27"", ""headline"": ""Dexcom, Inc. (DXCM) Q1 2023 Earnings Call Transcript"", ""summary"": ""Dexcom, Inc. (NASDAQ:NASDAQ:DXCM) Q1 2023 Earnings Conference Call April 27, 2023 4:30 PM ETCompany ParticipantsSean Christensen - Director, Corporate Affairs & Head of IRKevin Sayer -...""}, {""date"": ""2023-04-27"", ""headline"": ""Dexcom Reports First Quarter 2023 Financial Results"", ""summary"": ""SAN DIEGO, April 27, 2023--Dexcom Reports First Quarter 2023 Financial Results""}, {""date"": ""2023-04-27"", ""headline"": ""DexCom quarterly profit halves, revenue up; expects growth full-year"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-27"", ""headline"": ""DexCom: Q1 Earnings Snapshot"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-27"", ""headline"": ""2 Growth Stocks That Could Double in 5 Years"", ""summary"": ""As a group, growth stocks had a year to forget in 2022.  Let's consider why both healthcare stocks could double in the next five years -- and for those keeping score at home, that amounts to a compound annual growth rate of almost 15%.  Vertex Pharmaceuticals is a biotech company best known for its lineup of medicines that treat the underlying causes of cystic fibrosis (CF), a rare genetic disease.""}, {""date"": ""2023-04-27"", ""headline"": ""Dexcom G6 Real-Time CGM System Now Accessible to Any Eligible Client Managing Diabetes With Insulin Through NIHB"", ""summary"": ""BURNABY, British Columbia, April 27, 2023--Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, applauds the progressive expansion of coverage for continuous glucose monitoring systems through the Non-Insured Health Benefits (NIHB) program. Following an announcement made earlier this year, this decision further broadens the coverage criteria, now enabling any client managing diabetes with insulin to access the standard of care.""}, {""date"": ""2023-04-27"", ""headline"": ""BTIG Reaffirms Their Buy Rating on Dexcom (DXCM)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-27"", ""headline"": ""Fly Intel: After-Hours Movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-27"", ""headline"": ""DexCom raises outlook on Q1 beat and Medicare coverage"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-28"", ""headline"": ""BTIG Maintains Dexcom (DXCM) Buy Recommendation"", ""summary"": """"}, {""date"": ""2023-04-28"", ""headline"": ""Stifel Maintains Dexcom (DXCM) Buy Recommendation"", ""summary"": """"}, {""date"": ""2023-04-28"", ""headline"": ""DexCom (DXCM) Q1 2023 Earnings Call Transcript"", ""summary"": ""Thank you, Abby, and welcome to DexCom's first-quarter 2023 earnings call.  Please note that there are also slides available related to our first-quarter performance on the DexCom's investor relations website on the events and presentations page.""}, {""date"": ""2023-04-28"", ""headline"": ""DexCom Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of DexCom Inc. slipped 1.81% to $121.34 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-04-28"", ""headline"": ""Canaccord Genuity Maintains Dexcom (DXCM) Buy Recommendation"", ""summary"": """"}, {""date"": ""2023-04-28"", ""headline"": ""Raymond James Maintains Dexcom (DXCM) Strong Buy Recommendation"", ""summary"": """"}, {""date"": ""2023-04-28"", ""headline"": ""DexCom (DXCM) Q1 Earnings Beat Estimates, Volumes Remain Strong"", ""summary"": ""DexCom's (DXCM) first-quarter 2023 results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system.""}, {""date"": ""2023-04-28"", ""headline"": ""DexCom Q1 Earnings Beat Sets Stage For Upcoming Catalysts During 2023, Analyst Says"", ""summary"": ""DexCom Inc (NASDAQ: DXCM) raised its 2023 financial guidance following strong Q1 FY23 financial results. It posted Q1 sales of $741.50 million, up 18% Y/Y (19% organic basis), beating the consensus of $720.74 million. Volume growth, in conjunction with strong new customer additions, continues to be the primary driver of revenue growth. Highlights in the quarter included the U.S. launch of the next-generation Dexcom G7 CGM, initiated with a Super Bowl commercial. The company also finalized covera""}, {""date"": ""2023-04-28"", ""headline"": ""Dow Jones Futures Fall: Amazon Warns Of Slowing Cloud Growth; Cloudflare, Snap Plunge"", ""summary"": ""Amazon reversed lower late slowing on cloud computing growth. Cloudflare and Snap are the latest huge earnings losers. Megacaps led Thursday's market rally but the gains were broad-based.""}, {""date"": ""2023-04-28"", ""headline"": ""DexCom price target raised to $140 from $130 at Stifel"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-28"", ""headline"": ""DexCom price target raised to $150 from $142 at UBS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-28"", ""headline"": ""DexCom price target raised to $134 from $132 at BTIG"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-28"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Dexcom (DXCM) and Merck & Company (MRK)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-28"", ""headline"": ""DexCom selloff a buying opportunity, says Piper Sandler"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-28"", ""headline"": ""Analysts` Top Healthcare Picks: Amgen (AMGN), Dexcom (DXCM)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-28"", ""headline"": ""DexCom price target raised to $135 from $125 at Canaccord"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-28"", ""headline"": ""Dexcom (DXCM) Gets a Buy from Raymond James"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-28"", ""headline"": ""Bank of America Securities Reaffirms Their Buy Rating on Dexcom (DXCM)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-28"", ""headline"": ""DexCom price target raised to $140 from $138 at Raymond James"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-29"", ""headline"": ""Amazon Leads 5 S&P 500 Stocks Near Buy Points After Earnings"", ""summary"": ""Amazon is among S&P 500 stocks holding near buy points after surviving some volatility around earnings, removing a key risk.""}]",{}
16,2023-04-30,121.33999633789062,2023-05-07,120.81999969482422,-0.0042854512836673075,D1,"[{""date"": ""2023-05-01"", ""headline"": ""Barclays Maintains Dexcom (DXCM) Equal-Weight Recommendation"", ""summary"": """"}, {""date"": ""2023-05-01"", ""headline"": ""DexCom Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of DexCom Inc. shed 2.39% to $118.44 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-05-01"", ""headline"": ""Elliott Wave Technical Analysis: DexCom Inc, May 1"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-01"", ""headline"": ""Elliott Wave Technical Analysis: DexCom Inc, Monday, May 1"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-01"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK) and Dexcom (DXCM)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-01"", ""headline"": ""DexCom price target raised to $115 from $110 at Barclays"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-02"", ""headline"": ""Baron Opportunity Fund Q1 2023 Shareholder Letter"", ""summary"": ""Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing.""}, {""date"": ""2023-05-02"", ""headline"": ""DexCom Inc. stock falls Tuesday, still outperforms market"", ""summary"": ""Shares of DexCom Inc. slumped 0.27% to $118.12 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-05-02"", ""headline"": ""Video: S&P 500 Analyst Moves: DXCM"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-02"", ""headline"": ""Dexcom Announces Proposed Offering of $1.0 Billion of Convertible Senior Notes"", ""summary"": ""SAN DIEGO, May 02, 2023--Dexcom Announces Proposed Offering of $1.0 Billion of Convertible Senior Notes""}, {""date"": ""2023-05-02"", ""headline"": ""DexCom Takes Over #24 Spot From Mastercard"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-02"", ""headline"": ""Is Dexcom a Good Stock to Buy Now?"", ""summary"": ""A poorly received first-quarter earnings report has investors wondering if this stock's best days are behind it.""}, {""date"": ""2023-05-02"", ""headline"": ""Wall Street Analysts Are Bullish on Top Healthcare Picks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-02"", ""headline"": ""DexCom proposes $1B notes offering"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-02"", ""headline"": ""DexCom offers to sell $1.0B in convertible senior notes due 2028"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-03"", ""headline"": ""DexCom Inc. stock outperforms market despite losses on the day"", ""summary"": ""Shares of DexCom Inc. slipped 0.68% to $117.32 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-05-03"", ""headline"": ""Dexcom Prices Upsized Offering of $1.1 Billion of 0.375% Convertible Senior Notes Due 2028"", ""summary"": ""SAN DIEGO, May 03, 2023--Dexcom Prices Upsized Offering of $1.1 Billion of 0.375% Convertible Senior Notes Due 2028""}, {""date"": ""2023-05-03"", ""headline"": ""Dexcom rtCGM is Likely to be Cost-Saving, Study Suggests"", ""summary"": ""EDINBURGH, Scotland, May 03, 2023--Dexcom rtCGM is associated with significant improvements over patients\u2019 lifetimes and is likely to be cost-saving to the NHS""}, {""date"": ""2023-05-03"", ""headline"": ""DexCom prices $1.1B senior notes"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-03"", ""headline"": ""DexCom prices upsized convertible senior note offering of $1.1B"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-04"", ""headline"": ""Tracking Baillie Gifford's 13F Portfolio - Q1 2023 Update"", ""summary"": ""Baillie Gifford\u00e2\u0080\u0099s 13F portfolio value increased from ~$96B to ~$111B this quarter. Click here to see an update on the portfolio for Q1 2023.""}, {""date"": ""2023-05-04"", ""headline"": ""DexCom Inc. stock rises Thursday, outperforms market"", ""summary"": ""Shares of DexCom Inc. inched 0.09% higher to $117.42 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-05-04"", ""headline"": ""3 HealthTech Stocks to Watch as Digital Health Transforms the Industry"", ""summary"": ""Increasingly, technologies other than drugs are working to improve patient health. From diagnostic systems like MRIs and CAT scans to high-tech glucose monitoring systems to devices that destroy tumors, medicine makes use of many such technologies. Companies that develop technologies for the healthcare sector are referred to as healthtech companies. In this column, I will provide information about three of the best healthtech stocks available, focusing on companies that have developed non-drug t""}, {""date"": ""2023-05-04"", ""headline"": ""Baron Health Care Fund Q1 2023 Shareholder Letter"", ""summary"": ""Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing.""}, {""date"": ""2023-05-04"", ""headline"": ""Tracking Baillie Gifford`s 13F Portfolio - Q1 2023 Update"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-05"", ""headline"": ""DexCom Inc. stock rises Friday, outperforms market"", ""summary"": ""Shares of DexCom Inc. rose 2.90% to $120.82 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-05-05"", ""headline"": ""DexCom participates in a conference call with JPMorgan"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
17,2023-05-07,120.81999969482422,2023-05-14,121.69999694824219,0.007283539609673317,U1,"[{""date"": ""2023-05-08"", ""headline"": ""DexCom Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of DexCom Inc. slid 0.53% to $120.18 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-05-09"", ""headline"": ""DexCom Inc. stock outperforms market despite losses on the day"", ""summary"": ""Shares of DexCom Inc. slumped 0.44% to $119.65 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-05-10"", ""headline"": ""Dexcom Showcases Accuracy, Reliability and Ease of Use of Its Dexcom G6 CGM System at the 66th Annual Meeting of the Japan Diabetes Society"", ""summary"": ""KAGOSHIMA, Japan, May 10, 2023--DexCom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, will showcase the accuracy, reliability and ease of use of its Dexcom G6 CGM System and will highlight the latest clinical evidence that continues to demonstrate the effectiveness of Dexcom CGM during the 66th Annual Meeting of the Japan Diabetes Society held May 11-13, 2023 in Kagoshima, Japan.""}, {""date"": ""2023-05-10"", ""headline"": ""DexCom Inc. stock rises Wednesday, outperforms market"", ""summary"": ""Shares of DexCom Inc. advanced 2.44% to $122.57 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-05-10"", ""headline"": ""What Makes DexCom (DXCM) an Attractive Investment?"", ""summary"": ""Baron Funds, an investment management company, released its \u201cBaron Opportunity Fund\u201d first quarter 2023 investor letter. A copy of the same can be downloaded here. In the first quarter, the fund outperformed the broader market and increased by 17.96% (Institutional Shares) compared to a 13.85% return for the Russell 3000 Growth Index and a 7.50% return [\u2026]""}, {""date"": ""2023-05-11"", ""headline"": ""Dexcom Shows Strength As Glucose Monitor Attracts Buyers"", ""summary"": ""Dexcom stock rebounds as glucose monitor maker sees expanding market. The med tech raised revenue guidance in its Q1 earnings report.""}, {""date"": ""2023-05-11"", ""headline"": ""DexCom Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of DexCom Inc. slipped 1.22% to $121.07 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-05-12"", ""headline"": ""DexCom Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of DexCom Inc. inched 0.52% higher to $121.70 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-05-13"", ""headline"": ""S&P 500 Medtech Play DexCom Leads Five Stocks Near Buy Points"", ""summary"": ""S&P 500 stock DexCom along with New Relic, Flywire, ASML and Kinsale Capital are in focus this week.  Leading the group is the S&P 500 medical technology stock DexCom.  Meanwhile, the Dow Jones Industrial Average along with the S&P 500 and other major stock indexes were down modestly Friday.""}, {""date"": ""2023-05-14"", ""headline"": ""Why Medtronic Could Have 25% Upside From Today's Levels"", ""summary"": ""Medtronic has faced hurdles of its own making over the last three years, but its pipeline delivered some wins recently. Read why MDT stock is a Buy.""}, {""date"": ""2023-05-14"", ""headline"": ""Why Medtronic Could Have 25% Upside From Today`s Levels"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
18,2023-05-14,121.69999694824219,2023-05-21,117.12999725341797,-0.03755135422696676,D4,"[{""date"": ""2023-05-14"", ""headline"": ""Why Medtronic Could Have 25% Upside From Today's Levels"", ""summary"": ""Medtronic has faced hurdles of its own making over the last three years, but its pipeline delivered some wins recently. Read why MDT stock is a Buy.""}, {""date"": ""2023-05-14"", ""headline"": ""Why Medtronic Could Have 25% Upside From Today`s Levels"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-15"", ""headline"": ""DexCom Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of DexCom Inc. slipped 1.72% to $119.61 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-05-15"", ""headline"": ""3 Stocks on the Verge of Breaking Out"", ""summary"": ""Andrew Rocco combines fundamentals and technicals to bring you 3 top stocks on the verge of breaking out.""}, {""date"": ""2023-05-16"", ""headline"": ""DexCom Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-16"", ""headline"": ""DexCom Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of DexCom Inc. shed 0.84% to $118.61 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-05-16"", ""headline"": ""Zacks Investment Ideas feature highlights: Dexcom, Rambus, Advanced Micro Devices, Nvidia and Vipshops"", ""summary"": ""Dexcom, Rambus, Advanced Micro Devices, Nvidia and Vipshops are part of the Zacks Investment Ideas article.""}, {""date"": ""2023-05-17"", ""headline"": ""DexCom Inc. stock rises Thursday, still underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-17"", ""headline"": ""What Recession? These Companies Expect 20% Sales Growth This Year."", ""summary"": ""Recession or not, don't expect these businesses to run out of growth opportunities anytime soon.""}, {""date"": ""2023-05-17"", ""headline"": ""Applied Materials, Lowe`s added to Jefferies franchise picks list"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-18"", ""headline"": ""DexCom Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
19,2023-05-21,117.12999725341797,2023-05-28,115.05000305175781,-0.017757997527823366,D2,"[{""date"": ""2023-05-21"", ""headline"": ""These stock pickers led the health-fund category over the past 5 years. Here\u2019s where they\u2019re investing now."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-22"", ""headline"": ""DexCom Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-22"", ""headline"": ""Noteworthy Tuesday Option Activity: DXCM, LMND, PINS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-22"", ""headline"": ""Billionaire Ken Griffin\u2019s 2023 Portfolio: Top 15 Stock Picks"", ""summary"": ""In this piece, we will take a look at the top fifteen stocks in billionaire Ken Griffin\u2019s 2023 portfolio. For more stocks, head on over to Billionaire Ken Griffin\u2019s 2023 Portfolio: Top 5 Stock Picks. The stock market crash of 2022 hammered several major hedge funds. One of the biggest funds that bled capital last [\u2026]""}, {""date"": ""2023-05-22"", ""headline"": ""DexCom management to meet virtually with BTIG"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-23"", ""headline"": ""DexCom Inc. stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-23"", ""headline"": ""Investing $1,000 in These 2 Top Growth Stocks Would Be a Brilliant Move"", ""summary"": ""Given the market volatility over the past few years, some investors are questioning whether they should still be putting their hard-earned money into the stock market.  Let's take a closer look at two excellent growth stocks to buy right now: Teladoc Health (NYSE: TDOC) and DexCom (NASDAQ: DXCM).  Last year was a horror show for Teladoc.""}, {""date"": ""2023-05-23"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-23"", ""headline"": ""Elliott Wave Technical Analysis: DexCom Inc. - Tuesday, May 23"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-24"", ""headline"": ""DexCom Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-24"", ""headline"": ""DexCom Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-24"", ""headline"": ""4 Growth Stocks to Buy and Hold Forever"", ""summary"": ""Some products and services are bigger than any economic, cultural, technological, or societal cycle.""}, {""date"": ""2023-05-24"", ""headline"": ""Insider Sell: EVP CFO Jereme Sylvain Sells 2,400 Shares of DexCom Inc (DXCM)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-24"", ""headline"": ""DexCom: Growth Should Accelerate From Here"", ""summary"": ""DexCom has shown positive performance and growth prospects in 1Q23. Check out why I reiterate my buy rating on DXCM stock.""}, {""date"": ""2023-05-25"", ""headline"": ""3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio"", ""summary"": ""Investors continue to be optimistic about DexCom (DXCM), owing to its strong product portfolio.""}, {""date"": ""2023-05-25"", ""headline"": ""The Best Stocks to Invest $500 in Right Now"", ""summary"": ""While some investors may be discouraged by the market volatility that has continued from last year into 2023, the fact remains that truly great businesses are still growing even in an ongoing economic maelstrom.  While a full-fledged recession has the ability to hamper growth across a range of businesses and sectors, when you're looking at a multi-year buy-and-hold horizon for any stock you own, even these periods can be a short window against your overall investment period.  DexCom (NASDAQ: DXCM) has built a name for itself as a leader in diabetes care, a highly fragmented space with increasing levels of competition.""}, {""date"": ""2023-05-25"", ""headline"": ""DexCom: 120 Times Free Cash Flow Is Still Unreasonable"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-26"", ""headline"": ""DexCom Inc. stock rises Friday, still underperforms market"", ""summary"": ""Shares of DexCom Inc. inched 0.38% higher to $115.05 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""2023-05-26"", ""headline"": ""How Dexcom and Abbott are moving beyond diabetes with blood sugar monitoring"", ""summary"": ""CNBC spoke with both Abbott and Dexcom about the technology inside continuous glucose monitors and how they see the technology expanding.""}, {""date"": ""2023-05-26"", ""headline"": ""The rise of continuous glucose monitors"", ""summary"": ""According to the Center for Disease Control and Prevention, more than 37 million people in the U.S. have diabetes. Diabetics must monitor their blood sugar, a task traditionally done with glucometers by pricking your finger over and over again for drops of blood. But over the last decade, technology like continuous glucose monitoring has been on the rise. Abbott and Dexcom are the two most dominant players in the space. CNBC spoke with both companies about the technology inside CGM's.""}]",{}
20,2023-05-28,115.05000305175781,2023-06-04,122.56999969482422,0.065362854790046,U5+,"[{""date"": ""2023-05-29"", ""headline"": ""DexCom management to meet virtually with BTIG"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-29"", ""headline"": ""LLY, DXCM, or ISRG: Which Healthcare Stock is the Top Stock Pick?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-29"", ""headline"": ""LLY, DXCM, or ISRG: Which Healthcare Stock is the Most Attractive Pick?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-30"", ""headline"": ""DexCom Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of DexCom Inc. slid 1.30% to $113.56 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-05-30"", ""headline"": ""Where DexCom Stands With Analysts"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-30"", ""headline"": ""Elliott Wave Technical Analysis: DexCom Inc. - Tuesday, May 30"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-30"", ""headline"": ""DexCom assumed with an Equal Weight at Morgan Stanley"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-31"", ""headline"": ""2 Incredible Growth Stocks to Buy Before the Next Bull Market"", ""summary"": ""These companies have what it takes to keep growing and enriching investors in the years ahead.""}, {""date"": ""2023-05-31"", ""headline"": ""3 Stock-Split Stocks Billionaires Can't Stop Buying"", ""summary"": ""Based on the latest round of 13F filings, a number of prominent billionaire investors piled into three fast-growing stock-split stocks.""}, {""date"": ""2023-06-01"", ""headline"": ""DexCom Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of DexCom Inc. advanced 1.98% to $119.58 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-06-01"", ""headline"": ""15 Best Healthcare Stocks To Buy Now"", ""summary"": ""In this article, we will take a look at the 15 best healthcare stocks to buy now. For more stocks, head on over to 5 Best Healthcare Stocks To Buy Now. In the midst of uncertain economic conditions globally, the healthcare sector has displayed a notable degree of resilience. Historically, the demand for healthcare products [\u2026]""}, {""date"": ""2023-06-01"", ""headline"": ""Dexcom Announces Upcoming Conference Presentation"", ""summary"": ""SAN DIEGO, June 01, 2023--DexCom, Inc. (NASDAQ:DXCM) today announced that Jereme Sylvain, Executive Vice President and Chief Financial Officer, will present an update on the company at William Blair's 43rd Annual Growth Stock Conference on Wednesday, June 7th.""}, {""date"": ""2023-06-01"", ""headline"": ""Analysts Are Bullish on Top Healthcare Stocks: Dr Reddy\u2019s Laboratories (RDY), Dexcom (DXCM)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-02"", ""headline"": ""Stock Market Rally Shows Character Change With Tesla, Apple In Focus; Here's What To Do Now"", ""summary"": ""The market rally is stepping up with broad gains. Tesla broke out while Apple has a big product reveal. Here's what you should do now.""}, {""date"": ""2023-06-02"", ""headline"": ""DexCom Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of DexCom Inc. rose 2.50% to $122.57 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-06-02"", ""headline"": ""Senseonics spikes on UnitedHealthcare coverage for glucose monitoring device"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-03"", ""headline"": ""Stock Market Rally Makes Bullish Character Change With Tesla, Apple In Focus; Here's What To Do Now"", ""summary"": ""The market rally is stepping up with broad gains. Tesla broke out while Apple has a big product reveal. Here's what you should do now.""}, {""date"": ""2023-06-03"", ""headline"": ""S&P 500 Giant Tesla Leads Five Stocks Near Buy Points As Market Revs Up"", ""summary"": ""The EV giant broke out this week, leading a group of stocks around buy points as the market rally attempts to gather steam.""}, {""date"": ""2023-06-03"", ""headline"": ""Want $1 Million in Retirement? Invest $250,000 in These 3 Stocks and Wait a Decade"", ""summary"": ""Let's consider three stocks that could: Vertex Pharmaceuticals (NASDAQ: VRTX), DexCom (NASDAQ: DXCM), and Amazon (NASDAQ: AMZN).  Vertex Pharmaceuticals is doing great things.  One of the drugmakers that was closest to entering this market with competing products recently threw in the towel.""}, {""date"": ""2023-06-04"", ""headline"": ""10 Internet of Things (IoT) Stocks Billionaires Are Loading Up On"", ""summary"": ""In this piece, we will take a look at the ten internet of things (IoT) stocks billionaires are loading on. For more IoT stocks, head on over to 5 Internet of Things (IoT) Stocks Billionaires Are Loading Up On. As a technology, the consumer use of the Internet is entering its fourth decade. And over [\u2026]""}]",{}
21,2023-06-04,122.56999969482422,2023-06-11,124.33999633789062,0.014440700395474959,U2,"[{""date"": ""2023-06-04"", ""headline"": ""If You Invested $100 In This Stock 15 Years Ago, You Would Have $6,800 Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-04"", ""headline"": ""Dow Jones Futures: Character Change For Market; Oil Prices Pop On Saudi Output Cut"", ""summary"": ""The market sent bullish signals last week. Crude prices jumped as Saudi Arabia cut output. Apple and Palo Alto have big news. Tesla is in a buy zone.""}, {""date"": ""2023-06-04"", ""headline"": ""10 Internet of Things (IoT) Stocks Billionaires Are Loading Up On"", ""summary"": ""In this piece, we will take a look at the ten internet of things (IoT) stocks billionaires are loading on. For more IoT stocks, head on over to 5 Internet of Things (IoT) Stocks Billionaires Are Loading Up On. As a technology, the consumer use of the Internet is entering its fourth decade. And over [\u2026]""}, {""date"": ""2023-06-05"", ""headline"": ""DexCom Now #152 Largest Company, Surpassing Roper Technologies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-05"", ""headline"": ""Frank Sands' Top 1st-Quarter Buys"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-05"", ""headline"": ""Market Rally Retreats On Apple Reveal, But Not Much; 5 Stocks In Buy Areas"", ""summary"": ""The market rally saw modest losses Monday as Apple dipped after unveiling its $3,499 Vision Pro goggles. Tesla leads five stocks in buy areas.""}, {""date"": ""2023-06-05"", ""headline"": ""Dow Jones Falls As Apple Unveils These Products; This Stock Soars After Cathie Wood Sells It"", ""summary"": ""The Dow Jones slid while Apple stock reversed despite unveiling the Vision Pro headset. A Cathie Wood stock popped higher.""}, {""date"": ""2023-06-05"", ""headline"": ""DexCom Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of DexCom Inc. rallied 1.71% to $124.66 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-06-05"", ""headline"": ""Early notable gainers among liquid option names on June 5th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-06"", ""headline"": ""Dow Jones Giant McDonald's Tests Key Support Level; Tesla Stock In Buy Range"", ""summary"": ""Dow Jones leader McDonald's is trying to find support around a key level, while Tesla stock is in buy range past its latest entry.""}, {""date"": ""2023-06-06"", ""headline"": ""DexCom Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of DexCom Inc. inched 0.58% higher to $125.38 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""2023-06-06"", ""headline"": ""Dow Jones Futures Fall: Market Rally Retreats On Apple; 5 Stocks In Buy Areas"", ""summary"": ""The market rally saw modest losses Monday as Apple dipped after unveiling its $3,499 Vision Pro goggles. Tesla leads five stocks in buy areas.""}, {""date"": ""2023-06-06"", ""headline"": ""10 Top-Rated Stocks Billionaires Are Loading Up On"", ""summary"": ""In this piece, we will take a look at the ten top rated stocks billionaires are loading up on. For more stocks, head on over to 5 Top-Rated Stocks Billionaires Are Loading Up On. The U.S. economy has undergone several shocks over the past couple of years. This turmoil started after the onset of the [\u2026]""}, {""date"": ""2023-06-06"", ""headline"": ""Have $1,500? 2 Top Growth Stocks to Buy and Hold for the Long Haul"", ""summary"": ""In a time where recession concerns remain for many investors, and the market is continuing to deal with regular bouts of volatility, it can be easy to lose sight of your long-term investment horizon and get caught up in the day-to-day machinations of the market.  If you're looking for two compelling businesses to invest $1,500 in this month, here are two names to consider hitting the buy button on right now.  Fiverr (NYSE: FVRR) continues to help customers, from small enterprises to massive brands, connect with freelancers that meet their business needs.""}, {""date"": ""2023-06-07"", ""headline"": ""DexCom Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of DexCom Inc. shed 4.52% to $119.71 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2023-06-07"", ""headline"": ""SPY ETF Gains 13% YTD; Analysts See Further Upside"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-08"", ""headline"": ""15 Healthcare Stocks Billionaires Are Loading Up On"", ""summary"": ""In this article, we discuss 15 best healthcare stocks billionaires are loading up on. You can skip our detailed discussion on the healthcare sector and its performance, and go directly to read 5 Healthcare Stocks Billionaires Are Loading Up On. The healthcare sector in the US is a multifaceted industry that plays a crucial role [\u2026]""}, {""date"": ""2023-06-08"", ""headline"": ""DexCom Inc. stock rises Thursday, outperforms market"", ""summary"": ""Shares of DexCom Inc. rallied 1.19% to $121.13 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-06-08"", ""headline"": ""Dow Jones Rises After Surprise Jump In Jobless Claims; GME Stock Crashes 22% After Firing CEO"", ""summary"": ""The Dow Jones rose Thursday on a surprise jump in weekly jobless claims. GME stock crashed after the company fired its chief executive.""}, {""date"": ""2023-06-08"", ""headline"": ""Dexcom to Host Investor Day on June 23, 2023"", ""summary"": ""SAN DIEGO, June 08, 2023--DexCom, Inc. (NASDAQ:DXCM) today announced that it will host an Investor Day on June 23rd from 2:30 PM until approximately 5:00 PM PST (5:30 PM \u2013 8:00 PM EST). The event will include presentations from Dexcom management highlighting the company\u2019s market opportunities, business strategy, innovation efforts, and long-term financial outlook.""}, {""date"": ""2023-06-08"", ""headline"": ""Elliott Wave Technical Analysis: DexCom Inc. - Thursday, June 8"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-08"", ""headline"": ""Here\u2019s Why the QQQ ETF Could Be a Great Pick"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-09"", ""headline"": ""DexCom Inc. stock rises Friday, outperforms market"", ""summary"": ""Shares of DexCom Inc. rose 2.65% to $124.34 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-06-09"", ""headline"": ""Why Is Steris (STE) Down 0.9% Since Last Earnings Report?"", ""summary"": ""Steris (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.""}]",{}
22,2023-06-11,124.33999633789062,2023-06-18,130.10000610351562,0.04632467375961902,U5,"[{""date"": ""2023-06-12"", ""headline"": ""Dow Jones Rises Ahead Of Inflation Data, Fed Meeting; AMD, Amazon Rally On Price-Target Hikes"", ""summary"": ""The Dow Jones rose Monday ahead of this week's inflation data and two-day Fed meeting. AMD and Amazon rallied on price-target hikes.""}, {""date"": ""2023-06-12"", ""headline"": ""New Study Shows That 84% of People With Diabetes Struggle With Mental Health1"", ""summary"": ""LONDON, June 12, 2023--Dexcom to host uplifting Puppy Yoga Event in London with Roxy Horner and Henry Slade for Diabetes Awareness Week""}, {""date"": ""2023-06-12"", ""headline"": ""New Study Shows That 84% of People With Diabetes Struggle With Mental Health\u00b9"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-13"", ""headline"": ""Commit To Purchase DexCom At $110, Earn 8.8% Using Options"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-13"", ""headline"": ""DexCom Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of DexCom Inc. slipped 0.76% to $125.95 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-06-13"", ""headline"": ""Dow Jones Rallies On Cool CPI Inflation Data; Cathie Wood Sells $92 Million Of Tesla Stock"", ""summary"": ""The Dow Jones rose Tuesday on cooler-than-expected CPI inflation data. Cathie Wood's Ark Invest sold Tesla stock.""}, {""date"": ""2023-06-14"", ""headline"": ""DexCom Inc. stock underperforms Wednesday when compared to competitors despite daily gains"", ""summary"": ""Shares of DexCom Inc. inched 0.88% higher to $127.06 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P...""}, {""date"": ""2023-06-14"", ""headline"": ""Dow Jones Falls After Key Inflation Data; Fed Decision, Powell Comments Later"", ""summary"": ""The Dow Jones fell Wednesday after key inflation data. The Fed's interest rate decision and Fed Chair Powell's comments are later today.""}, {""date"": ""2023-06-14"", ""headline"": ""Elliott Wave Technical Analysis: Dexcom Inc., Wednesday, June 14"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-15"", ""headline"": ""Catalyst watch: Powell testifies to Congress, Microsoft-Activision Blizzard hearing and Dollar Tree event"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-15"", ""headline"": ""DexCom Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of DexCom Inc. advanced 3.09% to $130.98 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-06-15"", ""headline"": ""Spotlight Shines On Super Bowl, Chip Stocks And Nick Jonas"", ""summary"": ""As diabetes leader Dexcom pumps up 113% growth and a collaboration with Nick Jonas, Dexcom stock pokes at a new buy zone.""}, {""date"": ""2023-06-15"", ""headline"": ""Dow Jones Rallies After Surprise Rise In Jobless Claims; Tesla Stock Reverses Higher"", ""summary"": ""The Dow Jones rallied Thursday after a surprise rise in jobless claims. Tesla stock reversed higher after snapping a record win streak.""}, {""date"": ""2023-06-15"", ""headline"": ""DexCom (NASDAQ:DXCM) shareholder returns have been incredible, earning 410% in 5 years"", ""summary"": ""Long term investing can be life changing when you buy and hold the truly great businesses. While not every stock...""}, {""date"": ""2023-06-16"", ""headline"": ""I would use any upcoming sell-off as a chance to get into the stock market, say Jim Cramer"", ""summary"": ""'Mad Money' host Jim Cramer breaks down the market's strong week and looks ahead to next week's big earnings reports.""}, {""date"": ""2023-06-16"", ""headline"": ""DexCom Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of DexCom Inc. slipped 0.67% to $130.10 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-06-16"", ""headline"": ""As DexCom Breaks Out to the Upside, Further Gains Are Expected"", ""summary"": ""Medical device maker DexCom  has been climbing higher on the charts the past year.  Let's see what the indicators and price targets look like now.  The On-Balance-Volume (OBV) line dipped in May but has been climbing again in June.""}, {""date"": ""2023-06-16"", ""headline"": ""Dow Jones Rises After Cool Inflation Survey; Virgin Galactic Rockets 40% On Spaceflight Plans"", ""summary"": ""The Dow Jones rose Friday after a cool inflation survey. Virgin Galactic rocketed on plans to launch its first spaceflight in June.""}, {""date"": ""2023-06-16"", ""headline"": ""Dow Jones Rises Ahead Of Inflation Survey; Virgin Galactic Rockets 40% On Spaceflight Plans"", ""summary"": ""The Dow Jones rose Friday ahead of a key inflation survey. Virgin Galactic rocketed 40% on plans to launch its first spaceflight in June.""}]",{}
23,2023-06-18,130.10000610351562,2023-06-25,126.75,-0.025749469226389987,D3,"[{""date"": ""2023-06-20"", ""headline"": ""Here\u2019s Why the Invesco QQQ Trust ETF is Worth Considering"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-20"", ""headline"": ""If You Invested $1000 In This Stock 15 Years Ago, You Would Have $74,000 Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-20"", ""headline"": ""DexCom Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of DexCom Inc. slid 0.10% to $129.97 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-06-20"", ""headline"": ""Dow Jones Falls 375 Points After Key Housing Data; Alibaba Slides As CEO Steps Down"", ""summary"": ""The Dow Jones Industrial Average dropped Tuesday after key housing data. Chinese e-commerce giant Alibaba slid after the CEO stepped down.""}, {""date"": ""2023-06-20"", ""headline"": ""Elliott Wave Technical Analysis: DexCom Inc, June 20"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-21"", ""headline"": ""DexCom Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of DexCom Inc. slid 1.62% to $127.86 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-06-21"", ""headline"": ""Dow Jones Falls 150 Points As Powell Expects More Rate Hikes; Tesla Stock Downgraded"", ""summary"": ""The Dow Jones fell Wednesday, as Fed Chair Jerome Powell expects more rate hikes to fight inflation. Tesla stock was downgraded at Barclays.""}, {""date"": ""2023-06-21"", ""headline"": ""Dexcom G6 Strengthens Its Position as World\u2019s Most Connected CGM System"", ""summary"": ""LONDON, June 21, 2023--Dexcom G6 is now the first and only CGM to connect with the Omnipod\u00ae 5 Automated Insulin Delivery System in the United Kingdom""}, {""date"": ""2023-06-21"", ""headline"": ""Here\u2019s Why the Invesco QQQ Trust ETF is Appealing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-22"", ""headline"": ""DexCom Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of DexCom Inc. shed 1.05% to $126.52 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-06-22"", ""headline"": ""Dow Jones Falls After Jobless Claims; Powell Speech Now; Tesla Stock Downgraded"", ""summary"": ""The Dow Jones dropped Thursday morning after jobless claims ahead of Fed Chair Powell's speech. Tesla stock fell on another downgrade.""}, {""date"": ""2023-06-22"", ""headline"": ""3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio"", ""summary"": ""DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.""}, {""date"": ""2023-06-23"", ""headline"": ""Dow Jones Futures: Market Pullback Healthy As Apple Hits Record High; What To Do Now"", ""summary"": ""The market pullback appears healthy so far as Apple, Nvidia and other giants hold strong. MongoDB leads stocks near buy points.""}, {""date"": ""2023-06-23"", ""headline"": ""Dexcom, A Top 2% Stock, Raises 2025 Outlook Amid 'Rapidly' Expanding Diabetes Market"", ""summary"": ""Dexcom's revenue could reach $5 billion in 2025, the company said Friday as it announced a new CGM device. Dexcom stock could soar again.""}, {""date"": ""2023-06-23"", ""headline"": ""Global Continuous Glucose Monitoring Pioneer Dexcom Reveals New Plans to Bring Sensing Technology to Millions More"", ""summary"": ""SAN DIEGO, June 24, 2023--Global Continuous Glucose Monitoring Pioneer Dexcom Reveals New Plans to Bring Sensing Technology to Millions More""}, {""date"": ""2023-06-23"", ""headline"": ""Dexcom Updates Long-Range Financial Targets"", ""summary"": ""SAN DIEGO, June 24, 2023--Dexcom Updates Long-Range Financial Targets""}, {""date"": ""2023-06-23"", ""headline"": ""DexCom Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of DexCom Inc. inched 0.18% higher to $126.75 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-06-23"", ""headline"": ""DexCom Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-23"", ""headline"": ""DexCom call volume above normal and directionally bullish"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-23"", ""headline"": ""DexCom (DXCM) Stock Declined on Profit Taking"", ""summary"": ""The Ithaka Group, an investment advisory firm, released \u201cIthaka US Growth Strategy\u201d first-quarter investor letter. A copy of the same can be downloaded here. In the quarter, the strategy returned 21.8% gross and 21.7% net compared to 14.4% for the Russell 1000 Growth Index. The outperformance of the fund was due to stock selection, with [\u2026]""}, {""date"": ""2023-06-23"", ""headline"": ""Goldman adds 25 new stocks with growth potential to its ROE basket"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-25"", ""headline"": ""DexCom raises FY25 revenue guidance to $4.6B-$5.1B from $4B-$4.5B"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
24,2023-06-25,126.75,2023-07-02,128.50999450683594,0.013885558239336682,U2,"[{""date"": ""2023-06-25"", ""headline"": ""Dow Jones Futures Rise: Time To Buy These 5 Stocks Amid Market Pullback?"", ""summary"": ""Several stocks are near buy points, amid an orderly market pullback as Apple and other giants hold strong.""}, {""date"": ""2023-06-25"", ""headline"": ""What You Missed On Wall Street On Monday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-25"", ""headline"": ""DexCom raises 2025 financial targets after strong two years"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-25"", ""headline"": ""DexCom raises FY25 revenue guidance to $4.6B-$5.1B from $4B-$4.5B"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-26"", ""headline"": ""EVP Managing Director Steven Pacelli Sells 412 Shares of DexCom Inc (DXCM)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-26"", ""headline"": ""Dexcom, A Top 3% Stock, Raises 2025 Outlook Amid 'Rapidly' Expanding Diabetes Market"", ""summary"": ""Dexcom's revenue could reach $5 billion in 2025, the company said Friday as it announced a new CGM device. But Dexcom stock fell Monday.""}, {""date"": ""2023-06-26"", ""headline"": ""DexCom Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of DexCom Inc. slid 1.68% to $124.62 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-06-26"", ""headline"": ""DexCom Revises 2025 Outlook, Announces New Product For Diabetics"", ""summary"": ""DexCom Inc (NASDAQ: DXCM) disclosed the 2025 financial targets revision at its investor day last week. The company raised the outlook for revenue to $4.6 billion - $5.1 billion (from $4.0 billion - $4.5 billion), adjusted operating profit margin to 21% (from 20%), and adjusted EBITDA margin to 31% (from 30%) for 2025. On the other hand, the company reiterated 2025 guidance for an adjusted gross margin of 65%. \""Dexcom continues to execute on our vision to drive better health outcomes throughout t""}, {""date"": ""2023-06-26"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-26"", ""headline"": ""Dow Jones Futures Fall: Time To Buy These Stocks Amid Market Pullback? Tesla Downgraded Again"", ""summary"": ""Several stocks are near buy points, amid an orderly market pullback as Apple and other giants hold strong.""}, {""date"": ""2023-06-26"", ""headline"": ""DexCom Unusual Options Activity For June 26"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-26"", ""headline"": ""DexCom price target raised to $150 from $134 at BTIG"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-26"", ""headline"": ""Dexcom (DXCM) Gets a Buy from Jefferies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-26"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Dexcom (DXCM) and Genmab (GMAB)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-27"", ""headline"": ""BTIG Maintains Dexcom (DXCM) Buy Recommendation"", ""summary"": """"}, {""date"": ""2023-06-27"", ""headline"": ""DexCom Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of DexCom Inc. slumped 0.90% to $123.50 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-06-27"", ""headline"": ""Dexcom (DXCM) to Launch New Product in 2024, Ups Long-Term View"", ""summary"": ""Dexcom (DXCM) announces encouraging developments in 2024, including faster coverage for its products by private payers and new product launch for diabetic patients not on insulin.""}, {""date"": ""2023-06-28"", ""headline"": ""Peering Into DexCom's Recent Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-28"", ""headline"": ""Looking for a Growth Stock? 3 Reasons Why DexCom (DXCM) is a Solid Choice"", ""summary"": ""DexCom (DXCM) could produce exceptional returns because of its solid growth attributes.""}, {""date"": ""2023-06-28"", ""headline"": ""Here's How Much a $1000 Investment in DexCom Made 10 Years Ago Would Be Worth Today"", ""summary"": ""Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.""}, {""date"": ""2023-06-28"", ""headline"": ""Early notable gainers among liquid option names on June 28th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-29"", ""headline"": ""DexCom Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of DexCom Inc. rose 1.20% to $127.94 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-06-29"", ""headline"": ""DexCom (DXCM) Just Flashed Golden Cross Signal: Do You Buy?"", ""summary"": ""Should investors be excited or worried when a stock crosses above the 20-day simple moving average?""}, {""date"": ""2023-06-29"", ""headline"": ""Elliott Wave Technical Analysis: DexCom Inc. - Thursday, June 29"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-30"", ""headline"": ""DexCom Inc. stock rises Friday, still underperforms market"", ""summary"": ""Shares of DexCom Inc. inched 0.45% higher to $128.51 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""2023-06-30"", ""headline"": ""Friday's ETF Winners And Losers: Large-Cap Fund Flows - VOO and SPY Add More Than $1.5 Billion Each"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]","{""assetTurnoverTTM"": 0.5653, ""bookValue"": 2100.4, ""cashRatio"": 0.5773300478330193, ""currentRatio"": 2.4172, ""ebitPerShare"": 0.2969, ""eps"": 0.2686, ""ev"": 51685.71, ""fcfMargin"": 0.1507, ""fcfPerShareTTM"": 1.2069, ""grossMargin"": 0.6271, ""inventoryTurnoverTTM"": 2.9955, ""longtermDebtTotalAsset"": 0.3564, ""longtermDebtTotalCapital"": 0.4532, ""longtermDebtTotalEquity"": 1.1572, ""netDebtToTotalCapital"": 0.3856, ""netDebtToTotalEquity"": 0.9846, ""netMargin"": 0.133, ""operatingMargin"": 0.147, ""pb"": 23.623, ""peTTM"": 138.7908, ""pfcfTTM"": 106.4758, ""pretaxMargin"": 0.1828, ""psTTM"": 15.5172, ""ptbv"": 25.4947, ""quickRatio"": 2.122, ""receivablesTurnoverTTM"": 4.8766, ""roaTTM"": 0.0632, ""roeTTM"": 0.1725, ""roicTTM"": 0.0811, ""rotcTTM"": 0.1016, ""salesPerShare"": 2.0192, ""sgaToSale"": 0.3729, ""tangibleBookValue"": 1946.2, ""totalDebtToEquity"": 1.5535, ""totalDebtToTotalAsset"": 0.4784, ""totalDebtToTotalCapital"": 0.6084, ""totalRatio"": 1.445, ""period"": ""2023-06-30""}"
25,2023-07-02,128.50999450683594,2023-07-09,126.70999908447266,-0.014006657064074002,D2,"[{""date"": ""2023-07-03"", ""headline"": ""Netflix, Disney, Datadog among BofA's 10 best ideas for Q3"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-03"", ""headline"": ""Goldman Sachs Reveals Winning Portfolio: 'Rule of 10' Unlocks S&P 500's Future Top Performers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-04"", ""headline"": ""A Look Into DexCom Inc's Price Over Earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-04"", ""headline"": ""GLOBAL BRIEFING: Growth in China's services sector slows in June"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-04"", ""headline"": ""Dexcom G7 Receives Health Canada Approval: Next-Generation Continuous Glucose Monitoring System With Unmatched Accuracy Coming to Canadians"", ""summary"": ""BURNABY, British Columbia, July 04, 2023--Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, announced today that Health Canada has approved the next-generation Dexcom G7 Continuous Glucose Monitoring System for people with all types of diabetes, ages two years and older.""}, {""date"": ""2023-07-04"", ""headline"": ""DexCom's continuous glucose monitoring system gets Canadian approval"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-04"", ""headline"": ""Dexcom G7 Receives Health Canada Approval : Next-Generation Continuous Glucose Monitoring System With Unmatched Accuracy Coming to Canadians"", ""summary"": ""Dexcom G7 is the most accurate CGM system1 approved by Health Canada, building on the trusted performance of Dexcom CGM, which is clinically proven to lower A1C, reduce hypoglycemia, and improve time in range2,3,4.\n\n\n\nMade with users in mind, Dexcom G7 combines simplicity and power, introducing a better way to manage diabetes2,3,4.""}, {""date"": ""2023-07-04"", ""headline"": ""DexCom says Health Canada approved Dexcom G7"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-05"", ""headline"": ""DexCom Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of DexCom Inc. inched 0.83% higher to $128.07 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P...""}, {""date"": ""2023-07-05"", ""headline"": ""DexCom's (DXCM) G7 CGM System Gets Nod From Health Canada"", ""summary"": ""DexCom's (DXCM) G7 CGM System's latest approval by Health Canada is expected to combine simplicity and power, thereby providing a better way to manage diabetes.""}, {""date"": ""2023-07-05"", ""headline"": ""Dexcom G7 Continuous Glucose Monitoring System Gets Regulatory Nod From Health Canada"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-05"", ""headline"": ""Dexcom announces Health Canada approval for Dexcom G7"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-06"", ""headline"": ""Here's How Much You Would Have Made Owning DexCom Stock In The Last 5 Years"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-06"", ""headline"": ""Dow Jones Futures: Jobs Report On Tap; Threads Off To Record Start As Elon Musk Rips 'Cheating'"", ""summary"": ""Stocks retreated as Treasury yields jumped on hot economic data ahead of Friday's jobs report. Meta's Threads had record first-day downloads as Elon Musk decried \""cheating.\""""}, {""date"": ""2023-07-06"", ""headline"": ""Dow Jones Falls With Jobs Report Due; Meta's Threads Has Record Launch As Elon Musk Decries 'Cheating'"", ""summary"": ""Stocks retreated as Treasury yields jumped on hot economic data ahead of Friday's jobs report. Meta's Threads had record first-day downloads as Elon Musk decried \""cheating.\""""}, {""date"": ""2023-07-06"", ""headline"": ""DexCom Inc. stock falls Thursday, still outperforms market"", ""summary"": ""Shares of DexCom Inc. shed 0.29% to $127.70 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-07-06"", ""headline"": ""15 Best NASDAQ Stocks To Buy Today"", ""summary"": ""In this piece, we will take a look at 15 best NASDAQ stocks to buy today. If you want to skip our analysis of the stock market, market indexes, and recent developments, head on over to 5 Best NASDAQ Stocks To Buy Today. The U.S. economy finally appears to be stabilizing. Throughout 2023, worries of [\u2026]""}, {""date"": ""2023-07-06"", ""headline"": ""DexCom: Fantastic Growth But A High Premium To Pay Right Now"", ""summary"": ""DexCom's share price has increased by 414% over the last five years. Read more to see why I rate DXCM stock a hold currently rather than a buy.""}, {""date"": ""2023-07-06"", ""headline"": ""Dexcom Schedules Second Quarter 2023 Earnings Release and Conference Call for July 27, 2023 at 4:30 p.m. Eastern Time"", ""summary"": ""SAN DIEGO, July 06, 2023--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2023 financial results after market close on Thursday, July 27, 2023. Management will hold a conference call to review the company's second quarter 2023 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations website at investors.dexcom.com and will be""}, {""date"": ""2023-07-06"", ""headline"": ""Dexcom Schedules Second Quarter 2023 Earnings Release and Conference Call for July 27, 2023 at 4 : 30 p.m. Eastern Time"", ""summary"": ""DexCom, Inc.  today announced that it plans to release its second quarter 2023 financial results after market close on Thursday, July 27, 2023. Management will hold a conference call to review the...""}, {""date"": ""2023-07-07"", ""headline"": ""DexCom Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of DexCom Inc. dropped 0.78% to $126.71 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-07-07"", ""headline"": ""2 Growth Stocks That Could Double in 5 Years"", ""summary"": ""Turning an initial capital of, say, $1000 into double that in half a decade amounts to a compound annual growth rate of nearly 15%.  Let's look at two companies that appear able to accomplish this feat: DexCom (NASDAQ: DXCM) and Etsy (NASDAQ: ETSY).  DexCom is looking at a massive opportunity in the market for continuous glucose monitoring (CGM) systems.""}, {""date"": ""2023-07-07"", ""headline"": ""Dow Jones Futures Fall With Jobs Report Due; Meta Leads 7 Resilient Stocks"", ""summary"": ""The jobs report looms with Treasury yields soaring. Meta is among stocks holding up as Threads had record first-day downloads.""}, {""date"": ""2023-07-08"", ""headline"": ""Nvidia And This AI Stock Lead 5 Names Near Buy Points"", ""summary"": ""Nvidia stock has soared this year, but the artificial intelligence play has traded in a super-tight range the past three weeks, creating a new buy point.""}, {""date"": ""2023-07-09"", ""headline"": ""Goldman Sachs sees rays of hope in underperforming health sector"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]","{""assetTurnoverTTM"": 0.5653, ""bookValue"": 2100.4, ""cashRatio"": 0.5773300478330193, ""currentRatio"": 2.4172, ""ebitPerShare"": 0.2969, ""eps"": 0.2686, ""ev"": 51685.71, ""fcfMargin"": 0.1507, ""fcfPerShareTTM"": 1.2069, ""grossMargin"": 0.6271, ""inventoryTurnoverTTM"": 2.9955, ""longtermDebtTotalAsset"": 0.3564, ""longtermDebtTotalCapital"": 0.4532, ""longtermDebtTotalEquity"": 1.1572, ""netDebtToTotalCapital"": 0.3856, ""netDebtToTotalEquity"": 0.9846, ""netMargin"": 0.133, ""operatingMargin"": 0.147, ""pb"": 23.623, ""peTTM"": 138.7908, ""pfcfTTM"": 106.4758, ""pretaxMargin"": 0.1828, ""psTTM"": 15.5172, ""ptbv"": 25.4947, ""quickRatio"": 2.122, ""receivablesTurnoverTTM"": 4.8766, ""roaTTM"": 0.0632, ""roeTTM"": 0.1725, ""roicTTM"": 0.0811, ""rotcTTM"": 0.1016, ""salesPerShare"": 2.0192, ""sgaToSale"": 0.3729, ""tangibleBookValue"": 1946.2, ""totalDebtToEquity"": 1.5535, ""totalDebtToTotalAsset"": 0.4784, ""totalDebtToTotalCapital"": 0.6084, ""totalRatio"": 1.445, ""period"": ""2023-06-30""}"
26,2023-07-09,126.70999908447266,2023-07-16,137.32000732421875,0.08373457751090996,U5+,"[{""date"": ""2023-07-09"", ""headline"": ""Goldman Sachs sees rays of hope in underperforming health sector"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-10"", ""headline"": ""DexCom Inc. stock rises Monday, outperforms market"", ""summary"": ""Shares of DexCom Inc. rose 3.09% to $130.62 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-07-10"", ""headline"": ""DexCom price target raised to $150 from $146 at Citi"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-11"", ""headline"": ""DexCom Inc. stock rises Tuesday, still underperforms market"", ""summary"": ""Shares of DexCom Inc. inched 0.47% higher to $131.23 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""2023-07-11"", ""headline"": ""Citigroup Maintains Dexcom (DXCM) Buy Recommendation"", ""summary"": """"}, {""date"": ""2023-07-12"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-13"", ""headline"": ""DexCom (DXCM) Gains But Lags Market: What You Should Know"", ""summary"": ""In the latest trading session, DexCom (DXCM) closed at $133.98, marking a +0.23% move from the previous day.""}, {""date"": ""2023-07-13"", ""headline"": ""DexCom Inc. stock rises Thursday, still underperforms market"", ""summary"": ""Shares of DexCom Inc. inched 0.23% higher to $133.98 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the...""}, {""date"": ""2023-07-13"", ""headline"": ""AngioDynamics (ANGO) Q4 Earnings Lag Estimates, Revenues Top"", ""summary"": ""AngioDynamics (ANGO) registers strong revenue growth in the Med Tech and Med Device businesses in fourth-quarter fiscal 2023.""}, {""date"": ""2023-07-14"", ""headline"": ""DexCom Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of DexCom Inc. rose 2.49% to $137.32 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2023-07-14"", ""headline"": ""Here is Why Growth Investors Should Buy DexCom (DXCM) Now"", ""summary"": ""DexCom (DXCM) could produce exceptional returns because of its solid growth attributes.""}, {""date"": ""2023-07-14"", ""headline"": ""DexCom (DXCM) Stock Hits 52-Week High: More Room to Grow?"", ""summary"": ""DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.""}]","{""assetTurnoverTTM"": 0.5653, ""bookValue"": 2100.4, ""cashRatio"": 0.5773300478330193, ""currentRatio"": 2.4172, ""ebitPerShare"": 0.2969, ""eps"": 0.2686, ""ev"": 51685.71, ""fcfMargin"": 0.1507, ""fcfPerShareTTM"": 1.2069, ""grossMargin"": 0.6271, ""inventoryTurnoverTTM"": 2.9955, ""longtermDebtTotalAsset"": 0.3564, ""longtermDebtTotalCapital"": 0.4532, ""longtermDebtTotalEquity"": 1.1572, ""netDebtToTotalCapital"": 0.3856, ""netDebtToTotalEquity"": 0.9846, ""netMargin"": 0.133, ""operatingMargin"": 0.147, ""pb"": 23.623, ""peTTM"": 138.7908, ""pfcfTTM"": 106.4758, ""pretaxMargin"": 0.1828, ""psTTM"": 15.5172, ""ptbv"": 25.4947, ""quickRatio"": 2.122, ""receivablesTurnoverTTM"": 4.8766, ""roaTTM"": 0.0632, ""roeTTM"": 0.1725, ""roicTTM"": 0.0811, ""rotcTTM"": 0.1016, ""salesPerShare"": 2.0192, ""sgaToSale"": 0.3729, ""tangibleBookValue"": 1946.2, ""totalDebtToEquity"": 1.5535, ""totalDebtToTotalAsset"": 0.4784, ""totalDebtToTotalCapital"": 0.6084, ""totalRatio"": 1.445, ""period"": ""2023-06-30""}"
27,2023-07-16,137.32000732421875,2023-07-23,130.60000610351562,-0.04893679625895231,D5,"[{""date"": ""2023-07-16"", ""headline"": ""DexCom Inc. stock rises Monday, still underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-17"", ""headline"": ""DexCom Inc. stock rises Tuesday, still underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-17"", ""headline"": ""If You Invested $1000 in DexCom a Decade Ago, This is How Much It'd Be Worth Now"", ""summary"": ""Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.""}, {""date"": ""2023-07-17"", ""headline"": ""DexCom Reaches Analyst Target Price"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-18"", ""headline"": ""Senseonics initiated with an Underperform at Jefferies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-18"", ""headline"": ""DexCom Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-19"", ""headline"": ""DexCom Inc. stock falls Thursday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-19"", ""headline"": ""Senseonics begun at underperform at Jefferies on glucose monitoring market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-19"", ""headline"": ""Elliott Wave Technical Analysis: DexCom Inc. - Wednesday, July 19"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""DexCom Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""Top Picks: 3 Stocks That (Almost) All Analysts Agree On"", ""summary"": ""Regarding the best stocks to buy, some investors look to analyst consensus stocks \u2014 companies that everyone on Wall Street fawns over. I did a quick Finviz.com screen of S&P 500 companies. The lowest rating from analysts \u2014 the lower, the better \u2014 was 1.50 for DexCom (NASDAQ:DXCM), a maker of glucose monitoring systems. The highest was a tie among four companies, each with a 3.50 rating. The top 20 companies (including those that tied) rated between 1.50 for DXCM and 1.80. Of the 36 at 1.80 or le""}, {""date"": ""2023-07-21"", ""headline"": ""DexCom (DXCM) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""DexCom (DXCM) closed the most recent trading day at $130.60, moving -0.04% from the previous trading session.""}, {""date"": ""2023-07-21"", ""headline"": ""3 Highly-Ranked Large Cap Stocks to Buy Before Earnings for Big Upside"", ""summary"": ""Exploring three highly-ranked large-cap stocks--Honeywell, DexCom, and NextEra Energy--that investors might want to buy before their upcoming earnings releases for both near-term and long-term upside.""}, {""date"": ""2023-07-21"", ""headline"": ""Invesco QQQ Trust ETF: What Lies Ahead?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-23"", ""headline"": ""Good News: New Bull Market, Bad News: Growth Stocks Earnings Disappoint"", ""summary"": ""The stock market is revealing a new positive message, even as market participants sell on earnings reports. Click here to read more about the market outlook.""}]",{}
28,2023-07-23,130.60000610351562,2023-07-30,132.3800048828125,0.013629392772662063,U2,"[{""date"": ""2023-07-23"", ""headline"": ""DexCom Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-23"", ""headline"": ""Good News: New Bull Market, Bad News: Growth Stocks Earnings Disappoint"", ""summary"": ""The stock market is revealing a new positive message, even as market participants sell on earnings reports. Click here to read more about the market outlook.""}, {""date"": ""2023-07-24"", ""headline"": ""Are Medical Stocks Lagging  Boston Scientific (BSX) This Year?"", ""summary"": ""Here is how Boston Scientific (BSX) and DexCom (DXCM) have performed compared to their sector so far this year.""}, {""date"": ""2023-07-24"", ""headline"": ""DexCom (DXCM) to Report Q2 Earnings: What's in the Cards?"", ""summary"": ""DexCom's (DXCM) second-quarter 2023 results are likely to reflect rising volumes across all channels.""}, {""date"": ""2023-07-25"", ""headline"": ""EVP Managing Director Steven Pacelli Sells 412 Shares of DexCom Inc"", ""summary"": ""On July 24, 2023, Steven Pacelli, the Executive Vice President and Managing Director of DexCom Inc (NASDAQ:DXCM), sold 412 shares of the company.""}, {""date"": ""2023-07-25"", ""headline"": ""DexCom Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of DexCom Inc. advanced 1.75% to $129.96 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-07-25"", ""headline"": ""Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick"", ""summary"": ""The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.""}, {""date"": ""2023-07-26"", ""headline"": ""DexCom Non-GAAP EPS of $0.34 beats by $0.11, revenue of $871.3M beats by $30.35M"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-26"", ""headline"": ""DexCom  sees FY23 revenue $3.5B-$3.55B, consensus $3.5B"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-26"", ""headline"": ""DexCom  reports Q2 EPS 28c, consensus 23c"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-26"", ""headline"": ""DexCom options imply 5.7% move in share price post-earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-26"", ""headline"": ""GLOBAL BRIEFING: Stocks rise on hopes Fed's hiking cycle is over"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-26"", ""headline"": ""DexCom Inc. stock underperforms Wednesday when compared to competitors despite daily gains"", ""summary"": ""Shares of DexCom Inc. inched 0.56% higher to $130.69 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...""}, {""date"": ""2023-07-26"", ""headline"": ""If You Invested $1000 In This Stock 15 Years Ago, You Would Have $75,000 Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-27"", ""headline"": ""Compared to Estimates, DexCom (DXCM) Q2 Earnings: A Look at Key Metrics"", ""summary"": ""Although the revenue and EPS for DexCom (DXCM) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.""}, {""date"": ""2023-07-27"", ""headline"": ""DexCom (DXCM) Beats Q2 Earnings and Revenue Estimates"", ""summary"": ""DexCom (DXCM) delivered earnings and revenue surprises of 54.55% and 4.10%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?""}, {""date"": ""2023-07-27"", ""headline"": ""Dexcom Earnings Tops Estimates, Medical Device Maker Hikes Outlook"", ""summary"": ""Dexcom reported June-quarter earnings and revenue that topped Wall Street targets and raised its full-year sales outlook.""}, {""date"": ""2023-07-27"", ""headline"": ""Dexcom, Inc. (DXCM) Q2 2023 Earnings Call Transcript"", ""summary"": ""Dexcom, Inc. (NASDAQ:NASDAQ:DXCM) Q2 2023 Earnings Conference Call July 27, 2023 4:30 PM ETCompany ParticipantsSean Christensen - Director, Corporate Affairs & Head of IRKevin Sayer -...""}, {""date"": ""2023-07-27"", ""headline"": ""Dexcom Reports Second Quarter 2023 Financial Results"", ""summary"": ""SAN DIEGO, July 27, 2023--Dexcom Reports Second Quarter 2023 Financial Results""}, {""date"": ""2023-07-27"", ""headline"": ""DexCom, Inc. 2023 Q2 - Results - Earnings Call Presentation"", ""summary"": ""The following slide deck was published by DexCom, Inc.""}, {""date"": ""2023-07-27"", ""headline"": ""Stocks making the biggest moves after hours: Intel, Ford, Roku, Enphase Energy and more"", ""summary"": ""These are the stocks posting the largest moves in extended trading. ""}, {""date"": ""2023-07-27"", ""headline"": ""Dexcom lifts revenue forecast on demand for glucose-monitoring devices"", ""summary"": ""Medical device maker Dexcom Inc\non Thursday raised its annual revenue forecast after\nstrong demand for its continuous glucose monitoring \nsystems boosted second-quarter results, lifting its shares...""}, {""date"": ""2023-07-27"", ""headline"": ""DexCom Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of DexCom Inc. shed 1.02% to $129.36 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-07-27"", ""headline"": ""DexCom : Q2 Earnings Snapshot"", ""summary"": ""SAN DIEGO  \u2014 SAN DIEGO  \u2014 DexCom Inc.  on Thursday reported second-quarter earnings of $115.9 million.\n  The San Diego-based company said it had profit of 28 cents per share. Earnings,...""}, {""date"": ""2023-07-27"", ""headline"": ""DexCom: Q2 Earnings Snapshot"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-27"", ""headline"": ""Notable companies reporting after market close"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-27"", ""headline"": ""Fly Intel: After-Hours Movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-27"", ""headline"": ""DexCom boosts 2023 revenue guidance on Q2 results"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-28"", ""headline"": ""DexCom Inc. stock rises Friday, outperforms market"", ""summary"": ""Shares of DexCom Inc. rose 2.33% to $132.38 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-07-28"", ""headline"": ""Dow Jones Rises, Market Rallies Back As Inflation Cools; 5 Earnings Winners"", ""summary"": ""The Dow Jones and other major indexes rebounded, with key inflation data cooling. Roku and Intel were big earnings winners.""}, {""date"": ""2023-07-28"", ""headline"": ""DexCom (DXCM) Q2 Earnings Beat Estimates, Volumes Remain Strong"", ""summary"": ""DexCom's (DXCM) second-quarter 2023 results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system.""}, {""date"": ""2023-07-28"", ""headline"": ""Q2 2023 Dexcom Inc Earnings Call"", ""summary"": ""Q2 2023 Dexcom Inc Earnings Call""}, {""date"": ""2023-07-28"", ""headline"": ""Is DexCom (DXCM) Stock Fairly Valued? An In-Depth Analysis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-28"", ""headline"": ""Skechers, Chart Industries, Roku, Beazer Homes And Other Big Stocks Moving Higher On Friday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-28"", ""headline"": ""Early notable gainers among liquid option names on July 28th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-28"", ""headline"": ""DexCom price target raised to $154 from $140 at Raymond James"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-28"", ""headline"": ""DexCom price target raised to $160 from $150 at Piper Sandler"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-28"", ""headline"": ""6 Analysts Have This to Say About DexCom"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-28"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Axonics Modulation Technologies (AXNX) and Dexcom (DXCM)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-28"", ""headline"": ""DexCom price target raised to $150 from $135 at Oppenheimer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-28"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), Evolus (EOLS) and Icon (ICLR)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-28"", ""headline"": ""DexCom price target raised to $150 from $135 at Canaccord"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-28"", ""headline"": ""DexCom price target raised to $153 from $145 at Baird"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-28"", ""headline"": ""DexCom (DXCM) Q2 2023 Earnings Call Transcript"", ""summary"": ""Image source: The Motley Fool.  DexCom\u00a0(NASDAQ: DXCM)Q2\u00a02023 Earnings CallJul 27, 2023, 4:30 p.m. ETContents:  Prepared Remarks Questions and Answers Call Participants  Prepared Remarks:  OperatorLadies and gentlemen, welcome to the DexCom second quarter 2023 earnings release conference call.""}, {""date"": ""2023-07-29"", ""headline"": ""Baird Maintains Dexcom (DXCM) Outperform Recommendation"", ""summary"": """"}, {""date"": ""2023-07-29"", ""headline"": ""Raymond James Maintains Dexcom (DXCM) Strong Buy Recommendation"", ""summary"": """"}, {""date"": ""2023-07-29"", ""headline"": ""Piper Sandler Maintains Dexcom (DXCM) Overweight Recommendation"", ""summary"": """"}, {""date"": ""2023-07-29"", ""headline"": ""Canaccord Genuity Maintains Dexcom (DXCM) Buy Recommendation"", ""summary"": """"}, {""date"": ""2023-07-30"", ""headline"": ""Baron Small Cap Fund Q2 2023 Shareholder Letter"", ""summary"": ""Baron Small Cap Fund\u00c2\u00ae was up 6.49% (Institutional Shares) in the Q2 2023 and was up 16.54% for the first half of the year. Click here to read the full fund letter.""}, {""date"": ""2023-07-30"", ""headline"": ""Baron Opportunity Fund Q2 2023 Shareholder Letter"", ""summary"": ""During Q2 2023, Baron Opportunity Fund\u00c2\u00ae climbed 16.31% (Institutional Shares), outperforming the broader market. Click here to read the full fund letter.""}]",{}
29,2023-07-30,132.3800048828125,2023-08-06,120.33000183105469,-0.09102585441377575,D5+,"[{""date"": ""2023-07-30"", ""headline"": ""Why Apellis Pharmaceuticals  Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Monday's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-30"", ""headline"": ""Monday Sector Laggards: Healthcare, Utilities"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-30"", ""headline"": ""Baron Small Cap Fund Q2 2023 Shareholder Letter"", ""summary"": ""Baron Small Cap Fund\u00c2\u00ae was up 6.49% (Institutional Shares) in the Q2 2023 and was up 16.54% for the first half of the year. Click here to read the full fund letter.""}, {""date"": ""2023-07-30"", ""headline"": ""Baron Opportunity Fund Q2 2023 Shareholder Letter"", ""summary"": ""During Q2 2023, Baron Opportunity Fund\u00c2\u00ae climbed 16.31% (Institutional Shares), outperforming the broader market. Click here to read the full fund letter.""}, {""date"": ""2023-07-31"", ""headline"": ""DexCom Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-31"", ""headline"": ""DexCom: I Expect Growth To Continue At This Strong Rate, Buy"", ""summary"": ""DexCom posted strong results for 2Q23, with revenues of $871 million and EPS beating expectations. See why we believe DXCM stock is a buy.""}, {""date"": ""2023-07-31"", ""headline"": ""S&P 500: Entertainment Giants, AI Play Lead Monday's 5 Best; Medtech Firms Sicken"", ""summary"": ""Paramount and Disney, along with AI play Adobe, led the S&P 500. Dexcom and several medical products firms struggled.""}, {""date"": ""2023-07-31"", ""headline"": ""DexCom Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of DexCom Inc. slipped 5.91% to $124.56 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-07-31"", ""headline"": ""Tracking Baillie Gifford's 13F Portfolio - Q2 2023 Update"", ""summary"": ""Baillie Gifford's 13F portfolio value increased from ~$111B to ~$118B this quarter. Top three holdings make up ~17% of the portfolio. Click here to read more.""}, {""date"": ""2023-07-31"", ""headline"": ""Barclays Maintains Dexcom (DXCM) Equal-Weight Recommendation"", ""summary"": """"}, {""date"": ""2023-07-31"", ""headline"": ""Video: Nasdaq 100 Movers: DXCM, SIRI"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-31"", ""headline"": ""DexCom price target raised to $138 from $115 at Barclays"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-01"", ""headline"": ""DexCom Inc. stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-02"", ""headline"": ""DexCom Inc. stock falls Thursday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-03"", ""headline"": ""DexCom Inc. stock falls Friday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-03"", ""headline"": ""DexCom put volume heavy and directionally bearish"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-04"", ""headline"": ""Stryker Corp (SYK): A High-Performing Medical Device Stock with a GF Score of 90"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
30,2023-08-06,120.33000183105469,2023-08-13,111.69000244140625,-0.07180253684180227,D5+,"[{""date"": ""2023-08-06"", ""headline"": ""DexCom Inc. stock rises Monday, still underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-07"", ""headline"": ""DexCom Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-08"", ""headline"": ""DexCom Inc. stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-08"", ""headline"": ""Is DexCom Inc (DXCM) Modestly Undervalued? A Comprehensive Analysis"", ""summary"": ""An in-depth look at the valuation, financial strength, profitability, and growth of DexCom Inc (DXCM)""}, {""date"": ""2023-08-08"", ""headline"": ""Inogen (INGN) Q2 Earnings Beat Estimates, Revenues Down Y/Y"", ""summary"": ""Despite higher domestic business-to-business sales and rental revenues, Inogen's (INGN) overall second-quarter results reflect soft performances.""}, {""date"": ""2023-08-08"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-08"", ""headline"": ""Here's Why You Should Retain Insulet (PODD) Stock for Now"", ""summary"": ""Investors continue to be optimistic about Insulet (PODD) on the strength of the Omnipod 5 AID system.""}, {""date"": ""2023-08-08"", ""headline"": ""DXCM Makes Notable Cross Below Critical Moving Average"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-09"", ""headline"": ""DexCom Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-09"", ""headline"": ""Masimo (MASI) Q2 Earnings Lag Estimates, Margins Rise"", ""summary"": ""Despite strength in Hearables category, Masimo's (MASI) overall second-quarter results reflect soft performances.""}, {""date"": ""2023-08-09"", ""headline"": ""Investing $1,000 in These 2 Top Stocks Would Be a Brilliant Move"", ""summary"": ""For those needing inspiration, let's consider two stocks worth investing in: HCA Healthcare (NYSE: HCA) and DexCom (NASDAQ: DXCM).  HCA Healthcare runs a business that most people will have to interact with at some point.  The company is one of the largest hospital chains in the U.S. It ended the second quarter with 182 hospitals, unchanged from the previous year's comparable period.""}, {""date"": ""2023-08-09"", ""headline"": ""At US$110, Is DexCom, Inc. (NASDAQ:DXCM) Worth Looking At Closely?"", ""summary"": ""DexCom, Inc. ( NASDAQ:DXCM ) received a lot of attention from a substantial price movement on the NASDAQGS over the...""}, {""date"": ""2023-08-09"", ""headline"": ""This Is What Whales Are Betting On DexCom"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-10"", ""headline"": ""DexCom Inc. stock falls Friday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-10"", ""headline"": ""Is DexCom Inc (DXCM) Modestly Undervalued? A Comprehensive Valuation Analysis"", ""summary"": ""Insights into DexCom's financial performance, growth prospects, and intrinsic value""}, {""date"": ""2023-08-10"", ""headline"": ""Accuray (ARAY) Q4 Earnings and Revenues Lag Estimates"", ""summary"": ""Accuray (ARAY) reports a solid fiscal fourth quarter top line on the back of robust segmental performances.""}, {""date"": ""2023-08-10"", ""headline"": ""Avanos (AVNS) Q2 Earnings and Revenues Fall Shy of Estimates"", ""summary"": ""Despite strength in Avanos' (AVNS) Digestive Health segment, its overall second-quarter results reflect soft performances.""}, {""date"": ""2023-08-10"", ""headline"": ""What Are the Best Companies to Invest in Now? Our 3 Picks for August"", ""summary"": ""Uncertainty from geopolitical tensions within the Ukraine war and China issues has led to slower United States labor market growth. In this environment of uncertainty, the United States labor market has displayed a degree of resilience but at a notably slower pace of growth. On the other hand, this has led to the rise of the best companies to invest in. Recent data released by the Labor Department underscores this cautious trend, as it\u2019s revealed that U.S. employers added 187,000 jobs in July, r""}, {""date"": ""2023-08-10"", ""headline"": ""$1000 Invested In DexCom 10 Years Ago Would Be Worth This Much Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-10"", ""headline"": ""Early notable gainers among liquid option names on August 10th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-10"", ""headline"": ""Analysts Have Conflicting Sentiments on These Healthcare Companies: Charles River Labs (CRL), Vertex (VERX) and Dexcom (DXCM)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-11"", ""headline"": ""How Is The Market Feeling About DexCom?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-13"", ""headline"": ""The Sell-Off Caused By Wegovy And Mounjaro In Medtech Stocks Offers A Huge Opportunity"", ""summary"": ""Medical device stocks have experienced sell-offs due to concerns about the future impact of Wegovy And Mounjaro drugs. Read more to see my thoughts.""}]",{}
31,2023-08-13,111.69000244140625,2023-08-20,106.05000305175781,-0.05049690452471112,D5+,"[{""date"": ""2023-08-13"", ""headline"": ""DexCom Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-13"", ""headline"": ""The Sell-Off Caused By Wegovy And Mounjaro In Medtech Stocks Offers A Huge Opportunity"", ""summary"": ""Medical device stocks have experienced sell-offs due to concerns about the future impact of Wegovy And Mounjaro drugs. Read more to see my thoughts.""}, {""date"": ""2023-08-14"", ""headline"": ""DexCom Inc. stock outperforms market despite losses on the day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-14"", ""headline"": ""Is DexCom Inc (DXCM) Modestly Undervalued? A Comprehensive Valuation Analysis"", ""summary"": ""Understanding DexCom's intrinsic value and its potential for future returns""}, {""date"": ""2023-08-14"", ""headline"": ""Abbott (ABT) EPD Arm Grows, Low Testing Sales Play Spoilsport"", ""summary"": ""Banking on the successful execution of Abbott's (ABT) branded generic operating model, EPD is well positioned for sustained growth in many of the growing pharmaceutical markets.""}, {""date"": ""2023-08-15"", ""headline"": ""DexCom Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-15"", ""headline"": ""Is Caribou Biosciences (CRBU) Stock Outpacing Its Medical Peers This Year?"", ""summary"": ""Here is how Caribou Biosciences, Inc. (CRBU) and DexCom (DXCM) have performed compared to their sector so far this year.""}, {""date"": ""2023-08-15"", ""headline"": ""Dexcom Canada Achieves Great Place to Work\u00ae Certification for Second Consecutive Year"", ""summary"": ""BURNABY, British Columbia, August 15, 2023--Dexcom, Inc. (NASDAQ:DXCM), a global leader in real-time continuous glucose monitoring (rtCGM), is proud to announce that for the second consecutive year, it has been certified as a Great Place to Work\u00ae in Canada for 2023-24. Awarded by Great Place to Work Institute\u00ae, the global authority on workplace culture, this certification is based on direct feedback from employees about their workplace experience, and the sentiment of pride they feel in represen""}, {""date"": ""2023-08-16"", ""headline"": ""DexCom Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-16"", ""headline"": ""Amazon Pharmacy will offer $35 insulin as price cuts continue throughout the industry"", ""summary"": ""Amazon Pharmacy announced Tuesday its latest move to improve price transparency for pharmacy customers.""}, {""date"": ""2023-08-17"", ""headline"": ""Cohen\u2019s Point72 Cuts Broadcom, Meta, Google to Push Into Microsoft, NVIDIA and Micron"", ""summary"": """"}, {""date"": ""2023-08-18"", ""headline"": ""DexCom Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of DexCom Inc. shed 1.63% to $106.05 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2023-08-20"", ""headline"": ""7 Top Stock Opportunities on the Heels of the Latest Jobs Report"", ""summary"": ""The latest jobs report showed a slowing pace of hiring which will affect stock market opportunities. The July jobs report showed slowing hiring with low unemployment. The economy continues to cool, which lessens the chances that the Fed will decide to raise rates when the FOMC meets next in September. This signals investors that a soft landing remains a distinct possibility and that the markets can continue to move upward. Yet the economy continues to be challenging to judge, with many prominent""}]",{}
32,2023-08-20,106.05000305175781,2023-08-27,100.76000213623047,-0.04988213826779009,D5,"[{""date"": ""2023-08-20"", ""headline"": ""DexCom price target lowered to $130 from $153 at Baird"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-20"", ""headline"": ""Where DexCom Stands With Analysts"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-20"", ""headline"": ""7 Top Stock Opportunities on the Heels of the Latest Jobs Report"", ""summary"": ""The latest jobs report showed a slowing pace of hiring which will affect stock market opportunities. The July jobs report showed slowing hiring with low unemployment. The economy continues to cool, which lessens the chances that the Fed will decide to raise rates when the FOMC meets next in September. This signals investors that a soft landing remains a distinct possibility and that the markets can continue to move upward. Yet the economy continues to be challenging to judge, with many prominent""}, {""date"": ""2023-08-21"", ""headline"": ""Check Out What Whales Are Doing With DXCM"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-21"", ""headline"": ""DexCom Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of DexCom Inc. slipped 1.29% to $104.68 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-08-21"", ""headline"": ""3 Best Stocks to Buy Now, 8/21/2023, According to Top Analysts"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-22"", ""headline"": ""Is DexCom Inc (DXCM) Modestly Undervalued? A Comprehensive Valuation Analysis"", ""summary"": ""Unveiling the intrinsic value of DexCom's stock through the lens of GuruFocus' proprietary valuation method""}, {""date"": ""2023-08-22"", ""headline"": ""DexCom Inc. stock rises Tuesday, outperforms market"", ""summary"": ""Shares of DexCom Inc. rallied 2.20% to $106.98 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-08-22"", ""headline"": ""3 Revolutionary Stocks I'd Buy Right Now Without Hesitation"", ""summary"": ""Investors looking to earn outsized returns over long periods (which describes most investors) would do well to consider shares of innovative companies such as CRISPR Therapeutics (NASDAQ: CRSP), Sarepta Therapeutics (NASDAQ: SRPT), and DexCom (NASDAQ: DXCM).  Gene-editing specialist CRISPR Therapeutics currently has no products on the market.""}, {""date"": ""2023-08-22"", ""headline"": ""Baird Maintains Dexcom (DXCM) Outperform Recommendation"", ""summary"": """"}, {""date"": ""2023-08-23"", ""headline"": ""DexCom Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of DexCom Inc. shed 2.43% to $104.38 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-08-23"", ""headline"": ""Elliott Wave Technical Analysis: DexCom Inc. - Wednesday, Aug. 23"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-24"", ""headline"": ""DexCom Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of DexCom Inc. shed 3.26% to $100.98 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-08-24"", ""headline"": ""DexCom put volume heavy and directionally bearish"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-24"", ""headline"": ""EVP Managing Director Steven Pacelli Sells 411 Shares of DexCom Inc"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-24"", ""headline"": ""Estimating The Intrinsic Value Of DexCom, Inc. (NASDAQ:DXCM)"", ""summary"": ""Key Insights The projected fair value for DexCom is US$100 based on 2 Stage Free Cash Flow to Equity With US$104 share...""}, {""date"": ""2023-08-25"", ""headline"": ""DexCom Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of DexCom Inc. sank 0.22% to $100.76 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}]",{}
33,2023-08-27,100.76000213623047,2023-09-03,101.9000015258789,0.011314007200070586,U2,"[{""date"": ""2023-08-28"", ""headline"": ""DexCom Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of DexCom Inc. slipped 1.46% to $99.29 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-08-28"", ""headline"": ""Dexcom Appoints Rimma Driscoll to Board of Directors"", ""summary"": ""SAN DIEGO, August 28, 2023--Dexcom Appoints Rimma Driscoll to Board of Directors""}, {""date"": ""2023-08-28"", ""headline"": ""1 Stock-Split Stock Billionaires Are Buying Hand Over Fist and 1 Unexpected Stock-Split Stock They're Selling"", ""summary"": ""From time to time, shares of successful companies rise so high that everyday investors begin to shun them for no other reason than their high share price.  Stock splits allow companies to lower their stock prices to levels within reach of everyday investors by turning one share into 10, for example.  In theory, multiplying the number of outstanding shares by a specific amount should lower the price by an equal magnitude In practice, though, the extra attention that surrounds stock splits tends to drive their prices higher.""}, {""date"": ""2023-08-28"", ""headline"": ""Jefferies healthcare analyst holds an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-29"", ""headline"": ""DexCom Inc. stock rises Tuesday, still underperforms market"", ""summary"": ""Shares of DexCom Inc. advanced 1.30% to $100.58 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-08-29"", ""headline"": ""Is DexCom (DXCM) Significantly Undervalued? A Comprehensive Analysis"", ""summary"": ""Unearthing the True Value of DexCom Inc (DXCM)""}, {""date"": ""2023-08-29"", ""headline"": ""JPMorgan says time to buy MedTech based on past"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-29"", ""headline"": ""$1000 Invested In DexCom 15 Years Ago Would Be Worth This Much Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-30"", ""headline"": ""Stocks Keep Up Summer Rally Ahead of Inflation Data"", ""summary"": ""The S&P 500 increased 0.4%.  The tech-heavy Nasdaq Composite gained 0.5% while the blue-chip Dow Jones Industrial Average rose 38 points, or 0.1%.  U.S. gross domestic product rose at a 2.1% annualized rate in April through June after adjusting for seasonal effects and inflation, the Commerce Department said Wednesday.""}, {""date"": ""2023-08-30"", ""headline"": ""DexCom Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of DexCom Inc. advanced 2.82% to $103.42 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-08-30"", ""headline"": ""Is Trending Stock DexCom, Inc. (DXCM) a Buy Now?"", ""summary"": ""Recently, Zacks.com users have been paying close attention to DexCom (DXCM). This makes it worthwhile to examine what the stock has in store.""}, {""date"": ""2023-08-30"", ""headline"": ""Dexcom Announces Upcoming Conference Presentations"", ""summary"": ""SAN DIEGO, August 30, 2023--DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming investor conferences:""}, {""date"": ""2023-08-30"", ""headline"": ""Early notable gainers among liquid option names on August 30th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-31"", ""headline"": ""DexCom Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of DexCom Inc. slid 2.36% to $100.98 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-08-31"", ""headline"": ""Should You Hold DexCom (DXCM)?"", ""summary"": ""Baron Funds, an investment management company, released its \u201cBaron Small Cap Fund\u201d second-quarter 2023 investor letter. A copy of the same can be downloaded here. The fund was 6.49% (Institutional Shares) up in the second quarter and 16.54% up for the first half of the year. This quarter, the Fund underperformed the broader S&P 500 Index, [\u2026]""}, {""date"": ""2023-09-01"", ""headline"": ""DexCom (DXCM) Outpaces Stock Market Gains: What You Should Know"", ""summary"": ""In the latest trading session, DexCom (DXCM) closed at $101.90, marking a +0.91% move from the previous day.""}, {""date"": ""2023-09-01"", ""headline"": ""DexCom Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of DexCom Inc. inched 0.91% higher to $101.90 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""2023-09-01"", ""headline"": ""Dexcom G6 Strengthens Its Position as World\u2019s Most Connected CGM System With a New Aid Offering in Germany"", ""summary"": ""MAINZ, Germany, September 01, 2023--The Dexcom G6 is now the first and only CGM to connect with the Omnipod 5 Automated Insulin Delivery (AID) System in Germany.""}, {""date"": ""2023-09-01"", ""headline"": ""Dexcom G6 strengthens position as world\u2019s most connected CGM system with a new aid offering in Germany"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-01"", ""headline"": ""Dexcom G6 Strengthens Its Position as World's Most Connected CGM System With a New Aid Offering in Germany"", ""summary"": ""The world\u2019s most connected continuous glucose monitoring system,\u2020 Dexcom G6, is now the first and only CGM to connect with the Omnipod 5 Automated Insulin Delivery System in Germany....""}]",{}
34,2023-09-03,101.9000015258789,2023-09-10,104.3499984741211,0.024043149279246778,U3,"[{""date"": ""2023-09-05"", ""headline"": ""DexCom cites rising glucose monitor use amid weight loss therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-05"", ""headline"": ""DexCom Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of DexCom Inc. shed 1.54% to $100.33 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-09-05"", ""headline"": ""Why DexCom (DXCM) is a Top Growth Stock for the Long-Term"", ""summary"": ""The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.""}, {""date"": ""2023-09-05"", ""headline"": ""DexCom's (DXCM) G6 CGM Connects With Omnipod 5 AID in Germany"", ""summary"": ""DexCom's (DXCM) G6 CGM system and Omnipod 5 AID system can now simplify diabetes management and improve health outcomes in Germany.""}, {""date"": ""2023-09-06"", ""headline"": ""S&P 500 Gains and Losses Today: Index Drops Amid Renewed Fears of More Fed Rate Hikes"", ""summary"": ""U.S. equities fell for a second straight session on Sept. 6, 2023, with the S&P 500 Index losing 0.7% amid investors' concerns the Federal Reserve isn't done with raising interest rates yet.""}, {""date"": ""2023-09-06"", ""headline"": ""UBS Maintains Dexcom (DXCM) Buy Recommendation"", ""summary"": """"}, {""date"": ""2023-09-06"", ""headline"": ""Dexcom Says It Won't Be The Biggest Loser In The Weight-Loss Battle \u2014 And Shares Soar"", ""summary"": ""Dexcom stock surged Wednesday after the company allayed concerns that popular weight-loss drugs would tamp on its diabetes devices.""}, {""date"": ""2023-09-06"", ""headline"": ""DexCom Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of DexCom Inc. rallied 6.53% to $106.88 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-09-06"", ""headline"": ""Unveiling DexCom (DXCM)'s Value: Is It Really Priced Right? A Comprehensive Guide"", ""summary"": ""A deep dive into DexCom's valuation, financial strength, profitability, and growth prospects""}, {""date"": ""2023-09-06"", ""headline"": ""DexCom indicates rising glucose monitor use amid weight loss therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-06"", ""headline"": ""DexCom indicate rising use of glucose monitors amid weight loss therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-06"", ""headline"": ""US Stocks Drop As Rising Dollar, Treasury Yields, Oil Prices Weigh On Sentiment: What's Driving Markets Wednesday?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-06"", ""headline"": ""AeroVironment, Daktronics, GitLab And Other Big Stocks Moving Higher On Wednesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-06"", ""headline"": ""Dexcom rises after pushing back on GLP-1 concerns"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-06"", ""headline"": ""Expert Ratings for DexCom"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-06"", ""headline"": ""Early notable gainers among liquid option names on September 6th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-06"", ""headline"": ""Analysts\u2019 Opinions Are Mixed on These Healthcare Stocks: Moderna (MRNA), Dexcom (DXCM) and BioNTech SE (BNTX)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-06"", ""headline"": ""DexCom says CGM use increases in T2 diabetics on GLP-1s, says Jefferies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-06"", ""headline"": ""DexCom price target lowered to $138 from $175 at UBS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-06"", ""headline"": ""Analysts Conflicted on These Healthcare Names: Healthequity (HQY), Illumina (ILMN) and Dexcom (DXCM)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-07"", ""headline"": ""DexCom (DXCM) Dips More Than Broader Markets: What You Should Know"", ""summary"": ""DexCom (DXCM) closed the most recent trading day at $104.91, moving -1.84% from the previous trading session.""}, {""date"": ""2023-09-07"", ""headline"": ""DexCom Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of DexCom Inc. slipped 1.84% to $104.91 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2023-09-07"", ""headline"": ""Strength Seen in DexCom (DXCM): Can Its 6.5% Jump Turn into More Strength?"", ""summary"": ""DexCom (DXCM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.""}, {""date"": ""2023-09-07"", ""headline"": ""Insulet, Tandem Diabetes drop as weight loss drugs impact insulin use"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-07"", ""headline"": ""Dexcom Denies Weight Loss Drug Threat To CGM Sales - I'd Be A Little Concerned"", ""summary"": ""Dexcom faces new competition from GLP-1 agonist drugs. Market cap valuation has reached $40 billion. Find out why DXCM stock is a Sell.""}, {""date"": ""2023-09-08"", ""headline"": ""DexCom Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of DexCom Inc. shed 0.53% to $104.35 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-09-08"", ""headline"": ""How Is The Market Feeling About DexCom?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
35,2023-09-10,104.3499984741211,2023-09-17,96.3499984741211,-0.0766650705987697,D5+,"[{""date"": ""2023-09-10"", ""headline"": ""DexCom Inc. stock rises Monday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-10"", ""headline"": ""$100 Invested In This Stock 15 Years Ago Would Be Worth $6,500 Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-11"", ""headline"": ""DexCom Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-11"", ""headline"": ""Is DexCom, Inc. (NASDAQ:DXCM) A High Quality Stock To Own?"", ""summary"": ""While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...""}, {""date"": ""2023-09-12"", ""headline"": ""DexCom Inc. stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-12"", ""headline"": ""DexCom (DXCM) Rises 7% in One Week: What's Driving It?"", ""summary"": ""DexCom's (DXCM) shares have rallied nearly 7% over the past week, presumably on positive outlook for its CGM devices amid rising competition.""}, {""date"": ""2023-09-12"", ""headline"": ""Dexcom Unlocks Access to Real-Time CGM for a Further Half a Million People With Diabetes in France"", ""summary"": ""PARIS, September 12, 2023--Dexcom has announced the availability of its Dexcom ONE real-time CGM sensor via reimbursement in France.""}, {""date"": ""2023-09-12"", ""headline"": ""Why DexCom May Be Up To 40% Undervalued"", ""summary"": ""DexCom's business model focuses on continuous glucose monitoring systems for individuals with diabetes. Find out what makes DXCM stock an attractive investment.""}, {""date"": ""2023-09-13"", ""headline"": ""DexCom Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-13"", ""headline"": ""DexCom, Tandem Diabetes fall on Apple glucose monitor new team lead"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-13"", ""headline"": ""DexCom (DXCM) Outpaces Stock Market Gains: What You Should Know"", ""summary"": ""DexCom (DXCM) closed the most recent trading day at $105.22, moving +0.34% from the previous trading session.""}, {""date"": ""2023-09-13"", ""headline"": ""November 17th Options Now Available For DexCom (DXCM)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-14"", ""headline"": ""Unveiling DexCom (DXCM)'s Value: Is It Really Priced Right? A Comprehensive Guide"", ""summary"": ""Exploring DexCom's Intrinsic Value, Financial Strength, Profitability, and Growth Prospects""}, {""date"": ""2023-09-14"", ""headline"": ""Here's Why You Should Retain DexCom (DXCM) Stock for Now"", ""summary"": ""DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.""}, {""date"": ""2023-09-15"", ""headline"": ""Why DexCom Stock Dove by 5% Today"", ""summary"": ""A note from an increasingly cautious pundit may have created a downdraft for this high-flying glucose monitor company.""}, {""date"": ""2023-09-15"", ""headline"": ""Raymond James Maintains Dexcom (DXCM) Strong Buy Recommendation"", ""summary"": """"}, {""date"": ""2023-09-15"", ""headline"": ""DexCom Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of DexCom Inc. shed 5.12% to $96.35 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-09-15"", ""headline"": ""Becton Dickinson & Co. stock falls Friday, still outperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. slid 0.33% to $263.74 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-09-15"", ""headline"": ""Apple Taps Seasoned Executive To Head 'Secret' Team Developing Glucose Monitoring Device - Stocks To Watch"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-15"", ""headline"": ""DexCom Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
36,2023-09-17,96.3499984741211,2023-09-24,87.5,-0.09185260627168701,D5+,"[{""date"": ""2023-09-18"", ""headline"": ""DexCom Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-18"", ""headline"": ""DexCom Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of DexCom Inc. shed 1.09% to $95.30 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-09-18"", ""headline"": ""DexCom (DXCM) Launches Latest CGM Sensor ONE in France"", ""summary"": ""DexCom's (DXCM) latest CGM sensor, DexCom ONE, secures reimbursement coverage in France, bringing the real-time CGM sensor to half a million diabetes patients in the country.""}, {""date"": ""2023-09-18"", ""headline"": ""Interesting DXCM Put And Call Options For March 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-19"", ""headline"": ""DexCom (DXCM) Dips More Than Broader Markets: What You Should Know"", ""summary"": ""DexCom (DXCM) closed at $94.16 in the latest trading session, marking a -1.19% move from the prior day.""}, {""date"": ""2023-09-19"", ""headline"": ""DexCom Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of DexCom Inc. shed 1.19% to $94.16 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-09-19"", ""headline"": ""Becton Dickinson & Co. stock outperforms market on strong trading day"", ""summary"": ""Shares of Becton Dickinson & Co. inched 0.53% higher to $265.96 Tuesday, on what proved to be an all-around poor trading session for the stock market, with...""}, {""date"": ""2023-09-19"", ""headline"": ""Unveiling DexCom (DXCM)'s Value: Is It Really Priced Right? A Comprehensive Guide"", ""summary"": ""A deep dive into DexCom's valuation and financial performance""}, {""date"": ""2023-09-19"", ""headline"": ""Dexcom U Kicks off 2023 Season With Expanded Roster of Athletes With Diabetes, Building on First-of-its-Kind NIL Program"", ""summary"": ""SAN DIEGO, September 19, 2023--DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the launch of the second season of Dexcom U, the first-ever NIL (name, image, likeness) program exclusively for college athletes with diabetes, which had its inaugural season last year.""}, {""date"": ""2023-09-19"", ""headline"": ""First Week of DXCM December 15th Options Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-20"", ""headline"": ""DexCom Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of DexCom Inc. slid 1.62% to $92.63 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-09-20"", ""headline"": ""Becton Dickinson & Co. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Becton Dickinson & Co. inched 0.44% higher to $267.13 Wednesday, on what proved to be an all-around dismal trading session for the stock market,...""}, {""date"": ""2023-09-20"", ""headline"": ""3 Healthcare Stocks That Turned $100,000 Into $1 Million in 10 Years"", ""summary"": ""You don't have to invest in artificial intelligence or the latest tech company to earn great returns on your investments.  The healthcare industry is full of promising investment opportunities of its own.  DexCom (NASDAQ: DXCM), Eli Lilly (NYSE: LLY), and West Pharmaceutical Services (NYSE: WST) are three stocks that have each turned $100,000 investments into $1 million over the past 10 years.""}, {""date"": ""2023-09-21"", ""headline"": ""3 Unstoppable Nasdaq 100 Stocks Just Waiting to Be Bought"", ""summary"": ""A remarkable 30-year bull run for the Nasdaq 100 saw it gain nearly 4,000% by 2020. But, the party came to a screeching halt when the pandemic hit. Within a matter of weeks the tech-heavy index lost a third of its value and plunged deep into a bear market. Yet just as quickly, it made a U-turn and more than doubled again over the next 18 months. While that roller coaster ride was intense, it\u2019s been a bit rocky since, and the Nasdaq 100 still hasn\u2019t regained those former highs. It is within strik""}, {""date"": ""2023-09-21"", ""headline"": ""DexCom Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of DexCom Inc. slipped 3.83% to $89.08 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-09-21"", ""headline"": ""Becton Dickinson & Co. stock outperforms market despite losses on the day"", ""summary"": ""Shares of Becton Dickinson & Co. slipped 0.78% to $265.04 Thursday, on what proved to be an all-around poor trading session for the stock market, with the...""}, {""date"": ""2023-09-21"", ""headline"": ""Weight-Loss Drugs Like Wegovy Are Bad News for These Stocks"", ""summary"": ""Shares of companies that treat everything from Type 2 diabetes to sleep apnea have been sinking since new weight-loss medications skyrocketed.""}, {""date"": ""2023-09-21"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-21"", ""headline"": ""Dexcom Canada and RxFood Corporation Partner on Industry-Leading, AI-powered Nutrition and Glucose Monitoring Solution for Diabetes Management and Personalized Therapeutic Nutrition"", ""summary"": ""BURNABY, British Columbia, September 21, 2023--Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, and RxFood Corporation, the leader in AI-driven personalized nutrition assessments, announced today a first-of-its-kind partnership in Canada to introduce an improved digital health solution for those living with diabetes.""}, {""date"": ""2023-09-21"", ""headline"": ""Weight-Loss Drugs Are Bad News for Companies That Treat Obesity Complications"", ""summary"": ""Shares of companies that treat everything from Type 2 diabetes to sleep apnea have been sinking since new weight-loss medications skyrocketed.""}, {""date"": ""2023-09-22"", ""headline"": ""DexCom Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of DexCom Inc. slid 1.77% to $87.50 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-09-22"", ""headline"": ""Becton Dickinson & Co. stock rises Friday, outperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. inched 0.06% higher to $265.20 Friday, on what proved to be an all-around poor trading session for the stock market, with...""}, {""date"": ""2023-09-22"", ""headline"": ""2 Healthcare Stocks That Could Make You Richer"", ""summary"": ""There are many ways one can become richer, from trying to buy a winning lottery ticket to pouncing on some get-rich-quick scheme.  Unfortunately, none of these methods is very reliable at all, unlike investing in equities.  The stock market is for those who are willing to wait, and it won't increase one's wealth substantially overnight.""}, {""date"": ""2023-09-22"", ""headline"": ""DexCom Unusual Options Activity For September 22"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-23"", ""headline"": ""3 Healthcare Stocks That Should Be on Every Investor\u2019s Radar This Fall"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-24"", ""headline"": ""Navigating The S&P 500 Landscape: Here Are The Stocks Analysts Believe Have The Highest Potential And Biggest Downside"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-24"", ""headline"": ""Weight-loss drugs are bad news for medtech makers, Barron's says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
37,2023-09-24,87.5,2023-10-01,93.30000305175781,0.0662857491629465,U5+,"[{""date"": ""2023-09-24"", ""headline"": ""Navigating The S&P 500 Landscape: Here Are The Stocks Analysts Believe Have The Highest Potential And Biggest Downside"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-24"", ""headline"": ""Weight-loss drugs are bad news for medtech makers, Barron's says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-25"", ""headline"": ""DexCom Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of DexCom Inc. shed 1.65% to $86.06 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-09-25"", ""headline"": ""Becton Dickinson & Co. stock rises Monday, outperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. inched 0.59% higher to $266.77 Monday, on what proved to be an all-around great trading session for the stock market, with...""}, {""date"": ""2023-09-26"", ""headline"": ""DexCom Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of DexCom Inc. rose 2.97% to $88.62 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-09-26"", ""headline"": ""Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Becton Dickinson & Co. slid 2.19% to $260.94 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P...""}, {""date"": ""2023-09-26"", ""headline"": ""Unveiling DexCom (DXCM)'s Value: Is It Really Priced Right? A Comprehensive Guide"", ""summary"": ""Exploring the intrinsic value of DexCom (DXCM) and its potential for value investors""}, {""date"": ""2023-09-26"", ""headline"": ""Wall Street analysts expect the S&P 500 to rise 19% over the next 12 months. Here are their 10 favorite stocks."", ""summary"": ""Outside of a handful of highflying technology stocks, U.S. stocks have been practically flat in 2023, but on Wall Street, some analysts remain as bullish as...""}, {""date"": ""2023-09-27"", ""headline"": ""DexCom (NASDAQ:DXCM) Is Looking To Continue Growing Its Returns On Capital"", ""summary"": ""To find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is...""}, {""date"": ""2023-09-27"", ""headline"": ""DexCom Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of DexCom Inc. rallied 3.92% to $92.09 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-09-27"", ""headline"": ""Becton Dickinson & Co. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. slid 0.82% to $258.80 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P...""}, {""date"": ""2023-09-27"", ""headline"": ""DexCom (DXCM) Partners With RxFood for Automated Dietary Monitoring"", ""summary"": ""DexCom's (DXCM) CGM systems will make dietary assessment through AI-enabled RxFood app, which automatically interprets food images for calorie count in Canada.""}, {""date"": ""2023-09-28"", ""headline"": ""DexCom Inc. stock falls Friday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-28"", ""headline"": ""(DXCM) - Analyzing DexCom's Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-28"", ""headline"": ""DexCom Inc. stock rises Thursday, outperforms market"", ""summary"": ""Shares of DexCom Inc. rose 3.66% to $95.46 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-09-28"", ""headline"": ""Becton Dickinson & Co. stock outperforms market on strong trading day"", ""summary"": ""Shares of Becton Dickinson & Co. rallied 1.52% to $262.74 Thursday, on what proved to be an all-around positive trading session for the stock market, with...""}, {""date"": ""2023-09-28"", ""headline"": ""DexCom put volume heavy and directionally bearish"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-28"", ""headline"": ""This Is What Whales Are Betting On DexCom"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-28"", ""headline"": ""Early notable gainers among liquid option names on September 28th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-29"", ""headline"": ""Morgan Stanley Maintains Dexcom (DXCM) Equal-Weight Recommendation"", ""summary"": """"}, {""date"": ""2023-09-29"", ""headline"": ""Dexcom Schedules Third Quarter 2023 Earnings Release and Conference Call for October 26, 2023 at 4:30 p.m. Eastern Time."", ""summary"": ""SAN DIEGO, September 29, 2023--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2023 financial results after market close on Thursday, October 26, 2023. Management will hold a conference call to review the company's third quarter 2023 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations website at investors.dexcom.com and w""}, {""date"": ""2023-09-29"", ""headline"": ""Analyst Expectations for DexCom's Future"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-29"", ""headline"": ""DexCom price target lowered to $98 from $131 at Morgan Stanley"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-29"", ""headline"": ""Insulet price target lowered to $185 from $208 at Morgan Stanley"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-30"", ""headline"": ""Wall Street Breakfast: What Moved Markets"", ""summary"": ""Listen on the go! A daily podcast of Wall Street Breakfast will be available this morning""}, {""date"": ""2023-09-30"", ""headline"": ""Buy this Tech Stock on the Dip in October for 50% Upside?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]","{""assetTurnoverTTM"": 0.5596, ""bookValue"": 2267.9, ""cashRatio"": 0.38347432384129637, ""currentRatio"": 2.799, ""ebitPerShare"": 0.4815, ""eps"": 0.2828, ""ev"": 38504.92, ""fcfMargin"": 0.2244, ""fcfPerShareTTM"": 1.2935, ""grossMargin"": 0.6393, ""inventoryTurnoverTTM"": 3.0027, ""longtermDebtTotalAsset"": 0.3688, ""longtermDebtTotalCapital"": 0.4982, ""longtermDebtTotalEquity"": 1.0725, ""netDebtToTotalCapital"": 0.4037, ""netDebtToTotalEquity"": 0.869, ""netMargin"": 0.1238, ""operatingMargin"": 0.2108, ""pb"": 16.1092, ""peTTM"": 96.9075, ""pfcfTTM"": 73.0975, ""pretaxMargin"": 0.2466, ""psTTM"": 10.7359, ""ptbv"": 17.2055, ""quickRatio"": 2.3984, ""receivablesTurnoverTTM"": 5.0422, ""roaTTM"": 0.062, ""roeTTM"": 0.1727, ""roicTTM"": 0.0808, ""rotcTTM"": 0.1084, ""salesPerShare"": 2.2844, ""sgaToSale"": 0.3607, ""tangibleBookValue"": 2123.4, ""totalDebtToEquity"": 1.1528, ""totalDebtToTotalAsset"": 0.3964, ""totalDebtToTotalCapital"": 0.5355, ""totalRatio"": 1.524, ""period"": ""2023-09-30""}"
38,2023-10-01,93.30000305175781,2023-10-08,83.22000122070312,-0.10803860130061138,D5+,"[{""date"": ""2023-10-01"", ""headline"": ""DexCom Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-01"", ""headline"": ""Here's How Much You Would Have Made Owning DexCom Stock In The Last 15 Years"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-02"", ""headline"": ""DexCom Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-02"", ""headline"": ""DexCom (DXCM) Outpaces Stock Market Gains: What You Should Know"", ""summary"": ""In the latest trading session, DexCom (DXCM) closed at $94.55, marking a +1.34% move from the previous day.""}, {""date"": ""2023-10-02"", ""headline"": ""Why the Weight-Loss Drug Hype Looks Overdone"", ""summary"": ""Wall Street says insulin pump maker Insulet and Tandem Diabetes, as well as glucose-monitor maker DexCom, look ready to rise after pressure from Novo Nordisk's Wegovy and Eli Lilly.""}, {""date"": ""2023-10-02"", ""headline"": ""Weight-Loss-Drug Stock Sting May Be Easing for Device Makers"", ""summary"": ""Wall Street says insulin pump maker Insulet and Tandem Diabetes, as well as glucose-monitor maker DexCom, look ready to rise after pressure from Novo Nordisk's Wegovy and Eli Lilly.""}, {""date"": ""2023-10-02"", ""headline"": ""Unveiling DexCom (DXCM)'s Value: Is It Really Priced Right? A Comprehensive Guide"", ""summary"": ""An in-depth analysis of DexCom's intrinsic value and its implications for value investors""}, {""date"": ""2023-10-02"", ""headline"": ""DexCom announces new CGM data at EASD"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-02"", ""headline"": ""DexCom price target lowered to $115 from $150 at Citi"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-02"", ""headline"": ""Dexcom Solidifies Global Leadership in Continuous Glucose Monitoring With New Clinical Data Presented at EASD"", ""summary"": ""SAN DIEGO, October 02, 2023--Dexcom Solidifies Global Leadership in Continuous Glucose Monitoring with New Clinical Data Presented at EASD""}, {""date"": ""2023-10-03"", ""headline"": ""DexCom Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-03"", ""headline"": ""Citi turns cautious on pharmaceuticals and biotech"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-04"", ""headline"": ""DexCom Inc. stock falls Thursday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-04"", ""headline"": ""Glucose Game-Changers: 3 Diabetes Stocks to Grab on the Downturn"", ""summary"": ""In recent months, diabetes stocks have retreated sharply, partly due to the increased popularity of the weight-loss drug Semaglutide. Some have contended that Semaglutide will greatly reduce the number of people suffering from diabetes in America. But, I believe that this thesis is misguided for three reasons. First, the drug only reduces patients\u2019 weight by 15%-20%. Even after losing that amount of weight, a high percentage of Americans will still be meaningful overweight and obese, rendering t""}, {""date"": ""2023-10-04"", ""headline"": ""Video: Nasdaq 100 Movers: DXCM, ASML"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-05"", ""headline"": ""DexCom Inc. stock falls Friday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-05"", ""headline"": ""Diabetes-related stocks take hit over weight loss drug craze"", ""summary"": ""Weight loss drugs, like Novo Nordisk's (NVO) Ozempic, have become popular across healthcare providers in regard to diabetes treatment. Although use is limited due to affordability, shares of diabetes drugmakers (DXCM, PODD, TNDM) have seen declines while Ozempic has been a favored choice for consumers. Yahoo Finance Health Reporter Anjalee Khemlani explains the growing hype around the drugs and provides insight into what it means for the future of diabetic patients, while also commenting on the demand drops for insulin pumps and glucose monitors. For more expert insight and the latest market action,\u00a0click here\u00a0to watch this full episode of Yahoo Finance Live.""}, {""date"": ""2023-10-05"", ""headline"": ""Next-Generation Dexcom G7 Continuous Glucose Monitoring System Now Available in Canada"", ""summary"": ""BURNABY, British Columbia, October 05, 2023--Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, announced today that its next-generation Dexcom G7 Continuous Glucose Monitoring (CGM) System will be available on October 10, 2023, for Canadians living with all types of diabetes ages two and older, including those who are pregnant. Its introduction brings the most accurate CGM on the market*,1 to Canadians, offering users a new""}, {""date"": ""2023-10-05"", ""headline"": ""DexCom put volume heavy and directionally bearish"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-05"", ""headline"": ""These diabetes stocks, pummeled by the Ozempic craze, now look like bargains, analysts say\u00a0"", ""summary"": ""DexCom could be the first stock to break out of \u2018GLP jail,\u2019 analysts say, as market continues to punish device makers""}, {""date"": ""2023-10-05"", ""headline"": ""These diabetes stocks, pummeled by the Ozempic craze, now look like bargains, analysts say"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-07"", ""headline"": ""Wall Street Breakfast: What Moved Markets"", ""summary"": ""Listen on the go! A daily podcast of Wall Street Breakfast will be available this morning on Seeking Alpha, iTunes, Spotify.""}, {""date"": ""2023-10-08"", ""headline"": ""A Bull Market Is Coming: 2 Magnificent Stock-Split Growth Stocks That Could Soar 40% and 51%, According to Wall Street"", ""summary"": ""After spending much of last year headed in the wrong direction, Wall Street turned the tables in 2023, with many stocks making up lost ground.  Each of the major market indexes climbed at least 20% from their respective bottoms, though they have since given back some of those gains.  While stock splits don't change the underlying value of the company in question, they are historically preceded by a period of strong financial and stock performance, leading them to split their shares.""}]","{""assetTurnoverTTM"": 0.5596, ""bookValue"": 2267.9, ""cashRatio"": 0.38347432384129637, ""currentRatio"": 2.799, ""ebitPerShare"": 0.4815, ""eps"": 0.2828, ""ev"": 38504.92, ""fcfMargin"": 0.2244, ""fcfPerShareTTM"": 1.2935, ""grossMargin"": 0.6393, ""inventoryTurnoverTTM"": 3.0027, ""longtermDebtTotalAsset"": 0.3688, ""longtermDebtTotalCapital"": 0.4982, ""longtermDebtTotalEquity"": 1.0725, ""netDebtToTotalCapital"": 0.4037, ""netDebtToTotalEquity"": 0.869, ""netMargin"": 0.1238, ""operatingMargin"": 0.2108, ""pb"": 16.1092, ""peTTM"": 96.9075, ""pfcfTTM"": 73.0975, ""pretaxMargin"": 0.2466, ""psTTM"": 10.7359, ""ptbv"": 17.2055, ""quickRatio"": 2.3984, ""receivablesTurnoverTTM"": 5.0422, ""roaTTM"": 0.062, ""roeTTM"": 0.1727, ""roicTTM"": 0.0808, ""rotcTTM"": 0.1084, ""salesPerShare"": 2.2844, ""sgaToSale"": 0.3607, ""tangibleBookValue"": 2123.4, ""totalDebtToEquity"": 1.1528, ""totalDebtToTotalAsset"": 0.3964, ""totalDebtToTotalCapital"": 0.5355, ""totalRatio"": 1.524, ""period"": ""2023-09-30""}"
39,2023-10-08,83.22000122070312,2023-10-15,76.19000244140625,-0.08447486993725228,D5+,"[{""date"": ""2023-10-08"", ""headline"": ""A Bull Market Is Coming: 2 Magnificent Stock-Split Growth Stocks That Could Soar 40% and 51%, According to Wall Street"", ""summary"": ""After spending much of last year headed in the wrong direction, Wall Street turned the tables in 2023, with many stocks making up lost ground.  Each of the major market indexes climbed at least 20% from their respective bottoms, though they have since given back some of those gains.  While stock splits don't change the underlying value of the company in question, they are historically preceded by a period of strong financial and stock performance, leading them to split their shares.""}, {""date"": ""2023-10-09"", ""headline"": ""DexCom (DXCM) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""DexCom (DXCM) closed the most recent trading day at $83.09, moving -0.16% from the previous trading session.""}, {""date"": ""2023-10-09"", ""headline"": ""DexCom Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of DexCom Inc. dropped 0.16% to $83.09 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-10-09"", ""headline"": ""Becton Dickinson & Co. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Becton Dickinson & Co. rose 1.29% to $265.80 Monday, on what proved to be an all-around favorable trading session for the stock market, with the...""}, {""date"": ""2023-10-09"", ""headline"": ""Here's Why DexCom (DXCM) is a Strong Growth Stock"", ""summary"": ""The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.""}, {""date"": ""2023-10-09"", ""headline"": ""DexCom (DXCM) to Launch Latest CGM System G7 in Canada"", ""summary"": ""DexCom's (DXCM) G7 CGM System (launched in Canada) is expected to combine simplicity and power, thereby providing a better way to manage diabetes.""}, {""date"": ""2023-10-09"", ""headline"": ""Best Buy Will Sell Its First Prescription Medical Device, Pushing Further Into Healthcare"", ""summary"": ""The company will soon sell equipment for monitoring glucose levels, the next step in carving out its presence in the healthcare sphere.""}, {""date"": ""2023-10-09"", ""headline"": ""Best Buy to sell DexCom continuous glucose monitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-09"", ""headline"": ""Best Buy to Sell Dexcom's Continuous Glucose Monitoring Systems"", ""summary"": ""By Will Feuer Best Buy plans to start selling continuous glucose monitoring systems made by Dexcom, marking the electronics retailer's first foray into...""}, {""date"": ""2023-10-10"", ""headline"": ""DexCom Inc. stock rises Tuesday, outperforms market"", ""summary"": ""Shares of DexCom Inc. advanced 2.55% to $85.21 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-10-10"", ""headline"": ""Stifel Maintains Dexcom (DXCM) Buy Recommendation"", ""summary"": """"}, {""date"": ""2023-10-10"", ""headline"": ""Portfolio Comeback: My Plan For Getting Back On Track"", ""summary"": ""Financial writer addresses portfolio issues, aiming to achieve balance and align investments with major trends of the century. Learn what investors need to know.""}, {""date"": ""2023-10-10"", ""headline"": ""Video: Nasdaq 100 Movers: DXCM, LCID"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-10"", ""headline"": ""DexCom outlook stronger than recent selloff suggests, says Stifel"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-11"", ""headline"": ""DexCom Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of DexCom Inc. slipped 7.32% to $78.97 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-10-11"", ""headline"": ""Becton Dickinson & Co. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Becton Dickinson & Co. slipped 2.22% to $261.30 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with...""}, {""date"": ""2023-10-11"", ""headline"": ""FDA forms advisory committee to regulate digital health"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-11"", ""headline"": ""FDA forms advisory committee for digital health"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-11"", ""headline"": ""Video: Nasdaq 100 Movers: DXCM, ADBE"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-12"", ""headline"": ""DexCom Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-12"", ""headline"": ""DexCom Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of DexCom Inc. slipped 4.41% to $75.49 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-10-12"", ""headline"": ""Becton Dickinson & Co. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Becton Dickinson & Co. slipped 1.62% to $257.07 Thursday, on what proved to be an all-around rough trading session for the stock market, with the...""}, {""date"": ""2023-10-12"", ""headline"": ""The FDA Crash - Are Regulations Killing The Bull Case For Medical Devices And IHI?"", ""summary"": ""The formation of an FDA advisory committee sparked a decline in the iShares U.S. Medical Devices ETF and medical device industry. Learn more on IHI ETF here.""}, {""date"": ""2023-10-12"", ""headline"": ""DexCom call volume above normal and directionally bullish"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-12"", ""headline"": ""Most crowded longs and shorts going into earnings season"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-13"", ""headline"": ""DexCom Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of DexCom Inc. inched 0.93% higher to $76.19 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2023-10-13"", ""headline"": ""Becton Dickinson & Co. stock outperforms market on strong trading day"", ""summary"": ""Shares of Becton Dickinson & Co. inched 0.63% higher to $258.70 Friday, on what proved to be an all-around mixed trading session for the stock market, with...""}, {""date"": ""2023-10-14"", ""headline"": ""Piper sees GLP-1 drugs having limited impact on diabetes device market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-15"", ""headline"": ""ClearBridge Large Cap Growth ESG Q2 2023 Portfolio Manager Commentary"", ""summary"": ""The ClearBridge Large Cap Growth ESG Strategy underperformed its benchmark in the third quarter of 2023. Click here to read the full fund letter.""}, {""date"": ""2023-10-15"", ""headline"": ""ClearBridge Large Cap Growth Strategy Q3 2023 Portfolio Manager Commentary"", ""summary"": ""A sharp rise in yields and weakness among several health care and consumer positions weighed on relative performance, offsetting strong stock selection in the technology sector.""}]","{""assetTurnoverTTM"": 0.5596, ""bookValue"": 2267.9, ""cashRatio"": 0.38347432384129637, ""currentRatio"": 2.799, ""ebitPerShare"": 0.4815, ""eps"": 0.2828, ""ev"": 38504.92, ""fcfMargin"": 0.2244, ""fcfPerShareTTM"": 1.2935, ""grossMargin"": 0.6393, ""inventoryTurnoverTTM"": 3.0027, ""longtermDebtTotalAsset"": 0.3688, ""longtermDebtTotalCapital"": 0.4982, ""longtermDebtTotalEquity"": 1.0725, ""netDebtToTotalCapital"": 0.4037, ""netDebtToTotalEquity"": 0.869, ""netMargin"": 0.1238, ""operatingMargin"": 0.2108, ""pb"": 16.1092, ""peTTM"": 96.9075, ""pfcfTTM"": 73.0975, ""pretaxMargin"": 0.2466, ""psTTM"": 10.7359, ""ptbv"": 17.2055, ""quickRatio"": 2.3984, ""receivablesTurnoverTTM"": 5.0422, ""roaTTM"": 0.062, ""roeTTM"": 0.1727, ""roicTTM"": 0.0808, ""rotcTTM"": 0.1084, ""salesPerShare"": 2.2844, ""sgaToSale"": 0.3607, ""tangibleBookValue"": 2123.4, ""totalDebtToEquity"": 1.1528, ""totalDebtToTotalAsset"": 0.3964, ""totalDebtToTotalCapital"": 0.5355, ""totalRatio"": 1.524, ""period"": ""2023-09-30""}"
40,2023-10-15,76.19000244140625,2023-10-22,85.97000122070312,0.12836328213558157,U5+,"[{""date"": ""2023-10-14"", ""headline"": ""Piper sees GLP-1 drugs having limited impact on diabetes device market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-15"", ""headline"": ""Hennessy Funds is bullish on stocks. These in specific."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-15"", ""headline"": ""ClearBridge Large Cap Growth ESG Q2 2023 Portfolio Manager Commentary"", ""summary"": ""The ClearBridge Large Cap Growth ESG Strategy underperformed its benchmark in the third quarter of 2023. Click here to read the full fund letter.""}, {""date"": ""2023-10-15"", ""headline"": ""ClearBridge Large Cap Growth Strategy Q3 2023 Portfolio Manager Commentary"", ""summary"": ""A sharp rise in yields and weakness among several health care and consumer positions weighed on relative performance, offsetting strong stock selection in the technology sector.""}, {""date"": ""2023-10-16"", ""headline"": ""Leerink Partners Initiates Coverage of Dexcom (DXCM) with Outperform Recommendation"", ""summary"": """"}, {""date"": ""2023-10-16"", ""headline"": ""Why DexCom Stock Rallied on Monday"", ""summary"": ""Shares of DexCom (NASDAQ: DXCM) surged higher on Monday, gaining as much as 5.3%.  The catalyst that sent the medical device maker higher was bullish commentary by one Wall Street analyst.  Leerink analysts initiated coverage of DexCom with an outperform rating, while simultaneously assigning a $110 price target, according to The Fly.""}, {""date"": ""2023-10-16"", ""headline"": ""DexCom Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of DexCom Inc. advanced 3.62% to $78.95 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-10-16"", ""headline"": ""Becton Dickinson & Co. stock rises Monday, still underperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. inched 0.41% higher to $259.75 Monday, on what proved to be an all-around favorable trading session for the stock market,...""}, {""date"": ""2023-10-16"", ""headline"": ""Unveiling DexCom (DXCM)'s Value: Is It Really Priced Right? A Comprehensive Guide"", ""summary"": ""Discover the true value of DexCom Inc (DXCM) and understand if this stock is significantly undervalued""}, {""date"": ""2023-10-16"", ""headline"": ""Wayfair upgraded, JD.com downgraded: Wall Street's top analyst calls"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-16"", ""headline"": ""DexCom initiated with an Outperform at Leerink"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-16"", ""headline"": ""BTIG Sticks to Their Buy Rating for Dexcom (DXCM)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""Diabetes device stocks gain after Abbott CEO downplays GLP-1 threat"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""JP Morgan Maintains Dexcom (DXCM) Overweight Recommendation"", ""summary"": """"}, {""date"": ""2023-10-17"", ""headline"": ""Why the Market Dipped But DexCom (DXCM) Gained Today"", ""summary"": ""The latest trading day saw DexCom (DXCM) settling at $80.49, representing a +1.95% change from its previous close.""}, {""date"": ""2023-10-17"", ""headline"": ""Becton Dickinson & Co. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. slipped 0.17% to $259.30 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""2023-10-17"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""DexCom selloff gone too far, Ozempic concerns overblown, Barron's says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""DexCom put volume heavy and directionally bearish"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""J.P. Morgan Reaffirms Their Buy Rating on Dexcom (DXCM)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""Looking Into DexCom's Recent Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""Ozempic Fears Hammered DexCom Stock. The Concerns Are Overblown."", ""summary"": ""Worries that new weight loss drugs will impact demand for continuous glucose monitoring devices have gone too far.""}, {""date"": ""2023-10-17"", ""headline"": ""Analyst Expectations for DexCom's Future"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-18"", ""headline"": ""Becton Dickinson & Co. stock rises Wednesday, outperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. inched 0.04% higher to $259.40 Wednesday, on what proved to be an all-around grim trading session for the stock market, with...""}, {""date"": ""2023-10-18"", ""headline"": ""Can DexCom (DXCM) Keep the Earnings Surprise Streak Alive?"", ""summary"": ""DexCom (DXCM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.""}, {""date"": ""2023-10-18"", ""headline"": ""2 Healthcare Stocks Near Their 52-Week Lows That Could Double in Value"", ""summary"": ""Two companies that are in solid positions to capitalize on that potential are\u00a0DexCom\u00a0(NASDAQ: DXCM) and\u00a0InMode\u00a0(NASDAQ: INMD).  DexCom makes continuous glucose monitoring (CGM) devices that help people with diabetes easily track their glucose levels.  The company has some attractive growth potential as even people without diabetes could benefit from the devices by adjusting their eating habits if they learn they have high glucose numbers.""}, {""date"": ""2023-10-18"", ""headline"": ""Abbott Laboratories, Nasdaq, Spirit AeroSystems And Other Big Stocks Moving Higher On Wednesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-18"", ""headline"": ""Price Over Earnings Overview: DexCom"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-18"", ""headline"": ""3 Stock-Split Stocks With 110% to 696% Upside, According to Select Wall Street Analysts and Pundits"", ""summary"": ""Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there are three stock-split stocks select people on Wall Street believe offer mouthwatering upside.""}, {""date"": ""2023-10-18"", ""headline"": ""Early notable gainers among liquid option names on October 18th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-18"", ""headline"": ""DexCom price target lowered to $115 from $140 at BofA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-19"", ""headline"": ""DexCom Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of DexCom Inc. rallied 2.28% to $86.04 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-10-19"", ""headline"": ""Becton Dickinson & Co. stock outperforms market despite losses on the day"", ""summary"": ""Shares of Becton Dickinson & Co. dropped 0.74% to $257.48 Thursday, on what proved to be an all-around grim trading session for the stock market, with the...""}, {""date"": ""2023-10-19"", ""headline"": ""DexCom (DXCM) Earnings Expected to Grow: Should You Buy?"", ""summary"": ""DexCom (DXCM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.""}, {""date"": ""2023-10-19"", ""headline"": ""Does DexCom (DXCM) Have an Attractive Long-Term Runway for Growth?"", ""summary"": ""Baron Funds, an investment management company, released its \u201cBaron Health Care Fund\u201d third quarter 2023 investor letter. A copy of the same can be downloaded here. The fund declined 6.05% (Institutional Shares) in the quarter compared to a 3.88% loss for the Russell 3000 Health Care Index and a 3.27% loss for the S&P 500 Index. [\u2026]""}, {""date"": ""2023-10-19"", ""headline"": ""The 7 Best Nasdaq Stocks To Buy Now: October 2023"", ""summary"": ""Nasdaq stocks generally equate to higher-growth, technology-dominated firms in the eyes of most investors. The index is generally more rate-sensitive than leading indexes like the Dow and the S&P 500. This growth has led to the rise of the best Nasdaq stocks to buy. In any case, the Nasdaq contains more than 3,300 publicly listed firms and is also a stock exchange and not only an index. Its counterpart, the New York Stock Exchange, includes less than 3,000 publicly listed firms. In 2023, Nasdaq-""}, {""date"": ""2023-10-19"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-19"", ""headline"": ""Baron Health Care Fund Q3 2023 Shareholder Letter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-20"", ""headline"": ""DexCom Inc. stock outperforms market despite losses on the day"", ""summary"": ""Shares of DexCom Inc. shed 0.08% to $85.97 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-10-20"", ""headline"": ""Becton Dickinson & Co. stock outperforms market on strong trading day"", ""summary"": ""Shares of Becton Dickinson & Co. inched 0.45% higher to $258.64 Friday, on what proved to be an all-around poor trading session for the stock market, with...""}, {""date"": ""2023-10-20"", ""headline"": ""Here's How Much You Would Have Made Owning DexCom Stock In The Last 15 Years"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-20"", ""headline"": ""Top Investors\u2019 Stock Portfolio: 10 Mid-Cap Stocks To Buy"", ""summary"": ""In this piece, we will take a look at Top Investors\u2019 Stock Portfolio: 10 Mid-cap Stocks To Buy. If you want to skip our introduction to mid-cap stocks and the stock market, then take a look at Top Investors\u2019 Stock Portfolio: 5 Mid-Cap Stocks To Buy. Mid-cap stocks are typically large companies that have a [\u2026]""}, {""date"": ""2023-10-21"", ""headline"": ""Boston Sci, Stryker, Dexcom, Shockwave are BoA's top medtech picks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-21"", ""headline"": ""Wall Street Breakfast: What Moved Markets"", ""summary"": ""Listen on the go! A daily podcast of Wall Street Breakfast will be available this morning on Seeking Alpha, iTunes, Spotify.""}]",{}
41,2023-10-22,85.97000122070312,2023-10-29,89.29000091552734,0.03861811850276786,U4,"[{""date"": ""2023-10-22"", ""headline"": ""Insulet gets FDA okay for iPhone app for Omnipod 5 insulin pump"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-23"", ""headline"": ""DexCom Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of DexCom Inc. inched 0.06% higher to $86.02 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-10-23"", ""headline"": ""Becton Dickinson & Co. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Becton Dickinson & Co. slid 1.05% to $255.93 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P...""}, {""date"": ""2023-10-23"", ""headline"": ""Did GLP-1 And AI 'Jump The Shark' How Are Stocks Affected"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-23"", ""headline"": ""Early notable gainers among liquid option names on October 23rd"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-24"", ""headline"": ""DexCom's Earnings: A Preview"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-24"", ""headline"": ""DexCom Inc. stock rises Tuesday, still underperforms market"", ""summary"": ""Shares of DexCom Inc. inched 0.38% higher to $86.35 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""2023-10-24"", ""headline"": ""Becton Dickinson & Co. stock outperforms market on strong trading day"", ""summary"": ""Shares of Becton Dickinson & Co. advanced 1.28% to $259.21 Tuesday, on what proved to be an all-around great trading session for the stock market, with the...""}, {""date"": ""2023-10-24"", ""headline"": ""Here\u2019s Why DexCom (DXCM) Detracted in Q3"", ""summary"": ""Aristotle Atlantic Partners, LLC, an investment advisor, released its \u201cLarge Cap Growth Strategy\u201d third quarter 2023 investor letter. A copy of the same can be downloaded here. In the third quarter, Aristotle Atlantic\u2019s Large Cap Growth Strategy delivered -5.34% gross of fees (-5.51% net of fees) underperforming the Russell 1000 Growth Index\u2019s return of -3.13%. Security [\u2026]""}, {""date"": ""2023-10-25"", ""headline"": ""DexCom stock soars +14% after hours on raised revenue guidance, $500M share buyback"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-25"", ""headline"": ""DexCom Non-GAAP EPS of $0.50 beats by $0.17, revenue of $975M beats by $37.38M"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-25"", ""headline"": ""DexCom raises FY23 revenue view to $3.575B-$3.6B, consensus $3.54B"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-25"", ""headline"": ""DexCom announces $500M share repurchase program"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-25"", ""headline"": ""DexCom reports Q3 EPS 50c, consensus 34c"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-25"", ""headline"": ""This Is What Whales Are Betting On DexCom"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-25"", ""headline"": ""DexCom options imply 7.4% move in share price post-earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-25"", ""headline"": ""GLOBAL BRIEFING: Dollar crosses JPY150; StanChart profit down 54%"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-25"", ""headline"": ""DexCom Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of DexCom Inc. slipped 2.32% to $84.35 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-10-25"", ""headline"": ""Becton Dickinson & Co. stock outperforms market despite losses on the day"", ""summary"": ""Shares of Becton Dickinson & Co. slid 1.40% to $255.57 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P...""}, {""date"": ""2023-10-25"", ""headline"": ""MedTech Stocks to Watch for Earnings on Oct 26: WST, DXCM & More"", ""summary"": ""MedTech companies' Q3 results are likely to reflect strength in customer demand. Let's see how WST, DXCM, MMSI and ITGR are placed ahead of their earnings releases.""}, {""date"": ""2023-10-25"", ""headline"": ""How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings"", ""summary"": ""The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.""}, {""date"": ""2023-10-25"", ""headline"": ""DexCom (DXCM) to Report Q3 Earnings: Is a Beat in Store?"", ""summary"": ""DexCom's (DXCM) third-quarter 2023 results are likely to reflect rising volumes across all channels.""}, {""date"": ""2023-10-26"", ""headline"": ""What You Missed On Wall Street On Friday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-26"", ""headline"": ""DexCom (DXCM) Q3 2023 Earnings Call Transcript"", ""summary"": ""Thank you, operator, and welcome to DexCom's third quarter 2023 earnings call.  Please note that there are also slides available related to our third quarter performance on the DexCom investor relations website on the Events and Presentations page.""}, {""date"": ""2023-10-26"", ""headline"": ""MedTech Giant DexCom Spotlight Is On G7 US Launch, Analyst Forecasts 22% Revenue Gain In 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-26"", ""headline"": ""US Stocks Waver, Tech Outperforms As September Inflation Data Solidifies Interest Rate Hold; Oil Giants Fall: What's Driving Markets Friday?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-26"", ""headline"": ""DexCom Inc (DXCM) Reports Q3 2023 Financial Results, Raises Revenue and Margin Guidance"", ""summary"": ""Announces $500 Million Share Repurchase Program""}, {""date"": ""2023-10-26"", ""headline"": ""DexCom (DXCM) Reports Q3 Earnings: What Key Metrics Have to Say"", ""summary"": ""The headline numbers for DexCom (DXCM) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.""}, {""date"": ""2023-10-26"", ""headline"": ""DexCom (DXCM) Q3 Earnings and Revenues Surpass Estimates"", ""summary"": ""DexCom (DXCM) delivered earnings and revenue surprises of 47.06% and 4.02%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?""}, {""date"": ""2023-10-26"", ""headline"": ""Dexcom Surges 15% After Shrugging Off Weight-Loss Woes In Boosted Outlook"", ""summary"": ""Dexcom topped third-quarter expectations Thursday, shrugging off concerns new weight-loss drugs would undercut its sales. DXCM stock popped.""}, {""date"": ""2023-10-26"", ""headline"": ""Dexcom Reports Third Quarter 2023 Financial Results, Raises 2023 Revenue and Margin Guidance, and Announces $500 Million Share Repurchase Program"", ""summary"": ""SAN DIEGO, October 26, 2023--Dexcom Reports Third Quarter 2023 Financial Results, Raises 2023 Revenue and Margin Guidance, and Announces $500 Million Share Repurchase Program""}, {""date"": ""2023-10-26"", ""headline"": ""Dexcom, Inc. (DXCM) Q3 2023 Earnings Call Transcript"", ""summary"": ""Dexcom, Inc. (NASDAQ:NASDAQ:DXCM) Q3 2023 Earnings Conference Call October 26, 2023 4:30 PM ETCompany ParticipantsSean Christensen - Director, Corporate...""}, {""date"": ""2023-10-26"", ""headline"": ""DexCom, Inc. 2023 Q3 - Results - Earnings Call Presentation"", ""summary"": ""The following slide deck was published by DexCom, Inc.""}, {""date"": ""2023-10-26"", ""headline"": ""DexCom Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of DexCom Inc. shed 3.86% to $81.09 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-10-26"", ""headline"": ""Glucose monitor maker DexCom\u2019s stock soars after big earnings beat, raised revenue outlook as real-time monitoring awareness grows"", ""summary"": ""Shares of DexCom Inc. shot up 15.3% to pace the S&P 500\u2019s after-hours gainers on Thursday, after of maker of glucose monitoring systems reported...""}, {""date"": ""2023-10-26"", ""headline"": ""Becton Dickinson & Co. stock falls Thursday, still outperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. shed 0.54% to $254.18 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P...""}, {""date"": ""2023-10-26"", ""headline"": ""DexCom 3Q Profit Jumps Amid New Customer Additions"", ""summary"": ""By Jeffrey T. Lewis DexCom's profit jumped in the third quarter after volume growth boosted sales in the U.S. and abroad. The San Diego-based medical devices...""}, {""date"": ""2023-10-26"", ""headline"": ""DexCom: Q3 Earnings Snapshot"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-26"", ""headline"": ""Here\u2019s Why DexCom (DXCM) Sold Off in Q3"", ""summary"": ""Carillon Tower Advisers, an investment management company, released its \u201cCarillon Eagle Mid Cap Growth Fund\u201d third quarter 2023 investor letter. A copy of the same can be downloaded here. In the third quarter, mid-cap stocks had negative returns, reversing their positive returns in the first half of the year. The Russell Midcap Growth Index was down [\u2026]""}, {""date"": ""2023-10-26"", ""headline"": ""2 Best Healthcare Stocks to Buy Right Now"", ""summary"": ""The healthcare industry may not be as hot with investors as artificial intelligence or other high-flying industries, but the range of essential needs these businesses serve provides opportunities ripe for investor cash in a range of market environments.  For long-term investors, that can pose a tempting buying proposition in both bull and bear market environments.  Vertex Pharmaceuticals (NASDAQ: VRTX) is one of those healthcare businesses that has proven its ability to penetrate, expand, and disrupt markets where patients have historically had few to no options to treat rare medical conditions.""}, {""date"": ""2023-10-26"", ""headline"": ""Notable companies reporting after market close"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-26"", ""headline"": ""Dexcom\u2019s Outstanding Q3 Performance and Future Prospects: A Comprehensive Analysis of its Bullish Stance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-26"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Veralto Corporation (VLTO), Dexcom (DXCM) and CSL (OtherCMXHF)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-26"", ""headline"": ""Fly Intel: After-Hours Movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-26"", ""headline"": ""Ithaka Group Q3 2023 U.S. Growth Commentary"", ""summary"": ""The market\u00e2\u0080\u0099s retracement coincided with fading expectations for a \u00e2\u0080\u009cFed pivot,\u00e2\u0080\u009d with Wall Street having to admit we are in a \u00e2\u0080\u009chigher for longer\u00e2\u0080\u009d scenario until proven otherwise.""}, {""date"": ""2023-10-26"", ""headline"": ""DXCM, GRPN and MASI are among materials  movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-26"", ""headline"": ""12 Health Care Stocks Moving In Thursday's After-Market Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-27"", ""headline"": ""Stock Market Ends Week Mixed; Nasdaq Was Only Winner Friday"", ""summary"": ""The stock market had mixed results on Friday afternoon with the Nasdaq the only major index with a gain.""}, {""date"": ""2023-10-27"", ""headline"": ""Dexcom Surges 10% After Shrugging Off Weight-Loss Woes In Boosted Outlook"", ""summary"": ""Dexcom topped third-quarter expectations, shrugging off concerns new weight-loss drugs would undercut its sales. DXCM stock popped Friday.""}, {""date"": ""2023-10-27"", ""headline"": ""Dexcom Stock Soars on Earnings. Ozempic Isn\u2019t the Threat It Was Supposed to Be."", ""summary"": ""The maker of continuous glucose monitoring devices said there was no sign weight-loss drugs were hurting demand for its products.""}, {""date"": ""2023-10-27"", ""headline"": ""DexCom Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of DexCom Inc. surged 10.11% to $89.29 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-10-27"", ""headline"": ""Dexcom Surges 11% After Shrugging Off Weight-Loss Woes In Boosted Outlook"", ""summary"": ""Dexcom topped third-quarter expectations, shrugging off concerns new weight-loss drugs would undercut its sales. DXCM stock popped Friday.""}, {""date"": ""2023-10-27"", ""headline"": ""Becton Dickinson & Co. stock falls Friday, underperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. slipped 1.02% to $251.60 Friday, on what proved to be an all-around dismal trading session for the stock market, with the...""}, {""date"": ""2023-10-27"", ""headline"": ""IN BRIEF: DexCom revenue and net income climb boosted by volume growth"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-27"", ""headline"": ""DexCom, Inc. (NASDAQ:DXCM) Q3 2023 Earnings Call Transcript"", ""summary"": ""DexCom, Inc. (NASDAQ:DXCM) Q3 2023 Earnings Call Transcript October 26, 2023 DexCom, Inc. beats earnings expectations. Reported EPS is $0.5, expectations were $0.34. Operator: Welcome to the Dexcom Third Quarter 2023 Earnings Release Conference Call. My name is Montieth [Ph] and I will be your operator for today\u2019s call. At this time, all participants are [\u2026]""}, {""date"": ""2023-10-27"", ""headline"": ""Markets Mixed at Midday as Tech Sector Gets a Boost From Amazon"", ""summary"": ""U.S. equities were mixed at midday on Friday, Oct. 27, 2023, as the tech sector got a lift from Amazon, which beat profit and sales estimates.""}, {""date"": ""2023-10-27"", ""headline"": ""Morgan Stanley Maintains Dexcom (DXCM) Equal-Weight Recommendation"", ""summary"": """"}, {""date"": ""2023-10-27"", ""headline"": ""3 Revolutionary Stocks I'd Buy Right Now Without Hesitation"", ""summary"": ""These businesses are in widely disparate industries, but each has a growth story poised for long-term investor gains.""}, {""date"": ""2023-10-27"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-27"", ""headline"": ""Amazon, Intel rise; Ford, Chart Industries fall, Friday, 10/27/2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-27"", ""headline"": ""Why Barnes Group Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Friday's Mid-Day Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-27"", ""headline"": ""Q3 2023 Dexcom Inc Earnings Call"", ""summary"": ""Q3 2023 Dexcom Inc Earnings Call""}, {""date"": ""2023-10-27"", ""headline"": ""DexCom (DXCM) Beats on Q3 Earnings, Raises Sales Outlook"", ""summary"": ""DexCom's (DXCM) third-quarter 2023 results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system.""}, {""date"": ""2023-10-27"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-27"", ""headline"": ""Chipotle, Amazon, Deckers Outdoor, Capital One And Other Stocks Move Higher On Friday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-27"", ""headline"": ""Investors Take Note: DexCom Is Back!"", ""summary"": ""DexCom's strong Q3 performance and market expansion strategy suggest resilience in healthcare. Click here to read my latest analysis of DXCM stock.""}, {""date"": ""2023-10-27"", ""headline"": ""Biggest stock movers today: Chipotle, Intel, Amazon, Ford Motor and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-27"", ""headline"": ""Sanofi, Dexcom among healthcare movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-27"", ""headline"": ""Diabetes stocks jump as obesity-drug recovery comes ahead of schedule, analysts say"", ""summary"": ""DexCom's strong quarterly results give device makers a boost.""}, {""date"": ""2023-10-27"", ""headline"": ""Early notable gainers among liquid option names on October 27th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-27"", ""headline"": ""12 Health Care Stocks Moving In Friday's Pre-Market Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-27"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), Aclaris Therapeutics (ACRS) and Merck & Company (MRK)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-27"", ""headline"": ""S&P 500 Futures Rise in Premarket Trading; Enphase Energy, Bio-Rad Labs A Lag"", ""summary"": ""With U.S. stock markets set to open in two hours, (DXCM) was up 18.1% in pre-market trading, and (DECK) was up 10.3%. (PODD), (INTC), and (AMZN) were all...""}, {""date"": ""2023-10-27"", ""headline"": ""Oppenheimer Sticks to Its Buy Rating for Dexcom (DXCM)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-27"", ""headline"": ""DexCom price target lowered to $135 from $160 at Piper Sandler"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-27"", ""headline"": ""Today\u2019s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on\u00a0Friday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-27"", ""headline"": ""DexCom price target lowered to $110 from $150 at TD Cowen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-27"", ""headline"": ""DexCom price target lowered to $112 from $150 at Canaccord"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-27"", ""headline"": ""Piper Sandler Remains a Buy on Dexcom (DXCM)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-27"", ""headline"": ""DexCom (NASDAQ:DXCM) Surges After Strong Q3 Results"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-27"", ""headline"": ""Dexcom\u2019s Strong Q3 Results and Promising Prospects: A Buy Rating Analysis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-27"", ""headline"": ""Biggest stock movers today: Intel, Amazon, Ford Motor and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-27"", ""headline"": ""Shares of Amazon, Intel climb after earnings beats, as NatWest and Sanofi tumble on warnings, and other stocks on the move"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-29"", ""headline"": ""The DexCom Inc (DXCM) Company: A Short SWOT Analysis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
42,2023-10-29,89.29000091552734,2023-11-05,97.45999908447266,0.09149958657380375,U5+,"[{""date"": ""2023-10-29"", ""headline"": ""The DexCom Inc (DXCM) Company: A Short SWOT Analysis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-30"", ""headline"": ""Wall Street Analysts Are Bullish on Top Healthcare Picks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-30"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), AbbVie (ABBV) and Merck & Company (MRK)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-30"", ""headline"": ""11 Undervalued Mid Cap Stocks To Buy According to Analysts"", ""summary"": ""In this piece, we will take a look at the 11 undervalued mid cap stocks to buy. If you want to skip our analysis of mid cap investing and the stock market, then check out 5 Undervalued Mid Cap Stocks To Buy. When it comes to selecting stocks, different sectors allow investors to cater to [\u2026]""}, {""date"": ""2023-10-30"", ""headline"": ""11 Best Long-term Stocks To Buy For High Returns"", ""summary"": ""In this piece, we will take a look at the 11 best long term stocks to buy for high returns. If you want to skip our introduction to the current drivers of stock market performance, then check out 5 Best Long-term Stocks To Buy For High Returns. The stock market is made up of thousands [\u2026]""}, {""date"": ""2023-10-30"", ""headline"": ""DexCom Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of DexCom Inc. shed 4.91% to $84.91 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-10-30"", ""headline"": ""Becton Dickinson & Co. stock falls Monday, underperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. shed 0.20% to $251.09 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""2023-10-30"", ""headline"": ""Ensign Group (ENSG) Q3 Earnings Beat on Occupancy, Stock Up 2.4%"", ""summary"": ""Ensign Group's (ENSG) third-quarter results benefit on solid segmental contribution and occupancy strength. Management currently expects adjusted EPS to be within $4.73-$4.79 for 2023.""}, {""date"": ""2023-10-30"", ""headline"": ""Dexcom (DXCM) Faces Challenges Over GLP-1s\u2019 Long-Term Effects on Its Target Market"", ""summary"": ""The Ithaka Group, an investment advisory firm, released the \u201cIthaka US Growth Strategy\u201d third-quarter 2023 investor letter. A copy of the same can be downloaded here. In the weak market, the fund underperformed during the quarter, by falling 6.3% compared to the Dow\u2019s 2.6% fall, the S&P 500\u2019s 3.7% decline, the NASDAQ\u2019s 4.1% decline, and the [\u2026]""}, {""date"": ""2023-10-30"", ""headline"": ""Unveiling DexCom (DXCM)'s Value: Is It Really Priced Right? A Comprehensive Guide"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-31"", ""headline"": ""DexCom: Q3 2023 Results Were Fantastic And I Remain Bullish"", ""summary"": ""Dexcom's impressive 3Q23 financial results, driven by growth in US & international markets, point to a strong outlook and potential premium trading. Read more here.""}, {""date"": ""2023-10-31"", ""headline"": ""3 Reasons Growth Investors Will Love DexCom (DXCM)"", ""summary"": ""DexCom (DXCM) is well positioned to outperform the market, as it exhibits above-average growth in financials.""}, {""date"": ""2023-10-31"", ""headline"": ""Becton Dickinson & Co. stock outperforms market on strong trading day"", ""summary"": ""Shares of Becton Dickinson & Co. inched 0.67% higher to $252.78 Tuesday, on what proved to be an all-around favorable trading session for the stock market,...""}, {""date"": ""2023-10-31"", ""headline"": ""What Makes DexCom (DXCM) a New Buy Stock"", ""summary"": ""DexCom (DXCM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).""}, {""date"": ""2023-10-31"", ""headline"": ""12 Best Internet of Things (IoT) Stocks To Buy"", ""summary"": ""In this piece, we will take a look at 12 of the best Internet of Things (IoT) stocks to buy. For more IoT stocks, head on over to 5 Internet of Things (IoT) Stocks To Buy. In the last several decades, technology has undergone significant evolution. It\u2019s not just computers and smartphones that are now [\u2026]""}, {""date"": ""2023-10-31"", ""headline"": ""Analysts\u2019 Top Healthcare Picks: Addus Homecare (ADUS), Dexcom (DXCM)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-01"", ""headline"": ""DexCom Inc. stock rises Wednesday, outperforms market"", ""summary"": ""Shares of DexCom Inc. rose 5.97% to $94.13 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-11-01"", ""headline"": ""Becton Dickinson & Co. stock rises Wednesday, still underperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. inched 0.40% higher to $253.78 Wednesday, on what proved to be an all-around favorable trading session for the stock market,...""}, {""date"": ""2023-11-02"", ""headline"": ""DexCom Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of DexCom Inc. slid 0.49% to $93.67 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-11-02"", ""headline"": ""Becton Dickinson & Co. stock rises Thursday, still underperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. inched 0.84% higher to $255.92 Thursday, on what proved to be an all-around great trading session for the stock market, with...""}, {""date"": ""2023-11-02"", ""headline"": ""Avanos (AVNS) Q3 Earnings Top Estimates, Margins Contract"", ""summary"": ""Despite strength in Avanos' (AVNS) Digestive Health segment, its overall third-quarter results reflect soft performances.""}, {""date"": ""2023-11-02"", ""headline"": ""Why DexCom (DXCM) Might be Well Poised for a Surge"", ""summary"": ""DexCom (DXCM) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.""}, {""date"": ""2023-11-02"", ""headline"": ""Nevro (NVRO) Q3 Earnings Top Estimates, FY23 Revenue View Up"", ""summary"": ""Nevro's (NVRO) worldwide revenues improve on a year-over-year basis in the third quarter, owing to robust domestic performance.""}, {""date"": ""2023-11-02"", ""headline"": ""McKesson (MCK) Beats on Q2 Earnings, Raises '23 EPS View"", ""summary"": ""McKesson's (MCK) second-quarter fiscal 2024 results benefit from growth in the United States. Divestment hurts the International segment.""}, {""date"": ""2023-11-02"", ""headline"": ""2 Growth Stocks That Could Help Set You Up for Life"", ""summary"": ""DexCom (NASDAQ: DXCM) makes and sells continuous glucose monitoring (CGM) devices, which have broad utility for both Type 1 and Type 2 diabetics, and can offer life-saving benefits for some users.  The company has been rolling out the newest generation of its flagship CGM this year, the G7.  The gist of the decision is that CGMs are now covered for Type 2 diabetics who take basal insulin, as well as some people who have hypoglycemia but do not use insulin.""}, {""date"": ""2023-11-02"", ""headline"": ""Wall Street Analysts Think DexCom (DXCM) Could Surge 36.81%: Read This Before Placing a Bet"", ""summary"": ""The average of price targets set by Wall Street analysts indicates a potential upside of 36.8% in DexCom (DXCM). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.""}, {""date"": ""2023-11-02"", ""headline"": ""DexCom (DXCM) Just Reclaimed the 50-Day Moving Average"", ""summary"": ""Good things could be on the horizon when a stock surpasses the 50-Day simple moving average. How should investors react?""}, {""date"": ""2023-11-02"", ""headline"": ""Selloffs on Weight Loss Drug Fears Are an \u2018Overreaction,\u2019 Novo CEO Says"", ""summary"": ""The drugmaker's chief does allow that snack food companies may suffer as more people take the medicines.""}, {""date"": ""2023-11-02"", ""headline"": ""Tandem Diabetes hits 52-week low after guidance cut"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""Tandem Diabetes hits 52-week after guidance cut"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""Tandem Diabetes (TNDM) Posts Wider Q3 Loss, Trims '23 Sales View"", ""summary"": ""Tandem Diabetes (TNDM) reports a higher-than-anticipated loss in the third quarter of 2023.""}, {""date"": ""2023-11-02"", ""headline"": ""Energy, Comm. serv. and Consumer Disc. are BofA ASM's most overweight sectors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-03"", ""headline"": ""DexCom Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of DexCom Inc. rose 4.05% to $97.46 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-11-03"", ""headline"": ""Becton Dickinson & Co. stock rises Friday, outperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. rallied 1.17% to $258.91 Friday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""2023-11-03"", ""headline"": ""Inari Medical (NARI) Q3 Earnings and Revenues Beat Estimates"", ""summary"": ""Inari Medical's (NARI) third-quarter results benefit from strong product adoption and geographical performances.""}, {""date"": ""2023-11-03"", ""headline"": ""AMN Healthcare (AMN) Q3 Earnings and Revenues Beat Estimates"", ""summary"": ""AMN Healthcare's (AMN) dismal results in all its segments led to a soft overall third-quarter performance.""}, {""date"": ""2023-11-03"", ""headline"": ""Cardinal Health (CAH) Beats on Q1 Earnings, Ups '24 EPS View"", ""summary"": ""Cardinal Health's (CAH) first-quarter fiscal 2024 results benefit from the Pharmaceutical segment's solid performance.""}, {""date"": ""2023-11-03"", ""headline"": ""Prestige Consumer (PBH) Q2 Revenues Top, Margins Expand"", ""summary"": ""Prestige Consumer's (PBH) second-quarter fiscal 2024 results benefit from a diverse brand portfolio and broad distribution.""}, {""date"": ""2023-11-03"", ""headline"": ""Omnicell (OMCL) Q3 Earnings and Revenues Beat, Margins Down"", ""summary"": ""Omnicell's (OMCL) third-quarter 2023 results reflect operational discipline in a weak demand environment.""}, {""date"": ""2023-11-05"", ""headline"": ""Baron Small Cap Fund Q3 2023 Shareholder Letter"", ""summary"": ""Baron Small Cap Fund is down 3.11% (Institutional Shares) in the third quarter of 2023. Click here to read the full fund letter.""}]",{}
43,2023-11-05,97.45999908447266,2023-11-12,94.05000305175781,-0.03498867294015939,D4,"[{""date"": ""2023-11-05"", ""headline"": ""Check Out What Whales Are Doing With DXCM"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-05"", ""headline"": ""Baron Small Cap Fund Q3 2023 Shareholder Letter"", ""summary"": ""Baron Small Cap Fund is down 3.11% (Institutional Shares) in the third quarter of 2023. Click here to read the full fund letter.""}, {""date"": ""2023-11-06"", ""headline"": ""3 Healthcare Stocks Getting Help From the Aging Population"", ""summary"": ""A record number of Americans are now turning 65, Forbes recently reported, amid tens of millions of Baby Boomers. In fact, according to one report, 76.4 million Baby Boomers are living in America currently. Consequently, the demand for healthcare services for aging individuals in the U.S. is prolific. Companies including drugmakers, medical device manufacturers, hospital and nursing home owners are benefitting. In addition, many Americans are living longer than ever. Thus, wise investors are loo""}, {""date"": ""2023-11-06"", ""headline"": ""DexCom Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of DexCom Inc. slipped 2.69% to $94.84 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-11-06"", ""headline"": ""Becton Dickinson & Co. stock rises Monday, still underperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. inched 0.07% higher to $259.10 Monday, on what proved to be an all-around great trading session for the stock market, with...""}, {""date"": ""2023-11-06"", ""headline"": ""UBS\u2019s top crowded longs and shorts in MedTech"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-06"", ""headline"": ""Tandem Diabetes Care: More Ozempic Roadkill"", ""summary"": ""Tandem Diabetes Care's balance sheet is in good shape and management is counting on new product launches to drive sales growth and reduce losses. Find out why TNDM stock is a Hold.""}, {""date"": ""2023-11-07"", ""headline"": ""Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Becton Dickinson & Co. slipped 1.15% to $256.11 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with...""}, {""date"": ""2023-11-07"", ""headline"": ""OPKO Health (OPK) Q3 Earnings Lag Estimates, Revenues Top"", ""summary"": ""Despite OPKO Health's (OPK) robust RAYALDEE sales and strength in the Pharmaceuticals segment, its overall third-quarter results reflect soft performances.""}, {""date"": ""2023-11-07"", ""headline"": ""Shockwave Medical (SWAV) Q3 Earnings Beat, Revenues Rise Y/Y"", ""summary"": ""Shockwave Medical's (SWAV) third-quarter results reflect robust revenue growth and gross margin expansion on the back of strong demand and new launches.""}, {""date"": ""2023-11-07"", ""headline"": ""Insulet (PODD) Banks on Omnipod for Consistent Market Share Gain"", ""summary"": ""Insulet's (PODD) Omnipod 5 continues to be a driving force behind U.S. and international growth.""}, {""date"": ""2023-11-08"", ""headline"": ""This Is What Whales Are Betting On DexCom"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-08"", ""headline"": ""DexCom put volume heavy and directionally bearish"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-08"", ""headline"": ""DexCom Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of DexCom Inc. slid 2.55% to $92.76 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-11-08"", ""headline"": ""Becton Dickinson & Co. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Becton Dickinson & Co. slipped 0.07% to $255.92 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""2023-11-08"", ""headline"": ""Inogen (INGN) Q3 Earnings Miss Estimates, Revenues Down Y/Y"", ""summary"": ""Despite higher international business-to-business sales and rental revenues, Inogen's (INGN) overall third-quarter results reflect soft performances.""}, {""date"": ""2023-11-08"", ""headline"": ""Accuray (ARAY) Q1 Earnings In-Line With Estimates, Revenues Top"", ""summary"": ""Accuray (ARAY) reports a solid fiscal first quarter top line on the back of robust Product revenues.""}, {""date"": ""2023-11-08"", ""headline"": ""DaVita (DVA) Q3 Earnings & Revenues Top Estimates, Margins Up"", ""summary"": ""DaVita's (DVA) robust segmental revenues drive its third-quarter performance.""}, {""date"": ""2023-11-08"", ""headline"": ""Chemed's (CHE) VITAS Performance Aids, Macro Issues Linger"", ""summary"": ""Chemed (CHE) believes Roto-Rooter is well-positioned for growth and anticipates continued expansion of the segment's market share.""}, {""date"": ""2023-11-08"", ""headline"": ""CHI: Nice Assets, But High Valuation Given The Risks Of A Distribution Cut"", ""summary"": ""Calamos Convertible Opportunities and Income Fund offers a high level of current income with an 11.12% current yield. Learn more about CHI CEF here.""}, {""date"": ""2023-11-08"", ""headline"": ""2 Medical Device Companies Experiencing Strong Demand Even as Weight-Loss Drugs Rise in Popularity"", ""summary"": ""There's a growing fear among investors that weight-loss drugs and treatments such as Ozempic could negatively impact many businesses, from food companies to healthcare businesses.  DexCom (NASDAQ: DXCM) and Abbott Laboratories (NYSE: ABT) are two businesses that are still doing well.  DexCom makes continuous glucose monitoring (CGM) devices that help people with diabetes track their glucose levels.""}, {""date"": ""2023-11-08"", ""headline"": ""Historic Victory as People With Diabetes Win Access to Life-Changing Technology, But Almost Half Don\u2019t Understand the Benefits1-2"", ""summary"": ""LONDON, November 08, 2023--Dexcom has announced new market research following the new Technology Appraisal from NICE for hybrid closed loop systems.""}, {""date"": ""2023-11-09"", ""headline"": ""3 Earnings Winners Poised to Outperform the Market"", ""summary"": ""Sound financial performance indicates that a company may be a good investment choice. The earnings season provides investors another window of opportunity to see which reporting companies exceeded expectations with solid financials and positive outlooks. These earnings winners present new and experienced investors with opportunities to get in on a company with strong growth potential. That is why investing in earnings season winners is one of the best thematic strategies investors can use to reb""}, {""date"": ""2023-11-09"", ""headline"": ""BD (BDX) Q4 Earnings In-Line With Estimates, Margins Contract"", ""summary"": ""BD's (BDX) overall top line benefits from revenue growth in all its segments and both geographic regions in the fiscal fourth quarter.""}, {""date"": ""2023-11-09"", ""headline"": ""Surmodics (SRDX) Q4 Earnings Top Estimates, Revenues Up Y/Y"", ""summary"": ""Surmodics (SRDX) reports a solid fiscal fourth quarter top line on the back of robust segmental revenues.""}, {""date"": ""2023-11-09"", ""headline"": ""Inspire Medical (INSP) Q3 Earnings Top Estimates, Revenues Lag"", ""summary"": ""Inspire Medical's (INSP) both geographic regions witness strong revenue growth in the third quarter.""}, {""date"": ""2023-11-09"", ""headline"": ""DexCom Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of DexCom Inc. dropped 0.39% to $92.40 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-11-09"", ""headline"": ""Becton Dickinson & Co. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Becton Dickinson & Co. slid 9.25% to $232.24 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P...""}, {""date"": ""2023-11-09"", ""headline"": ""Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick"", ""summary"": ""The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.""}, {""date"": ""2023-11-09"", ""headline"": ""Phibro (PAHC) Q1 Earnings and Revenues Miss, Margins Down"", ""summary"": ""Phibro's (PAHC) fiscal 2024 first-quarter performance reflects reduced sales in Mineral Nutrition and Performance Products.""}, {""date"": ""2023-11-10"", ""headline"": ""AVK: Good Concept, But Risky"", ""summary"": ""The Advent Convertible & Income Fund offers high yield, but disappointing performance and risky leverage pose concerns for sustainability. Learn more on AVK CEF here.""}, {""date"": ""2023-11-10"", ""headline"": ""DexCom Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of DexCom Inc. rose 1.79% to $94.05 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-11-10"", ""headline"": ""Becton Dickinson & Co. stock rises Friday, still underperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. advanced 1.04% to $234.65 Friday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""2023-11-10"", ""headline"": ""Hologic's (HOLX) Q4 Earnings Beat Estimates, Gross Margin Down"", ""summary"": ""Solid year-over-year growth in the Breast Health segment drives Hologic's (HOLX) Q4 performance.""}, {""date"": ""2023-11-10"", ""headline"": ""National Vision (EYE) Q3 Earnings Top Estimates, Margins Fall"", ""summary"": ""National Vision's (EYE) higher SG&A expenses in the third quarter reflect increases in performance-based incentives and stock-based compensations.""}, {""date"": ""2023-11-10"", ""headline"": ""Illumina (ILMN) Q3 Earnings Surpass Estimates, '23 View Cut"", ""summary"": ""Illumina (ILMN) reports solid earnings in the third quarter of 2023 amid a challenging macro environment.""}, {""date"": ""2023-11-10"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
44,2023-11-12,94.05000305175781,2023-11-19,104.97000122070312,0.11610842971409352,U5+,"[{""date"": ""2023-11-12"", ""headline"": ""Unveiling DexCom (DXCM)'s Value: Is It Really Priced Right? A Comprehensive Guide"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-13"", ""headline"": ""DexCom Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of DexCom Inc. rose 4.57% to $98.35 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2023-11-13"", ""headline"": ""Here's Why You Should Retain CVS Health (CVS) Stock for Now"", ""summary"": ""Investors are optimistic about CVS Health's (CVS) strength in Health Care Benefits business arm and stable solvency position.""}, {""date"": ""2023-11-13"", ""headline"": ""Quest Diagnostics (DGX) Introduces Mobile Phlebotomy Service"", ""summary"": ""Quest Diagnostics (DGX) can offer patients and physicians a seamless connection to Quest Diagnostic's laboratory testing with the launch of Quest Mobile.""}, {""date"": ""2023-11-13"", ""headline"": ""Novo Nordisk's Wegovy could reduce heart risks by 20%"", ""summary"": ""According to a new trial study, Novo Nordisk's (NVO) weight loss drug Wegovy may have the added benefit of cutting down risks tied to cardiovascular complications by at least 20%. Yahoo Finance Live monitors how Novo Nordisk's stock is reacting to this news in pre-market trading and analyzes how food brands may be planning to respond to the rise in GLP-1 drugs. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.""}, {""date"": ""2023-11-13"", ""headline"": ""Diabetes stocks are surprise winners from Novo Nordisk\u2019s Wegovy study, analysts say"", ""summary"": ""Eli Lilly also scores, analysts say, as trial results leave door open for Zepbound to top Wegovy\u2019s benefits.""}, {""date"": ""2023-11-13"", ""headline"": ""MedTech stocks gain after Novo Nordisk data for weight loss therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-13"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Curaleaf Holdings (OtherCURLF), Alkermes (ALKS) and Dexcom (DXCM)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-14"", ""headline"": ""Becton Dickinson & Co. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. slipped 1.07% to $233.34 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with...""}, {""date"": ""2023-11-14"", ""headline"": ""Here's Why You Should Retain Penumbra (PEN) Stock for Now"", ""summary"": ""Investors are optimistic about Penumbra (PEN) on strong vascular and neuro businesses growth and upbeat guidance.""}, {""date"": ""2023-11-14"", ""headline"": ""Bio-Rad (BIO) Hurt by Macroeconomic Woes, Margin Pressure"", ""summary"": ""Bio-Rad's (BIO) margin performance is affected by the inflationary trend of elevated raw material costs, increased logistics costs and higher employee-related expenses.""}, {""date"": ""2023-11-14"", ""headline"": ""Henry Schein (HSIC) Q3 Revenues Miss, 2023 Guidance Cut"", ""summary"": ""Henry Schein's (HSIC) third-quarter 2023 performance demonstrates remarkable sales growth in the Technology and Value-Added Service businesses.""}, {""date"": ""2023-11-14"", ""headline"": ""Behind the Scenes of DexCom's Latest Options Trends"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-14"", ""headline"": ""Frank Sands' Strategic Moves: Microsoft Corp Takes the Spotlight in Q3 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-14"", ""headline"": ""DexCom CEO: 1 in 10 people in the world has diabetes"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-14"", ""headline"": ""Dexcom Unveils Portrait Gallery to Portray Emotional Highs and Lows of Living With Diabetes on World Diabetes Day"", ""summary"": ""SAN DIEGO & EDINBURGH, Scotland, November 14, 2023--DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) systems for people with diabetes, is teaming up with Dexcom Warriors from around the globe to help raise awareness for the need to improve access to life-changing diabetes technology during National Diabetes Awareness Month in the U.S. and Canada (November) and on World Diabetes Day (November 14).""}, {""date"": ""2023-11-15"", ""headline"": ""DexCom Inc. stock underperforms Wednesday when compared to competitors despite daily gains"", ""summary"": ""Shares of DexCom Inc. inched 0.72% higher to $102.11 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P...""}, {""date"": ""2023-11-15"", ""headline"": ""Becton Dickinson & Co. stock rises Wednesday, outperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. inched 0.18% higher to $233.76 Wednesday, on what proved to be an all-around positive trading session for the stock market,...""}, {""date"": ""2023-11-15"", ""headline"": ""Alcon (ALC) Q3 Earnings Miss Estimates, Margins Increase"", ""summary"": ""Alcon (ALC) Q3 revenues increase year over year, driven by strength in Surgical and Vision Care segments.""}, {""date"": ""2023-11-15"", ""headline"": ""Prestige Consumer's (PBH) Brand Building, Innovation Aid Growth"", ""summary"": ""Prestige Consumer's (PBH) long-term brand-building efforts, efficient marketing, channel development and innovation help the company to continually hold a leading market share position.""}, {""date"": ""2023-11-15"", ""headline"": ""Tracking Baillie Gifford's 13F Portfolio - Q3 2023 Update"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-16"", ""headline"": ""DexCom Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of DexCom Inc. rose 2.61% to $104.77 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-11-16"", ""headline"": ""Becton Dickinson & Co. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Becton Dickinson & Co. inched 0.56% higher to $235.07 Thursday, on what proved to be an all-around mixed trading session for the stock market, with...""}, {""date"": ""2023-11-16"", ""headline"": ""Could DexCom Stock Help You Become a Millionaire?"", ""summary"": ""DexCom has achieved strong growth over the years, but there's a big question mark over how strong it will be in the future.""}, {""date"": ""2023-11-16"", ""headline"": ""QIAGEN (QGEN) Expands Sample Technologies Line With New Launch"", ""summary"": ""QIAGEN's (QGEN) latest launches will better address the special needs of researchers working with challenging samples, allowing them to work more efficiently.""}, {""date"": ""2023-11-16"", ""headline"": ""9 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-16"", ""headline"": ""Industry Comparison: Evaluating DexCom Against Competitors In Health Care Equipment & Supplies Industry"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-17"", ""headline"": ""DexCom Inc. stock rises Friday, outperforms market"", ""summary"": ""Shares of DexCom Inc. inched 0.19% higher to $104.97 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""2023-11-17"", ""headline"": ""Becton Dickinson & Co. stock falls Friday, underperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. dropped 0.77% to $233.27 Friday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""2023-11-17"", ""headline"": ""What's in the Cards for Medtronic (MDT) in Q2 Earnings?"", ""summary"": ""Strength in all four businesses is likely to drive Medtronic's (MDT) fiscal second-quarter performance.""}, {""date"": ""2023-11-17"", ""headline"": ""Is DexCom the Next Big Growth Stock?"", ""summary"": ""With shares of DexCom (NASDAQ: DXCM) falling 11% this year amid a steadily rising market, one might think that the medical device maker's growth potential is ebbing compared to its former glory.  Can DexCom become the next big growth stock thanks to its ever-increasing scale of operations, or has the market already priced in all of its future success?  DexCom makes continuous glucose monitors (CGMs) for people with diabetes, so they don't need to perform pinprick blood-sugar tests multiple times per day.""}, {""date"": ""2023-11-17"", ""headline"": ""Reasons to Add DexCom (DXCM) Stock to Your Portfolio Now"", ""summary"": ""DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.""}, {""date"": ""2023-11-17"", ""headline"": ""Obesity Drugs Put These Stocks on a Crash Diet\u2014Now They\u2019re Rebounding"", ""summary"": ""After reviewing the highly anticipated results from a study of Novo Nordisk\u2019s blockbuster obesity treatment Wegovy released over the weekend,\u00a0cardiologists at a major medical meeting and the pharma crowd on Wall Street were broadly upbeat.  \u201cToday\u2019s confirmatory results lay the groundwork for the coming paradigm shift of metabolic treatment,\u201d gushed Evan Seigerman, an analyst at BMO Capital Markets.  \u201cThere were some holes in the data,\u201d said Mizuho analyst Anthony Petrone, noting, for example, a limited impact on stroke reduction in the study.""}, {""date"": ""2023-11-17"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-17"", ""headline"": ""4 Best Stocks Exhibiting Solid Earnings Growth"", ""summary"": ""Invest in stocks such as DexCom (DXCM), Arthur J. Gallagher (AJG), Limbach (LMB) and Hartford Financial Services (HIG) for superb earnings growth.""}, {""date"": ""2023-11-17"", ""headline"": ""Looking Into DexCom's Recent Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-17"", ""headline"": ""Medtronic: 3 Key Issues To Consider Ahead Of Fiscal Q2 2024 Earnings"", ""summary"": ""Medtronic plc's Q2 earnings should reveal growth prospects amid easing pandemic pressures and emerging competitive threats. Click for my MDT Q2 earnings preview.""}, {""date"": ""2023-11-19"", ""headline"": ""2 Stock Split Growth Stocks to Buy and Hold"", ""summary"": ""These companies could continue delivering excellent results long after their most recent stock splits are forgotten.""}, {""date"": ""2023-11-19"", ""headline"": ""M&A, GLP-1s to dominate healthcare themes in 2024 as COVID fades: survey"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
45,2023-11-19,104.97000122070312,2023-11-26,112.94999694824219,0.0760216789057746,U5+,"[{""date"": ""2023-11-19"", ""headline"": ""DexCom Inc. stock rises Monday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-19"", ""headline"": ""2 Stock Split Growth Stocks to Buy and Hold"", ""summary"": ""These companies could continue delivering excellent results long after their most recent stock splits are forgotten.""}, {""date"": ""2023-11-19"", ""headline"": ""M&A, GLP-1s to dominate healthcare themes in 2024 as COVID fades: survey"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-20"", ""headline"": ""DexCom Inc. stock remains steady Tuesday, still outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-20"", ""headline"": ""DexCom (DXCM) is an Incredible Growth Stock: 3 Reasons Why"", ""summary"": ""DexCom (DXCM) is well positioned to outperform the market, as it exhibits above-average growth in financials.""}, {""date"": ""2023-11-20"", ""headline"": ""13 Stocks That Outperform the S&P 500 Every Year for the Last 5 Years"", ""summary"": ""In this article, we will take a look at the 13 stocks that outperform the S&P 500 every year for the last 5 years. To skip our analysis of the recent trends, and market activity, you can go directly to see the 5 Stocks That Outperform the S&P 500 Every Year for the Last 5 [\u2026]""}, {""date"": ""2023-11-20"", ""headline"": ""Zacks.com featured highlights include DexCom, Arthur J. Gallagher, Limbach and The Hartford Financial Services"", ""summary"": ""DexCom, Arthur J. Gallagher, Limbach and The Hartford Financial Services are part of the Zacks Screen of the Week article.""}, {""date"": ""2023-11-20"", ""headline"": ""Ozempic Might Be Helping Abbott Laboratories and DexCom Stock. Here's How."", ""summary"": ""Novo Nordisk's (NYSE: NVO) Ozempic is indicated to treat diabetes, and its wild success and household name is making a few cardiometabolic device companies rather nervous.  With a powerful tool to manage blood glucose levels in hand, patients may not have as much of a need for the glucose monitors and insulin pumps they formerly relied on, so the fearful argument goes.""}, {""date"": ""2023-11-20"", ""headline"": ""Investors\u2019 Concerns over the Impact of GLP-1 Drugs Dragged DexCom (DXCM)"", ""summary"": ""Fred Alger Management, an investment management company, released its \u201cAlger Mid Cap Focus Fund\u201d third quarter 2023 investor letter. A copy of the same can be downloaded here. In the third quarter, U.S equities fell after three positive consecutive quarters. The fund underperformed the Russell Midcap Growth Index in the quarter. Industrials and Consumer Staples were [\u2026]""}, {""date"": ""2023-11-21"", ""headline"": ""DexCom Inc. stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-21"", ""headline"": ""Dexcom Announces Upcoming Conference Presentation"", ""summary"": ""SAN DIEGO, November 21, 2023--DexCom, Inc. (NASDAQ:DXCM) today announced that Jereme Sylvain, Executive Vice President and Chief Financial Officer, will present an update on the company at the Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29th.""}, {""date"": ""2023-11-21"", ""headline"": ""3 Growth Stocks to Buy With $1,000 Right Now"", ""summary"": ""If you're having trouble finding your portfolio's next growth holding, here are three great options to choose from -- or you can choose all three.""}, {""date"": ""2023-11-22"", ""headline"": ""DexCom's (NASDAQ:DXCM) 29% CAGR outpaced the company's earnings growth over the same five-year period"", ""summary"": ""The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, you...""}, {""date"": ""2023-11-22"", ""headline"": ""DXCM Crosses Above Key Moving Average Level"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-22"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), Enanta Pharmaceuticals (ENTA) and Arvinas Holding Company (ARVN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-23"", ""headline"": ""DexCom Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-23"", ""headline"": ""Cardinal Health (CAH) Hits 52-Week High: What's Aiding It?"", ""summary"": ""Investors are optimistic about Cardinal Health's (CAH) diversified product portfolio.""}, {""date"": ""2023-11-23"", ""headline"": ""EssilorLuxottica (ESLOY), Moncler Ink Luxury Eyewear Deal"", ""summary"": ""The first Moncler Lunettes collection produced with EssilorLuxottica (ESLOY) is called Fall-Winter 2024.""}, {""date"": ""2023-11-23"", ""headline"": ""Here's Why You Should Retain Edward Lifesciences (EW) Stock Now"", ""summary"": ""Investors remain optimistic about Edward Lifesciences (EW) due to Surgical's differentiated portfolio and TMTT franchise.""}, {""date"": ""2023-11-25"", ""headline"": ""Insider Sell: EVP Chief Human Resources Officer Sadie Stern Sells Shares of DexCom Inc (DXCM)"", ""summary"": ""In the realm of insider trading, the actions of company executives can often provide valuable insights into the inner workings and future prospects of their organizations.""}, {""date"": ""2023-11-26"", ""headline"": ""Buying These 4 Hated Names Devastated By The GLP-1 Hype"", ""summary"": ""Many factors have led to the undervaluation of the MedTech sector. Click here for a detailed analysis.""}, {""date"": ""2023-11-26"", ""headline"": ""Goldman Sachs\u2019 Top 15 Stock Picks for 2024"", ""summary"": ""In this piece, we will take a look at Goldman Sachs\u2019 top 15 stock picks for 2024. If you want to skip our introduction to the investment bank and the latest saga surrounding its business, then take a look at Goldman Sachs\u2019 Top 15 Stock Picks for 2024. The Goldman Sachs Group, Inc. (NYSE:GS) is [\u2026]""}]",{}
46,2023-11-26,112.94999694824219,2023-12-03,116.62000274658203,0.032492305422740175,U4,"[{""date"": ""2023-11-26"", ""headline"": ""Buying These 4 Hated Names Devastated By The GLP-1 Hype"", ""summary"": ""Many factors have led to the undervaluation of the MedTech sector. Click here for a detailed analysis.""}, {""date"": ""2023-11-26"", ""headline"": ""Goldman Sachs\u2019 Top 15 Stock Picks for 2024"", ""summary"": ""In this piece, we will take a look at Goldman Sachs\u2019 top 15 stock picks for 2024. If you want to skip our introduction to the investment bank and the latest saga surrounding its business, then take a look at Goldman Sachs\u2019 Top 15 Stock Picks for 2024. The Goldman Sachs Group, Inc. (NYSE:GS) is [\u2026]""}, {""date"": ""2023-11-27"", ""headline"": ""DexCom Inc. stock rises Monday, outperforms market"", ""summary"": ""Shares of DexCom Inc. inched 0.91% higher to $113.98 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-11-27"", ""headline"": ""Becton Dickinson & Co. stock outperforms market despite losses on the day"", ""summary"": ""Shares of Becton Dickinson & Co. slipped 0.01% to $238.86 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P...""}, {""date"": ""2023-11-28"", ""headline"": ""DexCom Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of DexCom Inc. slipped 1.56% to $112.20 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-11-28"", ""headline"": ""Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Becton Dickinson & Co. dropped 0.66% to $237.28 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with...""}, {""date"": ""2023-11-28"", ""headline"": ""Why DexCom (DXCM) is a Top Growth Stock for the Long-Term"", ""summary"": ""Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.""}, {""date"": ""2023-11-28"", ""headline"": ""Is Connect Biopharma Holdings (CNTB) Stock Outpacing Its Medical Peers This Year?"", ""summary"": ""Here is how Connect Biopharma Holdings Limited Sponsored ADR (CNTB) and DexCom (DXCM) have performed compared to their sector so far this year.""}, {""date"": ""2023-11-29"", ""headline"": ""DexCom Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of DexCom Inc. rallied 3.55% to $116.18 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2023-11-29"", ""headline"": ""Becton Dickinson & Co. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. slumped 0.67% to $235.69 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""2023-11-30"", ""headline"": ""DexCom Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of DexCom Inc. sank 0.57% to $115.52 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-11-30"", ""headline"": ""Becton Dickinson & Co. stock rises Thursday, still underperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. inched 0.21% higher to $236.18 Thursday, on what proved to be an all-around great trading session for the stock market, with...""}, {""date"": ""2023-11-30"", ""headline"": ""Charles River (CRL) Gains on Price & Volume Growth Amid FX Woe"", ""summary"": ""At present, Charles River (CRL) is the largest provider of outsourced drug discovery, non-clinical development and regulated safety testing services worldwide.""}, {""date"": ""2023-11-30"", ""headline"": ""11 Best Long Term Growth Stocks To Invest In"", ""summary"": ""In this piece, we will look at the 11 best long-term growth stocks to invest in. If you want to skip our introduction to the current drivers of stock market performance, then check out 5 Best Long term Growth Stocks To Invest In. The year 2023 has proven to be dynamic for the stock market. [\u2026]""}, {""date"": ""2023-12-01"", ""headline"": ""DexCom Inc. stock rises Friday, outperforms market"", ""summary"": ""Shares of DexCom Inc. inched 0.95% higher to $116.62 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""2023-12-01"", ""headline"": ""Becton Dickinson & Co. stock outperforms market on strong trading day"", ""summary"": ""Shares of Becton Dickinson & Co. inched 0.88% higher to $238.25 Friday, on what proved to be an all-around positive trading session for the stock market,...""}, {""date"": ""2023-12-01"", ""headline"": ""Nevro (NVRO) Up 15.7% Since Last Earnings Report: Can It Continue?"", ""summary"": ""Nevro (NVRO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.""}, {""date"": ""2023-12-01"", ""headline"": ""2 Strong Stocks Trading 30% Below Their Highs to Buy in December"", ""summary"": ""Why investors might want to buy Global Payments (GPN) and DexCom (DXCM) stock right now for long-term growth, with both trading at least 30% below their record highs.""}]",{}
47,2023-12-03,116.62000274658203,2023-12-10,116.97000122070312,0.0030011873253137367,U1,"[{""date"": ""2023-12-04"", ""headline"": ""Market Whales and Their Recent Bets on DXCM Options"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-04"", ""headline"": ""Becton Dickinson & Co. stock falls Monday, still outperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. sank 0.29% to $237.57 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P...""}, {""date"": ""2023-12-04"", ""headline"": ""DexCom price target raised to $122 from $101 at Morgan Stanley"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-05"", ""headline"": ""DexCom Stock Earns Healthy Relative Strength Rating Upgrade"", ""summary"": ""A Relative Strength Rating upgrade for DexCom shows improving technical performance. Will it continue?""}, {""date"": ""2023-12-05"", ""headline"": ""DexCom Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of DexCom Inc. sank 0.88% to $117.20 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-12-05"", ""headline"": ""Becton Dickinson & Co. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. shed 1.67% to $233.60 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P...""}, {""date"": ""2023-12-05"", ""headline"": ""Insider Sell Alert: EVP Chief Legal Officer Michael Brown Sells 3,612 Shares of DexCom Inc (DXCM)"", ""summary"": ""Michael Brown, the Executive Vice President and Chief Legal Officer of DexCom Inc, has recently sold 3,612 shares of the company's stock.""}, {""date"": ""2023-12-05"", ""headline"": ""Should You Hold DexCom (DXCM)?"", ""summary"": ""Artisan Partners, an investment management company, released its \u201cArtisan Mid Cap Fund\u201d third quarter 2023 investor letter. A copy of the same can be downloaded here. Inflation remained on a downward trend in the quarter and the fund\u2019s Investor Class fund ARTMX returned -2.95%, Advisor Class fund APDMX posted a return of -2.92%, and Institutional Class [\u2026]""}, {""date"": ""2023-12-06"", ""headline"": ""Dexcom G7 is Now the Most Accurate, Smallest, Easy-to-Use CGM Connected to the Tandem t:slim X2 Insulin Pump"", ""summary"": ""SAN DIEGO, December 06, 2023--DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the Dexcom G7 Continuous Glucose Monitoring (CGM) System now connects with the t:slim X2\u2122 insulin pump by Tandem Diabetes Care in the United States, marking the first AID integration with the Dexcom G7 CGM, the world\u2019s most accurate1,2 CGM system.""}, {""date"": ""2023-12-06"", ""headline"": ""Is DexCom (DXCM) a Solid Growth Stock? 3 Reasons to Think \""Yes\"""", ""summary"": ""DexCom (DXCM) possesses solid growth attributes, which could help it handily outperform the market.""}, {""date"": ""2023-12-06"", ""headline"": ""DexCom Inc. stock rises Wednesday, outperforms market"", ""summary"": ""Shares of DexCom Inc. inched 0.63% higher to $117.94 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P...""}, {""date"": ""2023-12-06"", ""headline"": ""Becton Dickinson & Co. stock outperforms market despite losses on the day"", ""summary"": ""Shares of Becton Dickinson & Co. slipped 0.06% to $233.45 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the...""}, {""date"": ""2023-12-06"", ""headline"": ""HealthEquity (HQY) Q3 Earnings Surpass Estimates, Margins Up"", ""summary"": ""HealthEquity (HQY) witnesses solid growth in HSAs, besides recording robust performances in the majority of its segments, in the third quarter of fiscal 2024.""}, {""date"": ""2023-12-06"", ""headline"": ""Tandem Diabetes Care Shares Rise 7% on Technology Integration With Dexcom"", ""summary"": ""By Denny Jacob Tandem Diabetes Care shares rose 7%, to $22.65, following integration of its insulin-pump software with Dexcom's glucose-monitoring...""}, {""date"": ""2023-12-06"", ""headline"": ""30 Stocks shunned by hedge and mutual funds - GS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-06"", ""headline"": ""Top 30 stocks with highest hedge fund + mutual fund short positions \u2013 GS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-06"", ""headline"": ""(DXCM) - Analyzing DexCom's Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-06"", ""headline"": ""Tandem Diabetes launches updated t:slim X2 insulin pump software with DexCom CGM"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-06"", ""headline"": ""Dexcom G7, the Smallest, Most Accurate, Easy-to-Use CGM Now Connects to the Tandem t : slim X2 Insulin Pump"", ""summary"": ""With more than 10 years of pioneering CGM market leadership in AID integration, Dexcom is the most studied CGM brand with AID capabilities and the clear choice for powering AID systems3,4The...""}, {""date"": ""2023-12-07"", ""headline"": ""DexCom Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of DexCom Inc. inched 0.81% higher to $118.89 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P...""}, {""date"": ""2023-12-07"", ""headline"": ""Becton Dickinson & Co. stock rises Thursday, still underperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. inched 0.45% higher to $233.54 Thursday, on what proved to be an all-around favorable trading session for the stock market,...""}, {""date"": ""2023-12-07"", ""headline"": ""Veeva Systems (VEEV) Beats on Q3 Earnings, Revises FY24 Outlook"", ""summary"": ""Veeva Systems' (VEEV) fiscal Q3 results reflect impressive performances by both segments.""}, {""date"": ""2023-12-07"", ""headline"": ""Tandem Diabetes (TNDM) Launches Dexcom G7 Integrated t:slim X2"", ""summary"": ""Tandem Diabetes' (TNDM) t:slim X2 is the first AID system in the world to feature Dexcom's most advanced CGM technology.""}, {""date"": ""2023-12-07"", ""headline"": ""DexCom Insiders Sold US$5.1m Of Shares Suggesting Hesitancy"", ""summary"": ""In the last year, many DexCom, Inc. ( NASDAQ:DXCM ) insiders sold a substantial stake in the company which may have...""}, {""date"": ""2023-12-07"", ""headline"": ""If You Invested $1000 In This Stock 5 Years Ago, You Would Have $3,800 Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-07"", ""headline"": ""Dexcom, Hologic picked to outperform in 2024: William Blair"", ""summary"": ""For the medtech industry overall, the analysts wrote that procedure volume growth is likely to normalize after declining due to the COVID-19 pandemic.""}, {""date"": ""2023-12-08"", ""headline"": ""DexCom Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of DexCom Inc. shed 1.61% to $116.97 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-12-08"", ""headline"": ""Becton Dickinson & Co. stock falls Friday, underperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. sank 0.53% to $232.30 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""2023-12-08"", ""headline"": ""Beta Bionics Announces the Nationwide Launch of the iLet Bionic Pancreas with Dexcom G7 CGM System"", ""summary"": ""CONCORD - Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, announced today the nationwide launch of the iLet Bionic Pancreas automated insulin...""}]",{}
48,2023-12-10,116.97000122070312,2023-12-17,122.58999633789062,0.048046465405976235,U5,"[{""date"": ""2023-12-10"", ""headline"": ""William Blair says buy these stocks for 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-11"", ""headline"": ""DexCom Inc. stock rises Monday, outperforms market"", ""summary"": ""Shares of DexCom Inc. inched 0.80% higher to $117.90 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""2023-12-11"", ""headline"": ""Becton Dickinson & Co. stock outperforms market on strong trading day"", ""summary"": ""Shares of Becton Dickinson & Co. inched 0.47% higher to $233.39 Monday, on what proved to be an all-around favorable trading session for the stock market,...""}, {""date"": ""2023-12-11"", ""headline"": ""Up 60%, Why I Believe DexCom Is One Of The Best Healthcare Stocks Money Can Buy"", ""summary"": ""DexCom's strong position in the healthcare sector is expected to continue in 2024 due to M&A activity and growth of GLP-1 drugs. Learn more on DXCM stock here.""}, {""date"": ""2023-12-11"", ""headline"": ""Boasting A 17% Return On Equity, Is DexCom, Inc. (NASDAQ:DXCM) A Top Quality Stock?"", ""summary"": ""While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...""}, {""date"": ""2023-12-11"", ""headline"": ""Citi entering 2024 'cautiously optimistic' on U.S. MedTech companies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-11"", ""headline"": ""Citi entering 2024 'cautiously optimistic' on U.S. MedTech companiesZimmer Biomet"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-11"", ""headline"": ""Synchron Appoints Andy Rasdal to Board of Directors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-11"", ""headline"": ""A Milestone: The S&P 500's 4,600 Level On The Bull Plateau"", ""summary"": ""The S&P 500 reaches new highs as the strong bull plateau continues, extending its duration and offering opportunities for gains to traders. Click here for more.""}, {""date"": ""2023-12-12"", ""headline"": ""DexCom participates in a conference call with William Blair"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-12"", ""headline"": ""DexCom Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of DexCom Inc. advanced 1.07% to $119.16 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-12-12"", ""headline"": ""Becton Dickinson & Co. stock rises Tuesday, outperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. rallied 1.41% to $236.67 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""2023-12-12"", ""headline"": ""Analysts\u2019 Top Healthcare Picks: Biogen (BIIB), Penumbra (PEN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-13"", ""headline"": ""DexCom Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of DexCom Inc. rallied 2.63% to $122.29 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-12-13"", ""headline"": ""Becton Dickinson & Co. stock rises Wednesday, outperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. advanced 1.61% to $240.47 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with...""}, {""date"": ""2023-12-13"", ""headline"": ""Pet Parents Keep Spending"", ""summary"": ""We also talk with Dexcom CEO Kevin Sayer about the impact of weight loss drugs on diabetes care.""}, {""date"": ""2023-12-13"", ""headline"": ""Integer Holdings Corporation (ITGR) Hit a 52 Week High, Can the Run Continue?"", ""summary"": ""Integer (ITGR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.""}, {""date"": ""2023-12-13"", ""headline"": ""UBS\u2019 Top Global Stocks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-13"", ""headline"": ""Wells Fargo Reaffirms Their Buy Rating on Dexcom (DXCM)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""DexCom Inc. stock rises Thursday, outperforms market"", ""summary"": ""Shares of DexCom Inc. inched 0.66% higher to $123.10 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P...""}, {""date"": ""2023-12-14"", ""headline"": ""Becton Dickinson & Co. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Becton Dickinson & Co. slipped 0.82% to $238.51 Thursday, on what proved to be an all-around great trading session for the stock market, with the...""}, {""date"": ""2023-12-14"", ""headline"": ""Is DexCom (DXCM) Stock Outpacing Its Medical Peers This Year?"", ""summary"": ""Here is how DexCom (DXCM) and Exscientia PLC Sponsored ADR (EXAI) have performed compared to their sector so far this year.""}, {""date"": ""2023-12-15"", ""headline"": ""Why DexCom (DXCM) Dipped More Than Broader Market Today"", ""summary"": ""DexCom (DXCM) reachead $122.59 at the closing of the latest trading day, reflecting a -0.41% change compared to its last close.""}, {""date"": ""2023-12-15"", ""headline"": ""DexCom Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of DexCom Inc. sank 0.41% to $122.59 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2023-12-15"", ""headline"": ""Becton Dickinson & Co. stock falls Friday, underperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. sank 0.63% to $237.01 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...""}, {""date"": ""2023-12-16"", ""headline"": ""Is DexCom, Inc. (NASDAQ:DXCM) Potentially Undervalued?"", ""summary"": ""DexCom, Inc. ( NASDAQ:DXCM ) received a lot of attention from a substantial price increase on the NASDAQGS over the...""}]",{}
49,2023-12-17,122.58999633789062,2023-12-24,122.16999816894531,-0.0034260394933668392,D1,"[{""date"": ""2023-12-18"", ""headline"": ""DexCom Inc. stock rises Monday, outperforms market"", ""summary"": ""Shares of DexCom Inc. inched 0.62% higher to $123.35 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-12-18"", ""headline"": ""Reasons to Add DexCom (DXCM) Stock to Your Portfolio Now"", ""summary"": ""DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.""}, {""date"": ""2023-12-18"", ""headline"": ""Becton Dickinson & Co. stock rises Monday, still underperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. inched 0.30% higher to $237.72 Monday, on what proved to be an all-around mixed trading session for the stock market, with...""}, {""date"": ""2023-12-18"", ""headline"": ""Is DexCom (DXCM) a Worthy Investment?"", ""summary"": ""TimesSquare Capital Management, an equity investment management company, released its \u201cU.S. Mid Cap Growth Strategy\u201d third-quarter investor letter. A copy of the same can be downloaded here. In the third quarter, the strategy outperformed the Russell Midcap Growth Index and returned -4.11% (net) while the index return was -5.22%. The third quarter saw a decline in [\u2026]""}, {""date"": ""2023-12-19"", ""headline"": ""DexCom's (DXCM) G7 CGM Connects With Tandem's Insulin Pump"", ""summary"": ""Dexcom's (DXCM) G7 integrates with Tandem's t:slim X2, revolutionizing diabetes care. A perfect combination of accuracy and innovation, this synergy sets a new standard in continuous glucose monitoring.""}, {""date"": ""2023-12-19"", ""headline"": ""DexCom Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of DexCom Inc. dropped 0.05% to $123.29 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-12-19"", ""headline"": ""Becton Dickinson & Co. stock outperforms market on strong trading day"", ""summary"": ""Shares of Becton Dickinson & Co. advanced 1.22% to $240.62 Tuesday, on what proved to be an all-around positive trading session for the stock market, with...""}, {""date"": ""2023-12-19"", ""headline"": ""Dexcom to Present at 42nd Annual J.P. Morgan Healthcare Conference"", ""summary"": ""SAN DIEGO, December 19, 2023--DexCom, Inc. (NASDAQ:DXCM) today announced that Kevin Sayer, Chairman, President and Chief Executive Officer, will present an update on the company at the 42nd annual J.P. Morgan Healthcare Conference on January 8, 2024.""}, {""date"": ""2023-12-19"", ""headline"": ""SenesTech (SNES) Likely to Expand Into China With New Deal"", ""summary"": ""This partnership provides SenesTech (SNES) with a gateway into one of the largest pest control markets globally, with the support and expertise of Fruit Tree.""}, {""date"": ""2023-12-19"", ""headline"": ""Analysts Are Bullish on These Healthcare Stocks: Mirum Pharmaceuticals (MIRM), Ultragenyx Pharmaceutical (RARE)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-19"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Illumina (ILMN), Dexcom (DXCM) and Masimo (MASI)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-20"", ""headline"": ""$100 Invested In This Stock 15 Years Ago Would Be Worth $21,000 Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-20"", ""headline"": ""DexCom Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of DexCom Inc. slid 5.39% to $116.64 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-12-20"", ""headline"": ""Becton Dickinson & Co. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Becton Dickinson & Co. sank 0.33% to $239.82 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the...""}, {""date"": ""2023-12-20"", ""headline"": ""3 Reasons to Add HealthEquity (HQY) Stock to Your Portfolio"", ""summary"": ""HealthEquity's (HQY) strength in HSA raises optimism about the stock.""}, {""date"": ""2023-12-20"", ""headline"": ""DexCom's (NASDAQ:DXCM) Returns On Capital Are Heading Higher"", ""summary"": ""What are the early trends we should look for to identify a stock that could multiply in value over the long term...""}, {""date"": ""2023-12-20"", ""headline"": ""DexCom's Options Frenzy: What You Need to Know"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-20"", ""headline"": ""Video: Nasdaq 100 Movers: DXCM, SIRI"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-20"", ""headline"": ""Unveiling DexCom (DXCM)'s Value: Is It Really Priced Right? A Comprehensive Guide"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-21"", ""headline"": ""DexCom Inc. stock rises Thursday, outperforms market"", ""summary"": ""Shares of DexCom Inc. rallied 5.28% to $122.80 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-12-21"", ""headline"": ""Becton Dickinson & Co. stock rises Thursday, outperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. rose 1.38% to $243.13 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the...""}, {""date"": ""2023-12-22"", ""headline"": ""DexCom (DXCM) Stock Falls Amid Market Uptick: What Investors Need to Know"", ""summary"": ""In the closing of the recent trading day, DexCom (DXCM) stood at $122.17, denoting a -0.51% change from the preceding trading day.""}, {""date"": ""2023-12-22"", ""headline"": ""3 Reasons Why Growth Investors Shouldn't Overlook DexCom (DXCM)"", ""summary"": ""DexCom (DXCM) is well positioned to outperform the market, as it exhibits above-average growth in financials.""}, {""date"": ""2023-12-22"", ""headline"": ""DexCom Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of DexCom Inc. slumped 0.51% to $122.17 Friday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2023-12-22"", ""headline"": ""Becton Dickinson & Co. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Becton Dickinson & Co. dropped 0.05% to $243.00 Friday, on what proved to be an all-around mixed trading session for the stock market, with the S&P...""}, {""date"": ""2023-12-22"", ""headline"": ""Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio"", ""summary"": ""The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.""}]",{}
50,2023-12-24,122.16999816894531,2023-12-31,124.08999633789062,0.015715791092099307,U2,"[{""date"": ""2023-12-26"", ""headline"": ""3 Medical-Device Stocks Could Click in 2024"", ""summary"": ""Baird is bullish on Boston Scientific, Insulet, and DexCom, stocks set to benefit as those companies ramp up sales.""}, {""date"": ""2023-12-26"", ""headline"": ""DexCom Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of DexCom Inc. advanced 1.13% to $123.55 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""2023-12-26"", ""headline"": ""Becton Dickinson & Co. stock rises Tuesday, still underperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. inched 0.12% higher to $243.30 Tuesday, on what proved to be an all-around great trading session for the stock market, with...""}, {""date"": ""2023-12-26"", ""headline"": ""5 MedTech Stocks Poised to Continue Their Winning Streaks in 2024"", ""summary"": ""Stocks like DexCom Inc. (DXCM), Integer Holdings (ITGR), Penumbra (PEN), Haemonetics (HAE), Health Equity (HAE) and are likely to continue their strong performance in 2024.""}, {""date"": ""2023-12-26"", ""headline"": ""Calculating The Fair Value Of DexCom, Inc. (NASDAQ:DXCM)"", ""summary"": ""Key Insights Using the 2 Stage Free Cash Flow to Equity, DexCom fair value estimate is US$117 Current share price of...""}, {""date"": ""2023-12-26"", ""headline"": ""September 2024 Options Now Available For DexCom (DXCM)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-27"", ""headline"": ""DexCom Inc. stock underperforms Thursday when compared to competitors despite daily gains"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-27"", ""headline"": ""DexCom Inc. stock underperforms Wednesday when compared to competitors despite daily gains"", ""summary"": ""Shares of DexCom Inc. inched 0.15% higher to $123.73 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""2023-12-27"", ""headline"": ""Becton Dickinson & Co. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Becton Dickinson & Co. shed 0.33% to $242.50 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""2023-12-28"", ""headline"": ""DexCom Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-29"", ""headline"": ""DexCom (DXCM) Stock Moves -0.06%: What You Should Know"", ""summary"": ""The latest trading day saw DexCom (DXCM) settling at $124.09, representing a -0.06% change from its previous close.""}, {""date"": ""2023-12-30"", ""headline"": ""BTIG Remains a Buy on Dexcom (DXCM)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
51,2023-12-31,124.08999633789062,2024-01-07,123.9800033569336,-0.0008863968426393587,D1,"[{""date"": ""2023-12-30"", ""headline"": ""BTIG Remains a Buy on Dexcom (DXCM)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-01"", ""headline"": ""Analysts and Technical Indicators Agree: These 3 Stocks Are \u201cStrong Buys\u201d \u2013 1/2/2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-01"", ""headline"": ""Analysts and Technical Indicators Agree: These 3 Stocks Are \u201cStrong Buys\u201d \u2013 1/2/2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-01"", ""headline"": ""DexCom Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-02"", ""headline"": ""DexCom Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of DexCom Inc. dropped 0.81% to $123.09 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2024-01-02"", ""headline"": ""Becton Dickinson & Co. stock rises Tuesday, outperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. inched 0.65% higher to $245.42 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with...""}, {""date"": ""2024-01-02"", ""headline"": ""Dexcom (DXCM) Gets a Buy from BTIG"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-03"", ""headline"": ""DexCom Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of DexCom Inc. shed 2.29% to $120.27 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2024-01-03"", ""headline"": ""Becton Dickinson & Co. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. shed 2.02% to $240.47 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P...""}, {""date"": ""2024-01-03"", ""headline"": ""If You Invested $1000 in DexCom a Decade Ago, This is How Much It'd Be Worth Now"", ""summary"": ""Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.""}, {""date"": ""2024-01-03"", ""headline"": ""The Latest Analyst Ratings For DexCom"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-03"", ""headline"": ""Investors in DexCom (NASDAQ:DXCM) have seen impressive returns of 255% over the past five years"", ""summary"": ""When you buy a stock there is always a possibility that it could drop 100%. But on a lighter note, a good company can...""}, {""date"": ""2024-01-03"", ""headline"": ""1 Stock-Split Stock to Buy Hand Over Fist in 2024 and 1 to Avoid"", ""summary"": ""Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there's a historically cheap outperformer that's ripe for the picking, as well as an industry leader headed for a breakdown.""}, {""date"": ""2024-01-03"", ""headline"": ""DexCom price target raised by $25 at BTIG, here's why"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-04"", ""headline"": ""DexCom Inc. stock underperforms Thursday when compared to competitors despite daily gains"", ""summary"": ""Shares of DexCom Inc. rose 1.30% to $121.83 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2024-01-04"", ""headline"": ""Becton Dickinson & Co. stock rises Thursday, outperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. rallied 1.01% to $242.91 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""2024-01-05"", ""headline"": ""DexCom (DXCM) Exceeds Market Returns: Some Facts to Consider"", ""summary"": ""DexCom (DXCM) closed at $123.98 in the latest trading session, marking a +1.76% move from the prior day.""}, {""date"": ""2024-01-05"", ""headline"": ""DexCom Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of DexCom Inc. advanced 1.76% to $123.98 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""2024-01-05"", ""headline"": ""Becton Dickinson & Co. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Becton Dickinson & Co. dropped 0.34% to $242.09 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P...""}, {""date"": ""2024-01-05"", ""headline"": ""Should You Exit DexCom (DXCM)?"", ""summary"": ""ClearBridge Investments, an investment management company, released its \u201cClearBridge Large Cap Growth Strategy\u201d fourth quarter 2023 investor letter. A copy of the same can be downloaded here. For both the quarter and the whole year, the Strategy exceeded the benchmark, the Russell 1000 Growth Index, supported by robust Magnificent Seven stock selection, opportunistic management of earnings [\u2026]""}, {""date"": ""2024-01-07"", ""headline"": ""J.P. Morgan event in spotlight as biotech M&A, obesity frenzy, AI pick up"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-07"", ""headline"": ""Possible Bearish Signals With DexCom Insiders Disposing Stock"", ""summary"": ""Many DexCom, Inc. ( NASDAQ:DXCM ) insiders ditched their stock over the past year, which may be of interest to the...""}, {""date"": ""2024-01-07"", ""headline"": ""ClearBridge Large Cap Growth Strategy Q4 2023 Portfolio Manager Commentary"", ""summary"": ""The ClearBridge Large Cap Growth Strategy outperformed its benchmark in the fourth quarter of 2023. Click here to read the full fund letter.""}]",{}
52,2024-01-07,123.9800033569336,2024-01-14,125.0,0.00822710610944144,U1,"[{""date"": ""2024-01-07"", ""headline"": ""J.P. Morgan event in spotlight as biotech M&A, obesity frenzy, AI pick up"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-07"", ""headline"": ""Possible Bearish Signals With DexCom Insiders Disposing Stock"", ""summary"": ""Many DexCom, Inc. ( NASDAQ:DXCM ) insiders ditched their stock over the past year, which may be of interest to the...""}, {""date"": ""2024-01-07"", ""headline"": ""ClearBridge Large Cap Growth Strategy Q4 2023 Portfolio Manager Commentary"", ""summary"": ""The ClearBridge Large Cap Growth Strategy outperformed its benchmark in the fourth quarter of 2023. Click here to read the full fund letter.""}, {""date"": ""2024-01-08"", ""headline"": ""Dexcom\u2019s Strong Q4 Performance and Promising Outlook Merit a Buy Rating"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""3 Stocks to Capitalize on the Telehealth Explosion"", ""summary"": ""The COVID-19 pandemic highlighted the sometimes fragile nature of the American healthcare system. Many people had to delay elective surgeries and forego other treatments for an extended period. Others were scared of going to a clinic for fear of exposure to the virus. This crisis showed us the value of telehealth stocks. Thanks to the rise in broadband internet and high-quality video calls, it can now host doctors\u2019 visits online. While telemedicine isn\u2019t always the solution, sometimes a remote c""}, {""date"": ""2024-01-08"", ""headline"": ""Dexcom's Recent 66% Run Continues With A Breakout On Bullish Fourth-Quarter Sales"", ""summary"": ""Dexcom stock broke out Monday after the diabetes devices maker whipped fourth-quarter expectations and announced a new CGM due this summer.""}, {""date"": ""2024-01-08"", ""headline"": ""DexCom Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of DexCom Inc. rallied 4.56% to $129.63 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""2024-01-08"", ""headline"": ""Here's Why DexCom (DXCM) is a Strong Growth Stock"", ""summary"": ""Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.""}, {""date"": ""2024-01-08"", ""headline"": ""Glucose Monitor Maker Rallies On Higher 2024 Outlook"", ""summary"": ""Dexcom increased its full-year revenue outlook to a range of $3.575 billion-$3.6 billion, indicating growth of 23%-24%.""}, {""date"": ""2024-01-08"", ""headline"": ""Wearable Technology Market Gains Ground, 3 Stocks in Focus"", ""summary"": ""In the wearable medical devices industry, investors can keep a keen eye on stocks such as ABT, MDT and DXCM.""}, {""date"": ""2024-01-08"", ""headline"": ""Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2023 and Initial 2024 Outlook"", ""summary"": ""SAN DIEGO, January 08, 2024--Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2023 and Initial 2024 Outlook""}, {""date"": ""2024-01-08"", ""headline"": ""Dexcom stock rises 4% on preliminary Q4 results, 2024 forecast"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""A Closer Look at DexCom's Options Market Dynamics"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""IN BRIEF: DexCom sets optimistic 2024 outlook following strong year"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""DexCom sees FY24 revenue $4.15B-$4.35B, consensus $4.32B"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""DexCom sees FY23 revenue $3.62B, consensus $3.59B"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""DexCom reports preliminary Q4 revenue $1.03B, consensus $1.01B"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-09"", ""headline"": ""DexCom Inc. stock rises Tuesday, outperforms market"", ""summary"": ""Shares of DexCom Inc. inched 0.05% higher to $129.70 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...""}, {""date"": ""2024-01-09"", ""headline"": ""Becton Dickinson & Co. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. shed 3.99% to $237.84 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P...""}, {""date"": ""2024-01-09"", ""headline"": ""DexCom (DXCM) Preliminary Q4 Revenues Ride on Sensor Demand"", ""summary"": ""DexCom's (DXCM) revenue growth in the fourth quarter is likely to have been boosted by strong demand for its CGM sensors across the globe. It delivers robust revenue guidance for 2024.""}, {""date"": ""2024-01-09"", ""headline"": ""2 Growth Stocks That Could Make You Richer in 2024 and Beyond"", ""summary"": ""Last year wasn't great for either stock, but that's no reason to ignore them.""}, {""date"": ""2024-01-09"", ""headline"": ""Dexcom plans to launch new CGM this summer for people who don\u2019t take insulin"", ""summary"": ""The company also shared earnings expectations for 2024 at the J.P. Morgan Healthcare Conference.""}, {""date"": ""2024-01-09"", ""headline"": ""Analysts Are Bullish on Top Healthcare Stocks: Regeneron (REGN), Dexcom (DXCM)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-09"", ""headline"": ""Analysts Are Bullish on These Healthcare Stocks: Dexcom (DXCM), Evolent Health (EVH)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-10"", ""headline"": ""DexCom Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of DexCom Inc. slipped 1.31% to $128.00 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""2024-01-10"", ""headline"": ""Becton Dickinson & Co. stock rises Wednesday, still underperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. inched 0.24% higher to $238.41 Wednesday, on what proved to be an all-around positive trading session for the stock market,...""}, {""date"": ""2024-01-11"", ""headline"": ""DexCom (DXCM) Gains As Market Dips: What You Should Know"", ""summary"": ""The latest trading day saw DexCom (DXCM) settling at $128.93, representing a +0.73% change from its previous close.""}, {""date"": ""2024-01-11"", ""headline"": ""DexCom Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of DexCom Inc. inched 0.73% higher to $128.93 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...""}, {""date"": ""2024-01-11"", ""headline"": ""Becton Dickinson & Co. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Becton Dickinson & Co. slid 1.43% to $235.01 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...""}, {""date"": ""2024-01-11"", ""headline"": ""Dexcom\u2019s Strong Market Position and Promising Financial Outlook Justify Buy Rating"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Dexcom\u2019s Strong Financial Outlook and Promising Product Pipeline Merit a Buy Rating"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""DexCom price target raised by $9 at Wells Fargo, here's why"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-12"", ""headline"": ""DexCom Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of DexCom Inc. slipped 3.05% to $125.00 Friday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2024-01-12"", ""headline"": ""Becton Dickinson & Co. stock outperforms market on strong trading day"", ""summary"": ""Shares of Becton Dickinson & Co. inched 0.54% higher to $236.27 Friday, on what proved to be an all-around mixed trading session for the stock market, with...""}, {""date"": ""2024-01-12"", ""headline"": ""Q2 2023 Dexcom Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-12"", ""headline"": ""Q1 2023 Dexcom Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-12"", ""headline"": ""Q4 2022 Dexcom Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-12"", ""headline"": ""Q3 2022 Dexcom Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-12"", ""headline"": ""Q2 2022 Dexcom Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-12"", ""headline"": ""Q1 2022 Dexcom Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-12"", ""headline"": ""Q4 2021 Dexcom Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-12"", ""headline"": ""Q3 2021 Dexcom Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-12"", ""headline"": ""Q2 2021 Dexcom Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-12"", ""headline"": ""Q1 2021 Dexcom Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-12"", ""headline"": ""Q4 2020 DexCom Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-12"", ""headline"": ""Q3 2020 DexCom Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-12"", ""headline"": ""Q2 2020 DexCom Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-12"", ""headline"": ""Q1 2020 DexCom Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-12"", ""headline"": ""Q4 2019 DexCom Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-12"", ""headline"": ""Q3 2019 DexCom Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-12"", ""headline"": ""Q2 2019 DexCom Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-12"", ""headline"": ""Q1 2019 DexCom Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-12"", ""headline"": ""Q4 2018 DexCom Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-12"", ""headline"": ""Q3 2023 Dexcom Inc Earnings Call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-13"", ""headline"": ""Can DexCom, Inc. (NASDAQ:DXCM) Maintain Its Strong Returns?"", ""summary"": ""Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...""}, {""date"": ""2024-01-14"", ""headline"": ""The 3 Best Growth Stocks to Buy in January 2024"", ""summary"": ""Growth stocks are the best way to compound your portfolio. After all, growth has outperformed value since 2010 by a huge margin. This article highlights some of the best growth stocks to buy now. Picking growth stocks requires a new approach in this environment. Over the past decade, interest rates were near zero and even negative in Europe. However, there has been a drastic change due to higher inflation and the era of easy money is over. Analysts at RBC Wealth Management expect interest rates""}, {""date"": ""2024-01-14"", ""headline"": ""ClearBridge Large Cap Growth ESG Strategy Q4 2023 Portfolio Manager Commentary"", ""summary"": ""The ClearBridge Large Cap Growth ESG Strategy outperformed its benchmark in Q4 2023. Click here to read the full fund letter.""}, {""date"": ""2024-01-14"", ""headline"": ""Esperion Is Sitting On A Potential Blockbuster Drug"", ""summary"": ""Esperion has a potential blockbuster drug that is gaining traction among the medical community. Learn why I rate ESPR stock a strong buy.""}]",{}
53,2024-01-14,125.0,2024-01-21,125.44999694824219,0.0035999755859374982,U1,"[{""date"": ""2024-01-14"", ""headline"": ""A Powerful Alliance : Dexcom G7 Now Connects to Tandem t"", ""summary"": ""With more than 10 years of pioneering CGM market leadership in AID integration, Dexcom is the most clinically studied\u2021\u2021 CGM brand with AID capabilities and the clear choice for powering AID...""}, {""date"": ""2024-01-14"", ""headline"": ""Market Today: Medtech Stocks Surge as Baird Highlights Sector Strength"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-14"", ""headline"": ""Baird bullish on medtech in 2024, but sees weakness in dental market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-14"", ""headline"": ""The 3 Best Growth Stocks to Buy in January 2024"", ""summary"": ""Growth stocks are the best way to compound your portfolio. After all, growth has outperformed value since 2010 by a huge margin. This article highlights some of the best growth stocks to buy now. Picking growth stocks requires a new approach in this environment. Over the past decade, interest rates were near zero and even negative in Europe. However, there has been a drastic change due to higher inflation and the era of easy money is over. Analysts at RBC Wealth Management expect interest rates""}, {""date"": ""2024-01-14"", ""headline"": ""ClearBridge Large Cap Growth ESG Strategy Q4 2023 Portfolio Manager Commentary"", ""summary"": ""The ClearBridge Large Cap Growth ESG Strategy outperformed its benchmark in Q4 2023. Click here to read the full fund letter.""}, {""date"": ""2024-01-14"", ""headline"": ""Esperion Is Sitting On A Potential Blockbuster Drug"", ""summary"": ""Esperion has a potential blockbuster drug that is gaining traction among the medical community. Learn why I rate ESPR stock a strong buy.""}, {""date"": ""2024-01-15"", ""headline"": ""A Powerful Alliance: Dexcom G7 Now Connects to Tandem t:slim X2"", ""summary"": ""EDINBURGH, Scotland, January 15, 2024--DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, announced today the Dexcom G7 Continuous Glucose Monitoring (CGM) System now connects with the t:slim X2\u2122 insulin pump by Tandem Diabetes Care in countries across Europe and in South Africa. The announcement comes just a month after the system launched in the United States and combines the power and accuracy of Dexcom G7 with the discretion of t""}, {""date"": ""2024-01-16"", ""headline"": ""3 Mid-Cap Stocks Poised for a Breakout in 2024"", ""summary"": ""Important voices in the investment world predict that 2024 could be a very strong year for mid-cap stocks. Janus Henderson portfolio manager Brian Demain believes the outlook for mid caps looks favorable as rate hikes slow and cuts draw nearer. Demain also anticipates that they could perform very well due to their relative underperformance to large cap stocks in 2023. Other prominent investors including Fundstrat head Tom Lee also expect large cap stocks to become less important. So, mid-cap equ""}, {""date"": ""2024-01-16"", ""headline"": ""DexCom Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of DexCom Inc. slid 0.43% to $124.46 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2024-01-16"", ""headline"": ""Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Becton Dickinson & Co. shed 0.54% to $235.00 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P...""}, {""date"": ""2024-01-16"", ""headline"": ""Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick"", ""summary"": ""The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.""}, {""date"": ""2024-01-16"", ""headline"": ""Charts turn bullish on health-care stocks as sector takes early lead in 2024"", ""summary"": ""Health-care stocks are off to a strong start in 2024, and Wall Street analysts are taking notice.""}, {""date"": ""2024-01-16"", ""headline"": ""A Powerful Alliance Dexcom G7 Now Connects to Tandem t : slim X2"", ""summary"": ""EDINBURGH, Scotland - DexCom, Inc. , a global leader in real-time continuous glucose monitoring for people with diabetes, announced today the Dexcom G7 Continuous Glucose Monitoring System now...""}, {""date"": ""2024-01-17"", ""headline"": ""DexCom (DXCM) Advances While Market Declines: Some Information for Investors"", ""summary"": ""DexCom (DXCM) closed the most recent trading day at $125.45, moving +0.8% from the previous trading session.""}, {""date"": ""2024-01-17"", ""headline"": ""Why DexCom (DXCM) Could Beat Earnings Estimates Again"", ""summary"": ""DexCom (DXCM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.""}, {""date"": ""2024-01-17"", ""headline"": ""DexCom Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of DexCom Inc. inched 0.80% higher to $125.45 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P...""}, {""date"": ""2024-01-17"", ""headline"": ""Becton Dickinson & Co. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Becton Dickinson & Co. sank 0.30% to $234.30 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P...""}, {""date"": ""2024-01-17"", ""headline"": ""Why Investors Need to Take Advantage of These 2 Medical Stocks Now"", ""summary"": ""Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.""}, {""date"": ""2024-01-17"", ""headline"": ""DexCom: Stelo Stellar Outlook"", ""summary"": ""DexCom might not be the flashiest stock, but its focus on long-term growth and responsible expansion is music to any value investor's ears. Learn more about the risk DXCM stock carries.""}, {""date"": ""2024-01-18"", ""headline"": ""DexCom breaks ground on new manufacturing facility in Ireland"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-18"", ""headline"": ""DexCom, Inc. Breaks Ground on New Manufacturing Facility in Ireland"", ""summary"": ""DexCom, Inc. officially broken ground on its new manufacturing facility, located in Athenry Co. Galway. This marks the first step in the realisation of this facility, which will bring more than 1,000...""}, {""date"": ""2024-01-18"", ""headline"": ""DexCom Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of DexCom Inc. rallied 1.59% to $127.45 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""2024-01-18"", ""headline"": ""Becton Dickinson & Co. stock rises Thursday, still underperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. inched 0.30% higher to $235.00 Thursday, on what proved to be an all-around positive trading session for the stock market,...""}, {""date"": ""2024-01-18"", ""headline"": ""DexCom (DXCM) Crossed Above the 20-Day Moving Average: What That Means for Investors"", ""summary"": ""Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?""}, {""date"": ""2024-01-18"", ""headline"": ""DexCom's (DXCM) G7 Links With Tandem's Insulin Pump in Europe"", ""summary"": ""Dexcom's (DXCM) G7 integrates with Tandem's t:slim X2, revolutionizing diabetes care. A perfect combination of accuracy and innovation, this synergy sets a new standard in continuous glucose monitoring.""}, {""date"": ""2024-01-18"", ""headline"": ""EVP Chief Human Resources Sadie Stern Sells Shares of DexCom Inc"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-18"", ""headline"": ""Is DexCom, Inc. (NASDAQ:DXCM) Potentially Undervalued?"", ""summary"": ""DexCom, Inc. ( NASDAQ:DXCM ) received a lot of attention from a substantial price increase on the NASDAQGS over the...""}, {""date"": ""2024-01-19"", ""headline"": ""DexCom Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of DexCom Inc. dropped 0.13% to $127.29 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""2024-01-19"", ""headline"": ""Becton Dickinson & Co. stock rises Friday, still underperforms market"", ""summary"": ""Shares of Becton Dickinson & Co. inched 0.38% higher to $235.89 Friday, on what proved to be an all-around great trading session for the stock market, with...""}, {""date"": ""2024-01-19"", ""headline"": ""Reasons to Retain DexCom (DXCM) Stock in Your Portfolio for Now"", ""summary"": ""DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.""}, {""date"": ""2024-01-19"", ""headline"": ""Dexcom Secures Future in Europe, Middle East, and Africa by Breaking Ground on New Manufacturing Facility in Ireland"", ""summary"": ""GALWAY, Ireland, January 19, 2024--DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, has officially broken ground on its new state-of-the-art manufacturing facility, located in Athenry, Co. Galway. This marks the first step in the realisation of this facility, which will bring more than 1,000 jobs to the area and represents one of the biggest single private sector investments ever in the West of Ireland.""}, {""date"": ""2024-01-20"", ""headline"": ""Baron Health Care Fund Q4 2023 Shareholder Letter"", ""summary"": ""For Q4 2023, Baron Health Care Fund advanced 7.69% (Institutional Shares) vs. a 6.96% gain for the Russell 3000 Health Care Index. Click here to read the full fund letter.""}, {""date"": ""2024-01-20"", ""headline"": ""indie Semiconductor: 50 Top Growth Stocks, These 3 Worth Considering"", ""summary"": ""indie Semiconductor considering it\u00e2\u0080\u0099s benefiting from a massive secular trend, but has sold off hard this year. Explore more details here.""}]",{}
